<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":3.639467,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpaCAEOClwEHR9SSkYMVgoHEkkZTAJfXVscVwVUU09QAFRQAwIXVBBZCg==","queueTime":0,"ttGuid":"6956735b6c8c7746"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full">
<meta property="description" name="description" content="Esophageal squamous cell cancer (ESCC) is the eighth most common cancer around the world. Several reports have focused on somatic mutations and common germli...">
<meta property="og:title" name="title" content="Frontiers | Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer">
<meta property="og:description" name="description" content="Esophageal squamous cell cancer (ESCC) is the eighth most common cancer around the world. Several reports have focused on somatic mutations and common germli...">
<meta name="keywords" content="Esophageal squamous cell cancer,Cancer susceptibility gene,Double-hit,germline mutation,pathogenicity">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="11">
<meta name="citation_journal_title" content="Frontiers in Oncology">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Oncol.">
<meta name="citation_issn" content="2234-943X">
<meta name="citation_doi" content="10.3389/fonc.2021.637431">
<meta name="citation_firstpage" content="637431">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer">
<meta name="citation_keywords" content="Esophageal squamous cell cancer; Cancer susceptibility gene; Double-hit; germline mutation; pathogenicity">
<meta name="citation_abstract" content="Esophageal squamous cell cancer (ESCC) is the eighth most common cancer around the world. Several reports have focused on somatic mutations and common germline mutations in ESCC. However, the contributions of pathogenic germline alterations in cancer susceptibility genes (CSGs), highly frequently mutated CSGs, and pathogenically mutated CSG-related pathways in ESCC remain unclear. We obtained data on 571 ESCC cases from public databases and East Asian from the 1000 Genomes Project database and the China Metabolic Analytics Project database to characterize pathogenic mutations. We detected 157 mutations in 75 CSGs, accounting for 25.0% (143/571) of ESCC cases. Six genes had more than five mutations: TP53 (n = 15 mutations), GJB2 (n = 8), BRCA2 (n = 6), RECQL4 (n = 6), MUTYH (n = 6), and PMS2 (n = 5). Our results identified significant differences in pathogenic germline mutations of TP53, BRCA2, and RECQL4 between the ESCC and control cohorts. Moreover, we identified 84 double-hit events (16 germline/somatic double-hit events and 68 somatic/somatic double-hit events) occurring in 18 tumor suppressor genes from 83 patients. Patients who had ESCC with germline/somatic double-hit events were diagnosed at younger ages than patients with the somatic/somatic double-hit events, although the correlation was not significant. Fanconi anemia was the most enriched pathway of pathogenically mutated CSGs, and it appeared to be a primary pathway for ESCC predisposition. The results of this study identified the underlying roles that pathogenic germline mutations in CSGs play in ESCC pathogenesis; increased our awareness about the genetic basis of ESCC; and provided suggestions for using highly mutated CSGs and double-hit features in the early discovery, prevention, and genetic counseling of ESCC.">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2021/02/10">
<meta name="citation_publication_date" content="2021/04/06">
<meta name="citation_author" content="Zeng, Bing ">
<meta name="citation_author_institution" content="BGI Education Center, University of Chinese Academy of Sciences, China">
<meta name="citation_author" content="Huang, Peide ">
<meta name="citation_author_institution" content="BGI-Shenzhen, China">
<meta name="citation_author" content="Du, Peina ">
<meta name="citation_author_institution" content="BGI Genomics, China">
<meta name="citation_author" content="Sun, Xiaohui ">
<meta name="citation_author_institution" content="BGI Genomics, China">
<meta name="citation_author" content="Huang, Xuanlin ">
<meta name="citation_author_institution" content="BGI-Shenzhen, China">
<meta name="citation_author" content="Fang, Xiaodong ">
<meta name="citation_author_institution" content="BGI Education Center, University of Chinese Academy of Sciences, China">
<meta name="citation_author" content="Li, Lin ">
<meta name="citation_author_institution" content="BGI-Shenzhen, China">
<meta name="dc.identifier" content="doi:10.3389/fonc.2021.637431">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer","author":[{"@type":"Person","name":"Bing Zeng","affiliation":["BGI Education Center, University of Chinese Academy of Sciences, China","BGI-Shenzhen, China"]},{"@type":"Person","name":"Peide Huang","affiliation":["BGI-Shenzhen, China"]},{"@type":"Person","name":"Peina Du","affiliation":["BGI Genomics, China"]},{"@type":"Person","name":"Xiaohui Sun","affiliation":["BGI Genomics, China"]},{"@type":"Person","name":"Xuanlin Huang","affiliation":["BGI-Shenzhen, China"]},{"@type":"Person","name":"Xiaodong Fang","affiliation":["BGI Education Center, University of Chinese Academy of Sciences, China","BGI-Shenzhen, China","China National GeneBank, BGI-Shenzhen, China"]},{"@type":"Person","name":"Lin Li","affiliation":["BGI-Shenzhen, China"]}],"datePublished":"2021-04-06","dateModified":"2025-11-25","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2021","isPartOf":{"@type":"PublicationVolume","volumeNumber":"11","isPartOf":{"@type":"Periodical","name":"Frontiers in Oncology"}}},"citation":["https://doi.org/10.3389/fonc.2021.637431"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="purple"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/oncology" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Oncology</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=57&amp;specialtyid=0&amp;entitytype=2&amp;entityid=451" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/oncology" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Oncology</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/breast-cancer" data-event="iBarJournal-sections-a_id_500">Breast Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-cell-signaling" data-event="iBarJournal-sections-a_id_2606">Cancer Cell Signaling</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-epidemiology-and-prevention" data-event="iBarJournal-sections-a_id_513">Cancer Epidemiology and Prevention</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-genetics" data-event="iBarJournal-sections-a_id_506">Cancer Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-imaging-and-image-directed-interventions" data-event="iBarJournal-sections-a_id_515">Cancer Imaging and Image-directed Interventions</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-immunity-and-immunotherapy" data-event="iBarJournal-sections-a_id_527">Cancer Immunity and Immunotherapy</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-metabolism" data-event="iBarJournal-sections-a_id_1510">Cancer Metabolism</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-molecular-targets-and-therapeutics" data-event="iBarJournal-sections-a_id_507">Cancer Molecular Targets and Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cardio-oncology" data-event="iBarJournal-sections-a_id_1513">Cardio-Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-colorectal-cancer" data-event="iBarJournal-sections-a_id_2413">Gastrointestinal Cancers: Colorectal Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-gastric-and-esophageal-cancers" data-event="iBarJournal-sections-a_id_2415">Gastrointestinal Cancers: Gastric and Esophageal Cancers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-hepato-pancreatic-biliary-cancers" data-event="iBarJournal-sections-a_id_2414">Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/genitourinary-oncology" data-event="iBarJournal-sections-a_id_503">Genitourinary Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gynecological-oncology" data-event="iBarJournal-sections-a_id_2079">Gynecological Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/head-and-neck-cancer" data-event="iBarJournal-sections-a_id_517">Head and Neck Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/hematologic-malignancies" data-event="iBarJournal-sections-a_id_505">Hematologic Malignancies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/molecular-and-cellular-oncology" data-event="iBarJournal-sections-a_id_508">Molecular and Cellular Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/neuro-oncology-and-neurosurgical-oncology" data-event="iBarJournal-sections-a_id_150">Neuro-Oncology and Neurosurgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/pediatric-oncology" data-event="iBarJournal-sections-a_id_509">Pediatric Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/pharmacology-of-anti-cancer-drugs" data-event="iBarJournal-sections-a_id_192">Pharmacology of Anti-Cancer Drugs</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/radiation-oncology" data-event="iBarJournal-sections-a_id_511">Radiation Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/skin-cancer" data-event="iBarJournal-sections-a_id_1630">Skin Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/surgical-oncology" data-event="iBarJournal-sections-a_id_512">Surgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/thoracic-oncology" data-event="iBarJournal-sections-a_id_502">Thoracic Oncology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIR Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=57&amp;specialtyid=0&amp;entitytype=2&amp;entityid=451" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/oncology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Oncology</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/breast-cancer" data-event="iBarJournal-sections-a_id_500">Breast Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-cell-signaling" data-event="iBarJournal-sections-a_id_2606">Cancer Cell Signaling</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-epidemiology-and-prevention" data-event="iBarJournal-sections-a_id_513">Cancer Epidemiology and Prevention</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-genetics" data-event="iBarJournal-sections-a_id_506">Cancer Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-imaging-and-image-directed-interventions" data-event="iBarJournal-sections-a_id_515">Cancer Imaging and Image-directed Interventions</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-immunity-and-immunotherapy" data-event="iBarJournal-sections-a_id_527">Cancer Immunity and Immunotherapy</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-metabolism" data-event="iBarJournal-sections-a_id_1510">Cancer Metabolism</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-molecular-targets-and-therapeutics" data-event="iBarJournal-sections-a_id_507">Cancer Molecular Targets and Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cardio-oncology" data-event="iBarJournal-sections-a_id_1513">Cardio-Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-colorectal-cancer" data-event="iBarJournal-sections-a_id_2413">Gastrointestinal Cancers: Colorectal Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-gastric-and-esophageal-cancers" data-event="iBarJournal-sections-a_id_2415">Gastrointestinal Cancers: Gastric and Esophageal Cancers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-hepato-pancreatic-biliary-cancers" data-event="iBarJournal-sections-a_id_2414">Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/genitourinary-oncology" data-event="iBarJournal-sections-a_id_503">Genitourinary Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gynecological-oncology" data-event="iBarJournal-sections-a_id_2079">Gynecological Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/head-and-neck-cancer" data-event="iBarJournal-sections-a_id_517">Head and Neck Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/hematologic-malignancies" data-event="iBarJournal-sections-a_id_505">Hematologic Malignancies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/molecular-and-cellular-oncology" data-event="iBarJournal-sections-a_id_508">Molecular and Cellular Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/neuro-oncology-and-neurosurgical-oncology" data-event="iBarJournal-sections-a_id_150">Neuro-Oncology and Neurosurgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/pediatric-oncology" data-event="iBarJournal-sections-a_id_509">Pediatric Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/pharmacology-of-anti-cancer-drugs" data-event="iBarJournal-sections-a_id_192">Pharmacology of Anti-Cancer Drugs</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/radiation-oncology" data-event="iBarJournal-sections-a_id_511">Radiation Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/skin-cancer" data-event="iBarJournal-sections-a_id_1630">Skin Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/surgical-oncology" data-event="iBarJournal-sections-a_id_512">Surgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/thoracic-oncology" data-event="iBarJournal-sections-a_id_502">Thoracic Oncology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/oncology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Oncology</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/breast-cancer" data-event="iBarJournal-sections-a_id_500">Breast Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-cell-signaling" data-event="iBarJournal-sections-a_id_2606">Cancer Cell Signaling</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-epidemiology-and-prevention" data-event="iBarJournal-sections-a_id_513">Cancer Epidemiology and Prevention</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-genetics" data-event="iBarJournal-sections-a_id_506">Cancer Genetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-imaging-and-image-directed-interventions" data-event="iBarJournal-sections-a_id_515">Cancer Imaging and Image-directed Interventions</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-immunity-and-immunotherapy" data-event="iBarJournal-sections-a_id_527">Cancer Immunity and Immunotherapy</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-metabolism" data-event="iBarJournal-sections-a_id_1510">Cancer Metabolism</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cancer-molecular-targets-and-therapeutics" data-event="iBarJournal-sections-a_id_507">Cancer Molecular Targets and Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/cardio-oncology" data-event="iBarJournal-sections-a_id_1513">Cardio-Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-colorectal-cancer" data-event="iBarJournal-sections-a_id_2413">Gastrointestinal Cancers: Colorectal Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-gastric-and-esophageal-cancers" data-event="iBarJournal-sections-a_id_2415">Gastrointestinal Cancers: Gastric and Esophageal Cancers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gastrointestinal-cancers-hepato-pancreatic-biliary-cancers" data-event="iBarJournal-sections-a_id_2414">Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/genitourinary-oncology" data-event="iBarJournal-sections-a_id_503">Genitourinary Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/gynecological-oncology" data-event="iBarJournal-sections-a_id_2079">Gynecological Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/head-and-neck-cancer" data-event="iBarJournal-sections-a_id_517">Head and Neck Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/hematologic-malignancies" data-event="iBarJournal-sections-a_id_505">Hematologic Malignancies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/molecular-and-cellular-oncology" data-event="iBarJournal-sections-a_id_508">Molecular and Cellular Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/neuro-oncology-and-neurosurgical-oncology" data-event="iBarJournal-sections-a_id_150">Neuro-Oncology and Neurosurgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/pediatric-oncology" data-event="iBarJournal-sections-a_id_509">Pediatric Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/pharmacology-of-anti-cancer-drugs" data-event="iBarJournal-sections-a_id_192">Pharmacology of Anti-Cancer Drugs</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/radiation-oncology" data-event="iBarJournal-sections-a_id_511">Radiation Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/skin-cancer" data-event="iBarJournal-sections-a_id_1630">Skin Cancer</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/surgical-oncology" data-event="iBarJournal-sections-a_id_512">Surgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/oncology/sections/thoracic-oncology" data-event="iBarJournal-sections-a_id_502">Thoracic Oncology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/oncology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/oncology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=57&amp;specialtyid=0&amp;entitytype=2&amp;entityid=451" data-event="iBarJournal-a-submit"><span>Submit</span><span>your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Oncol.</span><span>, 06 April 2021</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Gastrointestinal Cancers</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 11 - 2021 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fonc.2021.637431">https://doi.org/10.3389/fonc.2021.637431</a></p><!----></div><!----><!----></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract">
<a id="h1" name="h1"></a>
<div class="authors"><span class="author-wrapper notranslate">
<a href="https://loop.frontiersin.org/people/930874" class="user-id-930874"><img class="pr5" src="https://loop.frontiersin.org/images/profile/930874/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="
Bing Zeng,">Bing Zeng</a><sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Peide Huang" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Peide Huang<sup>2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Peina Du" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Peina Du<sup>3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Xiaohui Sun" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Xiaohui Sun<sup>3</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Xuanlin Huang" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Xuanlin Huang<sup>2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Xiaodong Fang,,&#xA;" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Xiaodong Fang<sup>1,2,4</sup><sup>&#x0002A;</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Lin Li&#xA;" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Lin Li<sup>2</sup><sup>&#x0002A;</sup></span></div>
<ul class="notes">
<li><span><sup>1</sup></span>BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China</li>
<li><span><sup>2</sup></span>BGI-Shenzhen, Shenzhen, China</li>
<li><span><sup>3</sup></span>BGI Genomics, BGI-Shenzhen, Shenzhen, China</li>
<li><span><sup>4</sup></span>China National GeneBank, BGI-Shenzhen, Shenzhen, China</li>
</ul>
<p>Esophageal squamous cell cancer (ESCC) is the eighth most common cancer around the world. Several reports have focused on somatic mutations and common germline mutations in ESCC. However, the contributions of pathogenic germline alterations in cancer susceptibility genes (CSGs), highly frequently mutated CSGs, and pathogenically mutated CSG-related pathways in ESCC remain unclear. We obtained data on 571 ESCC cases from public databases and East Asian from the 1000 Genomes Project database and the China Metabolic Analytics Project database to characterize pathogenic mutations. We detected 157 mutations in 75 CSGs, accounting for 25.0% (143/571) of ESCC cases. Six genes had more than five mutations: <i>TP53</i> (<i>n</i> = 15 mutations), <i>GJB2</i> (<i>n</i> = 8), <i>BRCA2</i> (<i>n</i> = 6), <i>RECQL4</i> (<i>n</i> = 6), <i>MUTYH</i> (<i>n</i> = 6), and <i>PMS2</i> (<i>n</i> = 5). Our results identified significant differences in pathogenic germline mutations of <i>TP53, BRCA2</i>, and <i>RECQL4</i> between the ESCC and control cohorts. Moreover, we identified 84 double-hit events (16 germline/somatic double-hit events and 68 somatic/somatic double-hit events) occurring in 18 tumor suppressor genes from 83 patients. Patients who had ESCC with germline/somatic double-hit events were diagnosed at younger ages than patients with the somatic/somatic double-hit events, though the correlation was not significant. Fanconi anemia was the most enriched pathway of pathogenically mutated CSGs, and it appeared to be a primary pathway for ESCC predisposition. The results of this study identified the underlying roles that pathogenic germline mutations in CSGs play in ESCC pathogenesis, increased our awareness about the genetic basis of ESCC, and provided suggestions for using highly mutated CSGs and double-hit features in the early discovery, prevention, and genetic counseling of ESCC.</p>
<div class="clear"></div>
</div>
<div class="JournalFullText">
<a id="h2" name="h2"></a><h2>Introduction</h2>
<p class="mb15">Esophageal squamous cell cancer (ESCC) is one of the most common cancers in the world, and it is especially common in Asian countries, North America, and the eastern corridor of Africa (<a href="#B1">1</a>). In China, there are &#x0007E;478,000 new cases and &#x0007E;375,000 deaths related to ESCC each year (<a href="#B2">2</a>). Many factors reportedly have relationships with ESCC; these include smoking, drinking, and dietary habits (<a href="#B3">3</a>). However, the hereditary factors involved in ESCC remain unclear. Thus, understanding the genetic mutations and molecular events in ESCC might be pivotal to reduce the incidence and mortality rate of ESCC.</p>
<p class="mb0">Enormous efforts have been taken to identify somatic alterations by whole-genome sequencing (WGS) or whole-exome sequencing (WES) (<a href="#B4">4</a>, <a href="#B5">5</a>), and several studies reveal the complex process of tumor development (<a href="#B6">6</a>, <a href="#B7">7</a>). Many common germline single-nucleotide polymorphisms (SNPs) have been identified by genome-wide association studies (<a href="#B8">8</a>&#x02013;<a href="#B16">16</a>). rs138478634, a <i>CYP26B1</i> low-frequency variant, was proved to be involved in the ESCC development (<a href="#B14">14</a>). In 2018, several pan-cancer studies focused on pathogenic germline mutations to explore hereditary factors in cancers; 871 rare cancer predisposition mutations and copy number variations (CNVs) were observed in 8% of 10,389 cases, and 7.6% of the 914 patients with pediatric cancers had tumors that harbored pathogenic mutations in cancer predisposition genes (<a href="#B17">17</a>, <a href="#B18">18</a>). In 2019, Deng et al. (<a href="#B19">19</a>) identified germline profiles in Chinese patients with ESCC and uncovered the association between genotype and environment interactions. Additionally, <i>BRCA2</i> was associated with ESCC risk in Chinese patients (<a href="#B20">20</a>). Reflecting a critical part of cancer susceptibility, the two-hit hypothesis assumes that hereditary retinoblastoma involves double mutations and that one mutation is in germline DNA whereas non-hereditary retinoblastoma involves two somatic mutations (<a href="#B21">21</a>). On the basis of these findings, double-hit events in some studies were used to identify cancer predisposition genes (<a href="#B22">22</a>, <a href="#B23">23</a>). These studies demonstrated the significance of pathogenic germline mutations and double-hit events in genetic testing and risk assessment for cancer. To our knowledge, cancer predisposition genes and molecular events in ESCC remain poorly understood. Here, we identified pathogenic/likely pathogenic germline predisposition mutations and highly frequently mutated CSGs in a large ESCC cohort. We discovered significantly different pathogenic germline mutations of <i>TP53, BRCA2</i>, and <i>RECQL4</i> in ESCC cohorts, and we clarified the association between double-hit events and diagnosis age in patients with ESCC. In addition, we identified pathogenically mutated CSG-related pathways for ESCC to illuminate the mechanism affected by pathogenic mutations. Results of this study will improve genetic testing for relatives of patients with ESCC and facilitate the implementation of organizational or institutional measures for the ESCC prevention and surveillance.</p>
<a id="h3" name="h3"></a><h2>Materials and Methods</h2>
<h3 class="pt0">Sample Acquisition</h3>
<p class="mb0">We collected 592 ESCC samples from published studies and The Cancer Genome Atlas (a total of nine projects) (<a href="#SM1">Supplementary Table 1</a>), and we excluded poor-quality samples and hypermutant samples (<a href="#B4">4</a>, <a href="#B5">5</a>, <a href="#B24">24</a>&#x02013;<a href="#B29">29</a>). The clinical information is listed in <a href="#SM1">Supplementary Table 2</a>. The WGS and WES data from the same studies came from distinct patient cases. The quality control analysis uncovered an average sequencing depth of 55&#x000D7;&#x0007E;161&#x000D7; for WES samples and 30&#x000D7;&#x0007E;65&#x000D7; for WGS samples (<a href="#SM1">Supplementary Figure 1A</a>), the 10&#x000D7; average coverages were more than 90% in most WES and WGS samples (<a href="#SM1">Supplementary Figure 1B</a>). Moreover, the relationship between 10&#x000D7; average coverages and average sequencing depths showed a positive correlation (<a href="#SM1">Supplementary Figure 1C</a>), suggesting that the qualities of most samples were proofed. The mean depth of our data and the public databases we used as controls were able to provide enough variants to execute the downstream analysis (<a href="#B30">30</a>). The study protocol was reviewed by the institutional review board of the Beijing Genomics Institution.</p>
<h3>Data Processing and Mutation Calling</h3>
<p class="mb0">The fastq data from 571 samples (38 WGS samples and 533 WES samples) were trimmed and filtered using SOAPnuke (v1.5.6 with default parameters, except where -n 0.1 -l 11 -q 0.5 -G -T 1) (<a href="#B31">31</a>). Data from ESCC-P006 was transformed from bam files using the GATK SamToFastq (v4.0.6.0 with default parameters) (<a href="#B32">32</a>). The high-quality reads were aligned to the hg19 human reference genome with a Burrows-Wheeler Aligner (v0.7.17-r1194-dirty with default parameters, except where -o 1 -e 50 -m 100,000 -i 15 -q 10 -a 600) (<a href="#B33">33</a>). MarkDuplicates GATK (version as above with default parameters, except where -CREATE_INDEX true, -reportMemoryStats true, -VALIDATION_STRINGENCY SILENT) was used to mark duplicated reads. BaseRecalibrator (version as above with default parameters) and ApplyBQSR (version as above with default parameters, except where -create-output-bam-index true) were performed to base quality score recalibration (<a href="#B32">32</a>). Germline variants were joint-called using GenotypeGVCFs (version as above with default parameters, except where -ignore-variants-starting-outside-interval true) after CombineGVCFs (version as above with default parameters) and annotated with the Variant Effect Predictor (VEP v98.3) (<a href="#B32">32</a>, <a href="#B34">34</a>). The calling germline variants of nine projects are shown in <a href="#SM1">Supplementary Figure 1D</a>. Samples with fewer than 80,000 variants were filtered out. Somatic variants were detected by GATK MuTect2 (version as above with default parameters except where -af-of-alleles-not-in-resource 0.0000025, -native-pair-hmm-threads 1, -add-output-vcf-command-line false), and Oncotator (v1.9.9.0) was used for annotation (<a href="#B32">32</a>, <a href="#B35">35</a>). Loss of heterozygosity (LOH) and other somatic CNVs (SCNVs) were detected with FACETS (v0.5.14) and Pathwork (v1.0) for 533 WES and 38 WGS samples, respectively (<a href="#B36">36</a>, <a href="#B37">37</a>).</p>
<h3>CSG Sets</h3>
<p class="mb0">We curated CSGs from published papers and the Catalogue of Somatic Mutations in Cancer (COSMIC, V92) database (<a href="#B38">38</a>); we included cancer predisposition genes from three papers (<a href="#B17">17</a>, <a href="#B18">18</a>, <a href="#B39">39</a>) and genes with recorded germline associations in COSMIC (<a href="#SM1">Supplementary Table 4</a>). After we removed duplicated genes, the CSG set included 260 genes. CSGs were divided into three groups according to the literature (<a href="#B17">17</a>, <a href="#B40">40</a>&#x02013;<a href="#B42">42</a>); these groups were tumor suppressor genes (TSGs; <i>n</i> = 139), oncogenes (<i>n</i> = 36), and non-classified genes (<i>n</i> = 85).</p>
<h3>Pathogenicity Evaluation</h3>
<p class="mb0">We first leveraged an in-house pathogenicity database to match germline variants; the rest of the germline variants were evaluated using InterVar (InterVar_20190327) as a supplemental method to find germline pathogenic/likely pathogenic mutations (<a href="#B43">43</a>). Germline pathogenic or likely pathogenic variants are hereafter referred to as pathogenic mutations. The pathogenicity database included ClinVar, the Human Gene Mutation Database, mutations collected from papers, and mutations we assessed according to consensus guidelines by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (<a href="#B17">17</a>, <a href="#B44">44</a>&#x02013;<a href="#B46">46</a>). We filtered for pathogenic variants with an allele frequency of 0.5% or lower in the Genome Aggregation Database (gnomAD version v2.1) (<a href="#B47">47</a>). Pathogenic mutations in 260 high-interest CSGs (<a href="#SM1">Supplementary Table 6</a>) were selected for analysis and were checked by Deep Variant (<a href="#B48">48</a>); manual verification ruled out false-positive results. For somatic nonsilent variants, with the exception of frameshift, non-sense, and splice-site mutations, three silico tools SIFT (<a href="#B49">49</a>), Polyphen2_HDIV (<a href="#B50">50</a>), and CADD (<a href="#B51">51</a>) were used to predict pathogenicity. If a variant was predicted as damaging in any two silico tools (SIFT: D, Polyphen2_HDIV: D/P, CADD score &#x0003E;15), the variant was categorized as deleterious (<a href="#B39">39</a>, <a href="#B52">52</a>).</p>
<h3>Identification of potential Double-Hit Events</h3>
<p class="mb0">According to the two-hit hypothesis, potential double-hit events are identified after two or more hits have been found in the same CSG; in this study, we set rigorous standards for determining hits. Pathogenic germline mutations were considered hits. Effective somatic variations were defined as hits if they met the following requirements: frameshift, non-sense, splice-site mutations, or deleterious missense and in-frame variants and SCNVs that caused allele loss. Copy-neutral LOH, duplication LOH, homozygous deletion, and hemizygous deletion were assumed to be linked to allele loss and were termed allele loss SCNVs (<a href="#B53">53</a>, <a href="#B54">54</a>). Integrative Genomics Viewer software was used to examine the authenticity of biallelic events (<a href="#B55">55</a>). For double-hit events comprised of germline hits and allele loss SCNVs, we calculated SNP average depths and variant allelic frequency in normal and tumor tissues of ESCC to further validate allele loss SCNV events. Samples with variant allele frequencies &#x0003C;0.5 in tumors were removed.</p>
<h3>Statistical Analyses</h3>
<p class="mb0">To evaluate the correlations of the clinical features and genetic events, we used the two-sided Student&#x00027;s <i>t</i>-test. We conducted the two-sided Fisher&#x00027;s exact test to assess the gene-based association analysis and pathway enrichment. We also performed a burden test to determine the exact relationships between pathogenic mutations in CSGs and ESCC (<a href="#B56">56</a>); <i>p</i> &#x0003C; 0.05 was defined as statistically significant.</p>
<a id="h4" name="h4"></a><h2>Results</h2>
<h3 class="pt0">Population Characteristics</h3>
<p class="mb0">Overall, 469 of 571 patient cases were Asian (424 Chinese, 41 Vietnamese, one Canadian, one Brazilian, and two without country information), 41 were Caucasian, 58 were Black or African American, and the rest were Brazilian without ethnicity information. The entire population consisted of 105 women, 465 men, and one patient without gender information. The average diagnosed age for 567 patients (the rest had no information) was 58.81 years (the minimum diagnosed age was 24 years, and the maximum diagnosed age was 93 years). About 35 patients had family histories of ESCC, and the average age of patients with ESCC with a family history [mean age (SD) was 56.80 (9.3) years; range: 41&#x02013;82 years]. This average was lower than the age of patients with ESCC without a family history [mean age (SD): 60.00 (8.2) years; range: 36&#x02013;78 years; <i>t</i>-test <i>p</i> = 0.059; 95% CI, &#x02212;6.511 to 0.121) (<a href="#SM1">Supplementary Figure 2</a>). The average survival for 399 patients (the rest had no information) was 879.8 days (minimum survival, 3 days; maximum survival, 2,580 days). In this study, 347 patients had a smoking history, and 215 patients had histories of alcoholism. With regard to disease grade, 334 patients had disease with pathological grade 2 or lower, and 86 patients had disease with pathological grade &#x0003E;2; the pathological grade information was missing for 151 patients. All patients were diagnosed with disease stages I (<i>n</i> = 72), stage II (<i>n</i> = 207), stage III (<i>n</i> = 203), and stage IV (<i>n</i> = 7); 82 patients were not assigned disease stages for this study (their information was lost).</p>
<h3>Pathogenic Germline Mutations in CSGs</h3>
<p class="mb0">Overall, 2,484 pathogenic germline mutations were identified, including 1,973 SNPs and 511 insertions or deletions (<a href="#SM1">Supplementary Table 5</a>). Each sample had an average of 4.4 pathogenic mutations. After filtration by CSGs, 157 pathogenic mutations (113 SNPs and 44 insertions or deletions) were discovered from 25.0% (143/571) of the population (<a href="#SM1">Supplementary Figure 3</a>). Although each sample had an average of 1.1 pathogenic mutation in CSGs, only 12 (2.10%) of the 571 patients harbored one or more pathogenic mutation in CSGs (<a href="#F1">Figure 1</a>, <a href="#SM1">Supplementary Table 6</a>). The frequency of most mutations was rare in the gnomAD noncancer database and in the China Metabolic Analytics Project (ChinaMAP) database (<a href="#B47">47</a>, <a href="#B57">57</a>), indicating the sparsity of these deleterious mutations in the general population. As expected, most of the frequently mutated CSGs belonged to TSGs, and they were involved in biological processes, such as DNA repair.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg" name="figure1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a>
<p><strong>Figure 1</strong>. The frequency and distribution of cancer susceptibility genes (CSGs) with more than one pathogenic/likely pathogenic germline mutation detected in patients with esophageal squamous cell cancer (ESCC). Only tumor suppressor genes with more than five mutations are shown. Upper bars represent the cumulative mutation numbers of each sample. Bottom bars represent the clinical information (race, gender, age, and survival/death) about the patients. The left table presents the frequency of mutations shown in the non-cancer Genome Aggregation Database (gnomAD) and the China Metabolic Analytics Project (ChinaMAP) database. Right bars represent the mutation counts. The classification of the CSG is next to the mutation name (gene name &#x0002B; reference SNP number or gene name &#x0002B; chromosome position &#x0002B; nucleotide change).</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15">In general, the CSGs detected more than five times were <i>TP53</i> (<i>n</i> = 15 mutations), <i>GJB2</i> (<i>n</i> = 8), <i>BRCA2</i> (<i>n</i> = 6), <i>RECQL4</i> (<i>n</i> = 6), <i>MUTYH</i> (<i>n</i> = 6), and <i>PMS2</i> (<i>n</i> = 5). <i>TP53</i> was the most frequently mutated CSG, with pathogenic germline mutations in 2.63% (15/571) of patients with ESCC (<a href="#F1">Figure 1</a>, <a href="#SM1">Supplementary Table 6</a>, <a href="#SM1">Supplementary Figure 4</a>). The result was the same as <i>TP53</i> pathogenic mutations in a study of osteosarcoma (<a href="#B39">39</a>). In our study, 86.7% (13/15) of <i>TP53</i> mutations were non-synonymous single-nucleotide variations. c.A1073T (rs773553186; in 0.35%, or 2/571) and c.C742T (rs121912851; in 0.18%, or 1/571) were recorded in the International Agency for Research on Cancer TP53 database (<a href="#B58">58</a>). All <i>TP53</i> pathogenic mutations were found in Chinese patients, except c.A1073T (one each in a Chinese and a Caucasian patient) (<a href="#SM1">Supplementary Figure 4</a>). Three of the <i>TP53</i> mutations, c.C742T, c.C586T, and c.C817T, have been reported in osteosarcoma (<a href="#B39">39</a>), and <i>TP53</i> c.C742T has also been identified in low-grade glioma (<a href="#B17">17</a>) (<a href="#SM1">Supplementary Figure 4</a>). Pathogenic mutations in <i>GJB2</i> represented the second most frequently mutated CSGs (<a href="#F1">Figure 1</a>); their detection rate was 1.40% (8/571). The c.235delC (rs80338943) mutation, a common pathogenic frameshift deletion mutation in East Asian (EAS) populations, has been detected in six Asian (Chinese) patients with ESCC (<a href="#B59">59</a>). Because this mutation has not been detected in other populations, rs80338943 may be specific to Chinese or Asian populations.</p>
<p class="mb15">Non-synonymous single-nucleotide variations occupied &#x0003E;50% of pathogenic germline mutations in <i>BRCA2, RECQL4</i>, and <i>MUTYH</i> (<a href="#SM1">Supplementary Table 6</a>). In the upstream region, we detected a pathogenic splice mutation, <i>BRCA2</i> c.-39-1_-39delGA (rs758732038), in a patient, and the mutation was reported in ClinVar as likely pathogenic (<a href="#B46">46</a>). The mutation has also been reported in patients with breast cancer and medulloblastoma (<a href="#B60">60</a>&#x02013;<a href="#B62">62</a>). <i>RECQL4</i> pathogenic mutations were only detected in Asian (Chinese) patients in our study, and <i>RECQL4</i> c.C2272T has been reported in ovarian cancer/Rothmund&#x02013;Thomson syndrome. In our study, <i>MUTYH</i> c.C1178T (rs36053993) and c.C458T (rs762307622) were detected three times (0.53%, or 3/571) and two times (0.35%, or 2/571), respectively. rs36053993 only detected in Caucasian patients and rs762307622 only detected in Asian (Chinese) patients. From gnomAD, rs36053993 in a homozygous state was found in three non-Finnish Europeans; this mutation may have been caused by founder events (<a href="#B63">63</a>, <a href="#B64">64</a>). Pathogenic mutations in <i>PMS2</i> were detected five times in five patients in our study (0.88%), and c.2192_2196delAGTTA (rs63750695) was observed in only four patients, who were all African. The rs63750695 mutation has also been discovered in Lynch syndrome, colorectal cancer, and ovarian carcinoma (<a href="#B65">65</a>&#x02013;<a href="#B67">67</a>); however, it was rare in non-cancer gnomAD and ChinaMAP, for which frequencies were 1.15 &#x000D7;10<sup>&#x02212;5</sup> and 0, respectively (<a href="#F1">Figure 1</a>). rs63750695 is possibly specific to African ethnicity in ESCC.</p>
<p class="mb15">The total number of pathogenic germline mutations and the frequency of mutations were relatively lower in oncogenes and non-classified genes compared with TSGs. <i>TSHR</i> and <i>MPL</i> were oncogenes that were mutated in two patients with ESCC; other oncogenes occurred in just one patient. <i>SLC25A13</i> was one of the non-classified genes with the most pathogenic mutations.</p>
<p class="mb0">We also investigated our pathogenic germline mutations in a previous pan-cancer study (<a href="#B17">17</a>). Nine mutations were spread over 22 samples with diverse cancers (<a href="#SM1">Supplementary Table 9</a>). <i>SLC25A13</i> c.852_855delCATA (<i>n</i> = 7), <i>GJB2</i> c.235delC (<i>n</i> = 7), and <i>PALB2</i> c.C2257T (<i>n</i> = 2) were the variants observed more than once across cancers. We detected multiple susceptibility loci (31/47), also identified in previous genome-wide association studies, in our patients with ESCC (<a href="#SM1">Supplementary Table 10</a>) (<a href="#B8">8</a>&#x02013;<a href="#B16">16</a>). Of those genes with susceptibility loci, pathogenic mutations <i>PDE4D</i> c.T108A and <i>RUNX1</i> c.61&#x0002B;1delG were found in two patients separately (<a href="#SM1">Supplementary Table 5</a>). We also confirmed from the COSMIC database that 87.3% (137/157) of pathogenic mutations in CSGs had non-silent somatic mutations in the same or a nearby (within five) amino acid position (<a href="#SM1">Supplementary Table 6</a>). Among 137 mutations, 107 mutations were observed in TSGs, representing 89.2% (107/120) of all mutations.</p>
<h3>Pathogenic Germline Mutations Frequency in ESCC Cases vs. Controls</h3>
<p class="mb0">To reveal the relationships between highly frequent mutated CSGs and ESCC, we chose the Chinese patients to continue the study, to leverage the most population data and avoid any ethnicity-specific effect. We conducted gene-based association analyses by comparing various germline mutation data from individuals with ESCC vs. a 1000 Genomes Project EAS population and ESCC vs. a ChinaMAP population separately (<a href="#B57">57</a>, <a href="#B68">68</a>). We also conducted rare variant burden tests on the ESCC individuals and the 1000 Genomes Project EAS population (<a href="#B68">68</a>). Through the same pathogenicity evaluation pipeline, pathogenic mutations were identified in two public database populations. Analysis of results identified significantly higher pathogenic mutations in Chinese patients with ESCC vs. public population databases (including 1000 Genomes Project EAS and ChinaMAP data), as reflected by odd ratios (ORs) of pathogenic mutations in <i>TP53</i> from the Chinese ESCC populations compared with the 1000 Genomes Project EAS populations (OR = 4.26; 95% CI, 1.33&#x02013;17.91; Fisher&#x00027;s exact test <i>p</i> = 7.359 &#x000D7; 10<sup>&#x02212;3</sup>) and compared with the ChinaMAP populations (OR = 10.59; 95% CI, 5.21&#x02013;20.45; Fisher&#x00027;s exact test <i>p</i> = 1.851 &#x000D7; 10<sup>&#x02212;9</sup>); in <i>BRCA2</i> from the Chinese ESCC populations compared with the 1000 Genomes Project EAS populations (OR = infinity; 95% CI, 1.09&#x02013;infinity; Fisher&#x00027;s exact test <i>p</i> = 0.0197) and compared with the ChinaMAP populations (OR = 2.68; 95% CI, 0.83&#x02013;6.75; Fisher&#x00027;s exact test <i>p</i> = 0.0489); and in <i>RECQL4</i> from the Chinese ESCC populations compared with the 1000 Genomes Project EAS populations (OR = 7.21; 95% CI, 0.87&#x02013;332.23; Fisher&#x00027;s exact test <i>p</i> = 0.0519) and compared with the ChinaMAP populations (OR = 3.69; 95% CI, 1.27&#x02013;8.81; Fisher&#x00027;s exact test <i>p</i> = 0.0089) (<a href="#T1">Table 1</a>). Likewise, in the burden analyses (<a href="#T1">Table 1</a>), the numbers of pathogenic mutations from <i>TP53</i> (14/424, or 3.30%; burden test <i>p</i> = 3.050 &#x000D7; 10<sup>&#x02212;3</sup>), <i>BRCA2</i> (5/424, or 1.18%; burden test <i>p</i> = 0.015), and <i>RECQL4</i> (6/424, or 1.14%; burden test <i>p</i> = 0.035) in our Chinese ESCC cohort were higher than those observed in the 1000 Genomes Project EAS group.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">TABLE 1</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg" name="Table1" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>

</a>
<p><strong>Table 1</strong>. Significance of <i>TP53, BRCA2</i>, and <i>RECQL4</i> pathogenic or likely pathogenic variants for ESCC risk in Chinese patients.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Potential Double-Hit Events</h3>
<p class="mb0">To further survey the genetic predisposition of ESCC, we tried to identify potential double-hit events in ESCC. First, we identified 49,876 non-silent mutations (<a href="#SM1">Supplementary Table 3</a>) in protein-coding regions from patients with ESCC. (We filtered the somatic mutations that overlapped with our own panel of normal datasets and the Exome Aggregation Consortium database V1.0.) Then, by integrating pathogenic germline mutations and effective somatic mutations (<a href="#SM1">Supplementary Table 8</a>) or allele loss SCNVs, we found 84 potential double-hit events (<a href="#F2">Figure 2</a>). To distinguish hits with germline mutations, the double-hit events were classified as germline/somatic double-hit events and somatic/somatic double-hit events. We identified 16 potential germline/somatic double-hit events (two germline mutations coupled with somatic mutations, and 14 germline mutations accompanied with allele loss SCNVs) (<a href="#F2">Figure 2</a>, <a href="#SM1">Supplementary Table 11</a>, <a href="#SM1">Supplementary Figures 5</a>, <a href="#SM1">6</a>) in 16 patients with ESCC, and we identified 68 potential somatic/somatic double-hit events (three somatic mutations accompanied by allele loss SCNVs and 65 double somatic mutations) (<a href="#F2">Figure 2</a>, <a href="#SM1">Supplementary Table 12</a>) in 67 cases. The likelihood of two or more somatic mutations happening on the same chromosome was very low (<a href="#B52">52</a>, <a href="#B69">69</a>, <a href="#B70">70</a>). Therefore, we assumed that double somatic mutations were likely in the trans position. Briefly, 83 individuals with ESCC possessed potential double-hit events, representing 14.5% of the ESCC cohort (<a href="#F2">Figure 2</a>). Notably, one patient had two somatic/somatic double-hit events in different genes.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 2</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg" name="figure2" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg" alt="www.frontiersin.org" id="F2" loading="lazy">
  </picture>
</a>
<p><strong>Figure 2</strong>. The distribution of pathogenic/likely pathogenic germline mutations, somatic mutations, and allele loss somatic copy number variations (SCNVs) in esophageal squamous cell cancer (ESCC) cases with potential double-hit events. Upper bars represent the clinical information (age and race) about those patients. Squares represent somatic mutations, triangles represent germline mutations, and circles represent allele loss SCNVs.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb15 w100pc float_left mt15"><i>GJB2</i> and <i>TP53</i> were the top two CSGs that found germline/somatic double-hit events. Germline/somatic double-hit events were identified in eight CSGs, including <i>BRCA2, BRCA1, MUTYH, CDKN2A</i>, and <i>ATM</i>. The dominant type of germline/somatic double-hit events was a germline mutation accompanied by an allele loss SCNV. In the remaining, germline mutations were coupled with somatic mutations; these were only discovered in <i>TP53</i> and <i>BRCA1</i>, possibly because SCNVs are relatively abundant in tumors and cover large genome region. In the somatic/somatic double-hit events, the <i>TP53</i> gene had the highest frequency, and most of the remaining genes had one potential double-hit event. Double somatic mutation was the main type of somatic/somatic double-hit event (<a href="#SM1">Supplementary Table 12</a>).</p>
<p class="mb0">When we compared diagnosis ages of patients with different double-hit events, we found that patients with germline/somatic double-hit events (with pathogenic germline mutations) had younger diagnosis ages [mean age (SD), 54.6 (11.2) years; range, 36&#x02013;71 years] compared with patients in the somatic/somatic double-hit events [without pathogenic germline mutations; mean age (SD), 60.6 (7.8) years; range, 4&#x02013;80 years; <i>t</i>-test <i>p</i> = 0.056; 95% CI, &#x02212;12.216 to 0.177] (<a href="#F3">Figure 3</a>). The comparison was non-significant, maybe it was due to the limited number of samples with double-hit events in this comparison. However, the finding was consistent in the study by Knudson (<a href="#B21">21</a>). Using the empirical cumulative distribution function (ecdf) to calculated the expression percentiles of TSGs in an ESCC-P006 cancer cohort, two patients with somatic/somatic double-hit events showed low expression: one in <i>TP53</i> (5.32%) and one in <i>PTEN</i> (6.38%) (<a href="#SM1">Supplementary Figure 8</a>) (<a href="#B17">17</a>). Those results support the two-hit hypothesis and suggest that genetic screening in specific TSGs can detect patients with germline/somatic double-hit events earlier.</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 3</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg" name="figure3" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg" alt="www.frontiersin.org" id="F3" loading="lazy">
  </picture>
</a>
<p><strong>Figure 3</strong>. The two types of double-hit events. <strong>(A)</strong> The paradigm of double-hit events. <strong>(B)</strong> The correlation between age and double-hit event type in esophageal squamous cell cancer (ESCC) cases. The position of line is the median age, and the position of rhombus is the mean age in specific ESCC cohorts. The digits in the boxes are the numbers of ESCC cases in each category.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<h3>Pathway Enrichment</h3>
<p class="mb0">To obtain a more comprehensive understanding of pathogenic germline genetic mutations affecting pathways, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed for multiple gene lists. The Fanconi anemia (FA) pathway was the most significantly enriched in the analysis of 75 pathogenically mutated CSGs (Fisher&#x00027;s exact test <i>p</i> = 6.634 &#x000D7; 10<sup>&#x02212;19</sup>) (<a href="#F4">Figure 4A</a>, <a href="#SM1">Supplementary Table 7</a>). In addition, 1,226 pathogenic mutated genes and the genes involved in germline/somatic double-hit events were significantly enriched in this pathway. The top four pathways for CSGs involved in somatic/somatic double-hit events vs. for CSGs involved in germline/somatic double-hit events differed significantly (<a href="#SM1">Supplementary Figures 7A&#x02013;D</a>).</p>
<div class="DottedLine"></div>
<div class="Imageheaders">FIGURE 4</div>
<div class="FigureDesc">
<a href="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg" name="figure4" target="_blank">

  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg" alt="www.frontiersin.org" id="F4" loading="lazy">
  </picture>
</a>
<p><strong>Figure 4</strong>. Significantly enriched pathways and networks in esophageal squamous cell cancer (ESCC). <strong>(A)</strong> The network composed of genes involved in the top 10 pathways in the Kyoto Encyclopedia of Genes and Genomes pathway enrichment. The red dots represent genes, and the purple circles represent pathways. The larger the area, the higher the degree of enrichment. The different lines represent various categories of pathways; green lines indicate genetic information processing, and purple lines indicate human disease. <strong>(B)</strong> The <i>y</i>-axis represents cancer susceptibility genes mutated in the Fanconi anemia pathway; the <i>x</i>-axis represents the number of patients affected in our cohort. Red font: tumor-suppressor genes.</p>
</div>
<div class="clear"></div>
<div class="DottedLine"></div>
<p class="mb0 w100pc float_left mt15">In the tumor-suppressor network, the FA pathway functions to preserve genomic integrity by repairing DNA interstrand crosslinks, regulating cytokinesis, and mitigating replication stress (<a href="#B71">71</a>, <a href="#B72">72</a>). About 33 ESCC samples carried pathogenic mutations in 13 CSGs included in the FA pathway (<a href="#F4">Figure 4B</a>). The homologous recombination pathway and the mismatch repair pathway described in a previous ESCC project, and associated with cancer susceptibility, were found in our study (<a href="#SM1">Supplementary Figure 7A</a>) (<a href="#B19">19</a>, <a href="#B73">73</a>&#x02013;<a href="#B75">75</a>). Those pathways were also reported in pathway enrichments of ovarian cancer and osteosarcoma (<a href="#B39">39</a>, <a href="#B76">76</a>). We also interrogated the oncogenic signaling pathways upon which our mutated CSGs converged (<a href="#B77">77</a>). The cell cycle pathway was the most enriched, followed by p53 pathway, the phosphatidylinositol 3&#x02032;-kinase-Akt pathway, and the receptor tyrosine kinases-Ras pathway.</p>
<a id="h5" name="h5"></a><h2>Discussion</h2>
<p class="mb15">We reported the profile of pathogenic germline mutations of a larger ESCC cohort comparing with previous studies (<a href="#B17">17</a>, <a href="#B19">19</a>). We found 157 pathogenic mutations in CSGs from 143 (25.0%) of 571 patients with ESCC and identified 84 double-hit events in 83 individuals (14.5%). The double-hit events were found in almost all projects in our study except ESCC-P008, which demonstrated that double-hit events are relatively common in ESCC. As far as we know, there was no report about pathogenic mutations in <i>GJB2, RECQL4, MUTYH</i>, and <i>PMS2</i> in ESCC, however, they were discovered in our study. Overall, <i>TP53, GJB2, BRCA2, RECQL4, MUTYH</i>, and <i>PMS2</i> were highly frequently mutated CSGs. Significant pathways were identified for different CSGs with pathogenic mutations; the FA pathway appeared to be a primary pathway for cancer predisposition in ESCC. We showed that significantly more pathogenic mutations from <i>TP53, BRCA2</i>, and <i>RECQL4</i> occurred in patients with ESCC than in control cohorts, which indicates that these three CSGs may play vital roles in ESCC. Interestingly, <i>TP53</i> and <i>RECQL4</i> have also been found significantly associated with osteosarcoma (<a href="#B39">39</a>). The relationship with diagnosis age was not significant in our study, but double-hit events may be pivotal in ESCC carcinogenesis.</p>
<p class="mb15">We found that <i>TP53</i> had the highest frequency of pathogenic germline mutations and the most double-hit events in CSGs. In our study, 80% (12/15) of germline mutations in <i>TP53</i> were located in the p53 domain, which functions in DNA binding. This domain contains four conserved regions that are enriched for somatic mutation hot spots and are essential for the function of the TP53 protein as a transcription factor (<a href="#B78">78</a>, <a href="#B79">79</a>). Six of the 12 mutations were discovered in conserved regions. Environmental factors and specific DNA sequences drive higher mutation rates, which may explain why p53 domain was a hot-spot region (<a href="#B80">80</a>). Those pathogenic <i>TP53</i> mutations may disrupt the p53 transcriptional pathway, which would enhance tumor progression and metastatic potential (<a href="#B81">81</a>). The US Food and Drug Administration had approved drugs against the pocket in p53 domain (<a href="#B82">82</a>). These drugs provide treatment options to patients with tumors that have mutations in the p53 domain. Results of studies in other cancers contrast with our findings about <i>TP53</i>. In a renal cell carcinoma study, <i>FH</i>, instead of <i>TP53</i>, harbored the most double-hit events, and <i>BRCA1</i> harbored the most in a pan-cancer study (<a href="#B17">17</a>, <a href="#B22">22</a>). Previous studies have reported that most double-hit events with <i>TP53</i> involve a mutation accompanied by LOH (<a href="#B83">83</a>, <a href="#B84">84</a>). However, in our research, double somatic mutations were the dominant type of double-hit event. It was partially due to the lack of researches on <i>TP53</i> double somatic mutations before.</p>
<p class="mb15"><i>BRCA2</i> and <i>RECQL4</i> harbored more pathogenic germline mutations in ESCC than in public population. <i>BRCA2</i> is known for its involvement in breast cancer and ovarian cancer <i>via</i> the homologous recombination pathway, which is essential for repairing damaged DNA (<a href="#B85">85</a>, <a href="#B86">86</a>). And studies have reported <i>BRCA2</i> mutations related to ESCC risk in Chinese and Turkmen populations (<a href="#B20">20</a>, <a href="#B87">87</a>, <a href="#B88">88</a>). The double-hit events detected in <i>BRCA2</i> in our study were germline/somatic double-hit events; the germline mutations were accompanied by allele loss SCNVs. These results were distinct from those reported in pancreatic acinar-cell carcinomas (<a href="#B89">89</a>). <i>RECQL4</i> is a TSG that encodes RECQL4 helicase, which is involved in DNA replication and DNA repair. Germline mutations in <i>RECQL4</i> can cause the Rothmund&#x02013;Thomson syndrome and sporadic breast cancer (<a href="#B90">90</a>). Although the pathogenic mutations in our ESCC cohort and in the 1000 Genomes EAS group were not significantly different (Fisher&#x00027;s exact test <i>p</i> = 0.0519), the difference between them was also confirmed by analysis of the ChinaMAP cohort (Fisher&#x00027;s exact test <i>p</i> = 0.0089). Importantly, this is the first report, to our knowledge, that illustrates the role of pathogenic mutations in <i>RECQL4</i> in ESCC.</p>
<p class="mb15">The PMS2 protein is a homolog of the PMS1 protein (<a href="#B91">91</a>) and both of them are components of the mismatch repair system. Common polymorphisms of <i>PMS1</i> have been positively associated with ESCC in an African population (<a href="#B92">92</a>). This finding, together with the connection between PMS1 and PMS2, suggests a possible relationship between <i>PMS2</i> and ESCC. The double-hit events of mismatch repair genes could result in Lynch syndrome, as described in several studies (<a href="#B70">70</a>, <a href="#B93">93</a>), but we did not detect double-hit events in <i>PMS2</i> in our ESCC cohort. A larger ESCC cohort study might uncover double-hit events in <i>PMS2</i>, which would strengthen our understanding about ESCC susceptibility.</p>
<p class="mb15">The genetic variations in ESCC are complicated. Although not all ESCC samples carried pathogenic germline mutations in CSGs, the detection rate of pathogenic mutations was close to that found in osteosarcoma (<a href="#B39">39</a>). Because numerous susceptibility loci reported in genome-wide association studies were found in this research, we acknowledge that pathogenic mutations and known susceptibility loci may inform a genetic basis of ESCC. Our findings of variants and genes shared between ESCC and other cancers suggests that common hereditary factors exist in pan-cancer. Given the interplay of common SNPs and pathogenic mutations reported in breast cancer and colorectal cancer, the interaction between susceptibility loci and pathogenic mutations in ESCC suggests a need for future exploration (<a href="#B94">94</a>).</p>
<p class="mb15">To better understand the genetic factors causing ESCC initiation and development, we confirmed the putative germline&#x02013;somatic interplay by COSMIC proximity match. The results not only support the pathogenicity of those germline mutations but also imply a signal functional relevance between germline and somatic mutations (<a href="#B76">76</a>). In addition, we identified potential double-hit events in 83 patients with ESCC; although the difference was not significant, the patients with germline/somatic double-hit events were more likely to be diagnosed at younger ages. It is possible that pathogenic mutations confer the earliest genetic hits to TSGs in cells, so a somatic hit alone would cause loss of function in TSGs (<a href="#B95">95</a>). As a result of double-hit events, the cells generate malignancy. Furthermore, enriched pathways revealed the process of pathogenic mutations that affect ESCC tumorigenesis and development. In patients without pathogenic mutations or double-hit events, limited CSG sets, potential alternations in methylations of a promoter region, germline CNVs, and gene-environmental or gene&#x02013;lifestyle interactions are possible explanations for ESCC development.</p>
<p class="mb15">Despite our findings about the genetic characterization of and double-hit events in ESCC, we still acknowledge limitations to our study. The first is our inability to obtain detailed clinical information because of limited access to public databases. Second, merging different data, such as WGS and WES, may induce biases in cohort-wide variant processing. Third, directly adopting variants from different sources may influence comparisons, because the different sources applied distinct platforms and variant detection pipelines. Fourth, our sample size was not large enough for statistical tests, especially for individual variants.</p>
<p class="mb0">In sum, we report that &#x0007E;25.0% of patients with ESCC harbored at least one pathogenic germline mutation in CSGs, and &#x0007E;14.5% of ESCC cases could be explained by a two-hit hypothesis. Significantly enriched pathways also validated the significance of those pathogenic mutations. Myriad genome variations occur in patients; our findings represent, to our knowledge, the largest discovery of rare, germline predisposition mutations in ESCC so far. These results strengthen the understanding about genetic factors involved in ESCC and will help improve prevention, early detection, and risk management of ESCC for patients. We acknowledge the shortcomings in the analytical methods and the data sources used. Additional studies are needed to improve our observations and results.</p>
<a id="h6" name="h6"></a><h2>Data Availability Statement</h2>
<p class="mb0">The original contributions presented in the study are included in the article/<a href="#h11">Supplementary Material</a>, further inquiries can be directed to the corresponding author/s.</p>
<a id="h7" name="h7"></a><h2>Ethics Statement</h2>
<p class="mb0">The studies involving human participants were collected from published papers and were approved in corresponding ethical review organizations in previous studies, respectively. And our project was reviewed by the institutional review broad of Beijing Genomics institution.</p>
<a id="h8" name="h8"></a><h2>Author Contributions</h2>
<p class="mb0">LL and BZ contributed to the conceptualization of the study. BZ wrote the manuscript and performed the analysis. PD, XS, and XH provided help in the analysis. BZ, LL, XH, and PD collected the data from published literature or database. PH revised the manuscript. LL and XF supervised and supported this project. All authors contributed to the article and approved the submitted version.</p>
<a id="h9" name="h9"></a><h2>Conflict of Interest</h2>
<p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<a id="h10" name="h10"></a><h2>Acknowledgments</h2>
<p class="mb0">This study makes use of data generated by the Molecular Oncology Laboratory of Prof. Qimin Zhan, the Translational Medicine Research Center, Shanxi Medical University of Prof. Yongping Cui, the Department of Radiation Oncology, Fudan University Shanghai Cancer Center of Prof. Kuaile Zhao, the Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center of Prof. Han Liang, The Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine of Prof. Norman E. Sharpless, the Institute of Clinical Pathology, Shantou University Medical College of Prof. Min Su, the Cedars-Sinai Medical Center, UCLA School of Medicine, Prof. H. Phillip Koeffler and Prof. Jie He of Cancer Institute and Hospital, Chinese Academy of Medical Sciences. We also acknowledge other Professors for sharing the fastq data, and we acknowledge The National Center for Biotechnology Information, The European Genome-phenome Archive, and The Cancer Genome Atlas for sharing the esophageal squamous cell cancer data. This manuscript has been released as a pre-print at medRxiv (<a href="#B96">96</a>).</p>
<a id="h11" name="h11"></a><h2>Supplementary Material</h2>
<p class="mb0" id="SM1">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fonc.2021.637431/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fonc.2021.637431/full#supplementary-material</a></p>
<a id="h12" name="h12"></a><h2>References</h2>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B1" id="B1"></a> 1. Brown J, Stepien AJ, Willem P. Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa. <i>BMC Cancer.</i> (2020) 20:281. doi: 10.1186/s12885-020-06788-3 </p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1186/s12885-020-06788-3" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Brown&#x00026;author=AJ.+Stepien&#x00026;author=P.+Willem+&#x00026;publication_year=2020&#x00026;title=Landscape+of+copy+number+aberrations+in+esophageal+squamous+cell+carcinoma+from+a+high+endemic+region+of+South+Africa&#x00026;journal=BMC+Cancer.&#x00026;volume=20&#x00026;pages=281" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B2" id="B2"></a> 2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. <i>CA Cancer J Clin.</i> (2016) 66:115&#x02013;32. doi: 10.3322/caac.21338</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.3322/caac.21338" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W.+Chen&#x00026;author=R.+Zheng&#x00026;author=PD.+Baade&#x00026;author=S.+Zhang&#x00026;author=H.+Zeng&#x00026;author=F.+Bray+&#x00026;publication_year=2016&#x00026;title=Cancer+statistics+in+China,+2015&#x00026;journal=CA+Cancer+J+Clin.&#x00026;volume=66&#x00026;pages=115-32" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B3" id="B3"></a> 3. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. <i>J Natl Cancer Inst.</i> (2003) 95:1404&#x02013;13. doi: 10.1093/jnci/djg047</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/13130116" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/jnci/djg047" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=LS.+Engel&#x00026;author=WH.+Chow&#x00026;author=TL.+Vaughan&#x00026;author=MD.+Gammon&#x00026;author=HA.+Risch&#x00026;author=JL.+Stanford+&#x00026;publication_year=2003&#x00026;title=Population+attributable+risks+of+esophageal+and+gastric+cancers&#x00026;journal=J+Natl+Cancer+Inst.&#x00026;volume=95&#x00026;pages=1404-13" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B4" id="B4"></a> 4. Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. Identification of genomic alterations in oesophageal squamous cell cancer. <i>Nature.</i> (2014) 508:91&#x02013;5. doi: 10.1038/nature13176</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24670651" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature13176" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+Song&#x00026;author=L.+Li&#x00026;author=Y.+Ou&#x00026;author=Z.+Gao&#x00026;author=E.+Li&#x00026;author=X.+Li+&#x00026;publication_year=2014&#x00026;title=Identification+of+genomic+alterations+in+oesophageal+squamous+cell+cancer&#x00026;journal=Nature.&#x00026;volume=508&#x00026;pages=91-5" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B5" id="B5"></a> 5. Gao YB, Chen ZL, Li JG, Hu X, da Shi XJ, Sun ZM, et al. Genetic landscape of esophageal squamous cell carcinoma. <i>Nat Genet.</i> (2014) 46:1097&#x02013;102. doi: 10.1038/ng.3076</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25151357" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng.3076" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=YB.+Gao&#x00026;author=ZL.+Chen&#x00026;author=JG.+Li&#x00026;author=X.+Hu&#x00026;author=XJ.++da+Shi&#x00026;author=ZM.+Sun+&#x00026;publication_year=2014&#x00026;title=Genetic+landscape+of+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=46&#x00026;pages=1097-102" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B6" id="B6"></a> 6. Chen XX, Zhong Q, Liu Y, Yan SM, Chen ZH, Jin SZ, et al. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing. <i>Nat Commun.</i> (2017) 8:524. doi: 10.1038/s41467-017-00650-0</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28900112" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41467-017-00650-0" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=XX.+Chen&#x00026;author=Q.+Zhong&#x00026;author=Y.+Liu&#x00026;author=SM.+Yan&#x00026;author=ZH.+Chen&#x00026;author=SZ.+Jin+&#x00026;publication_year=2017&#x00026;title=Genomic+comparison+of+esophageal+squamous+cell+carcinoma+and+its+precursor+lesions+by+multi-region+whole-exome+sequencing&#x00026;journal=Nat+Commun.&#x00026;volume=8&#x00026;pages=524" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B7" id="B7"></a> 7. Liu X, Zhang M, Ying S, Zhang C, Lin R, Zheng J, et al. Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma. <i>Gastroenterology.</i> (2017) 153:166&#x02013;77. doi: 10.1053/j.gastro.2017.03.033</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28365443" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1053/j.gastro.2017.03.033" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X.+Liu&#x00026;author=M.+Zhang&#x00026;author=S.+Ying&#x00026;author=C.+Zhang&#x00026;author=R.+Lin&#x00026;author=J.+Zheng+&#x00026;publication_year=2017&#x00026;title=Genetic+alterations+in+esophageal+tissues+from+squamous+dysplasia+to+carcinoma&#x00026;journal=Gastroenterology.&#x00026;volume=153&#x00026;pages=166-77" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B8" id="B8"></a> 8. Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kawaguchi T, et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. <i>Gastroenterology.</i> (2009) 137:1768&#x02013;75. doi: 10.1053/j.gastro.2009.07.070</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/19698717" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1053/j.gastro.2009.07.070" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Cui&#x00026;author=Y.+Kamatani&#x00026;author=A.+Takahashi&#x00026;author=M.+Usami&#x00026;author=N.+Hosono&#x00026;author=T.+Kawaguchi+&#x00026;publication_year=2009&#x00026;title=Functional+variants+in+ADH1B+and+ALDH2+coupled+with+alcohol+and+smoking+synergistically+enhance+esophageal+cancer+risk&#x00026;journal=Gastroenterology.&#x00026;volume=137&#x00026;pages=1768-75" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.1em;"><a name="B9" id="B9"></a> 9. Wang LD, Zhou FY, Li XMXCXM, Sun LD, Song X, Jin Y, et al. Genome-wide association study of esophageal squamous cell carcinoma in chinese subjects identifies a susceptibility locus at PLCE1. <i>Nat Genet.</i> (2010) 42:759&#x02013;65. doi: 10.1038/ng.648</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/ng.648" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=LD.+Wang&#x00026;author=FY.+Zhou&#x00026;author=XMXCXM.+Li&#x00026;author=LD.+Sun&#x00026;author=X.+Song&#x00026;author=Y.+Jin+&#x00026;publication_year=2010&#x00026;title=Genome-wide+association+study+of+esophageal+squamous+cell+carcinoma+in+chinese+subjects+identifies+a+susceptibility+locus+at+PLCE1&#x00026;journal=Nat+Genet.&#x00026;volume=42&#x00026;pages=759-65" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B10" id="B10"></a> 10. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. <i>Nat Genet.</i> (2011) 43:679&#x02013;84. doi: 10.1038/ng.849</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21642993" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng.849" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Wu&#x00026;author=Z.+Hu&#x00026;author=Z.+He&#x00026;author=W.+Jia&#x00026;author=F.+Wang&#x00026;author=Y.+Zhou+&#x00026;publication_year=2011&#x00026;title=Genome-wide+association+study+identifies+three+new+susceptibility+loci+for+esophageal+squamous-cell+carcinoma+in+Chinese+populations&#x00026;journal=Nat+Genet.&#x00026;volume=43&#x00026;pages=679-84" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B11" id="B11"></a> 11. Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li Y, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. <i>Nat Genet.</i> (2012) 44:1090&#x02013;7. doi: 10.1038/ng.2411</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22960999" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng.2411" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Wu&#x00026;author=P.+Kraft&#x00026;author=K.+Zhai&#x00026;author=J.+Chang&#x00026;author=Z.+Wang&#x00026;author=Y.+Li+&#x00026;publication_year=2012&#x00026;title=Genome-wide+association+analyses+of+esophageal+squamous+cell+carcinoma+in+Chinese+identify+multiple+susceptibility+loci+and+gene-environment+interactions&#x00026;journal=Nat+Genet.&#x00026;volume=44&#x00026;pages=1090-7" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B12" id="B12"></a> 12. Wu C, Wang Z, Song X, Feng XS, Abnet CC, He J, et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. <i>Nat Genet.</i> (2014) 46:1001&#x02013;6. doi: 10.1158/1538-7445.AM2014-2204</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25129146" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1158/1538-7445.AM2014-2204" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Wu&#x00026;author=Z.+Wang&#x00026;author=X.+Song&#x00026;author=XS.+Feng&#x00026;author=CC.+Abnet&#x00026;author=J.+He+&#x00026;publication_year=2014&#x00026;title=Joint+analysis+of+three+genome-wide+association+studies+of+esophageal+squamous+cell+carcinoma+in+Chinese+populations&#x00026;journal=Nat+Genet.&#x00026;volume=46&#x00026;pages=1001-6" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B13" id="B13"></a> 13. Lin D, Wu C, Li D, Jia W, Hu Z, Zhou Y, et al. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. <i>Nat Genet.</i> (2013) 45:632&#x02013;8. doi: 10.1038/ng.2638</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23644492" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng.2638" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D.+Lin&#x00026;author=C.+Wu&#x00026;author=D.+Li&#x00026;author=W.+Jia&#x00026;author=Z.+Hu&#x00026;author=Y.+Zhou+&#x00026;publication_year=2013&#x00026;title=Genome-wide+association+study+identifies+common+variants+in+SLC39A6+associated+with+length+of+survival+in+esophageal+squamous-cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=45&#x00026;pages=632-8" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B14" id="B14"></a> 14. Chang J, Zhong R, Tian J, Li J, Zhai K, Ke J, et al. Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma. <i>Nat Genet.</i> (2018) 50:338&#x02013;43. doi: 10.1038/s41588-018-0045-8</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29379198" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41588-018-0045-8" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Chang&#x00026;author=R.+Zhong&#x00026;author=J.+Tian&#x00026;author=J.+Li&#x00026;author=K.+Zhai&#x00026;author=J.+Ke+&#x00026;publication_year=2018&#x00026;title=Exome-wide+analyses+identify+low-frequency+variant+in+CYP26B1+and+additional+coding+variants+associated+with+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=50&#x00026;pages=338-43" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B15" id="B15"></a> 15. Hu JL, Hu XL, Lu CX, Chen XJ, Fu L, Han Q, et al. Variants in the 3&#x00027;-untranslated region of CUL3 is associated with risk of esophageal squamous cell carcinoma. <i>J Cancer.</i> (2018) 9:3647&#x02013;50. doi: 10.7150/jca.27052</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30405832" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.7150/jca.27052" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JL.+Hu&#x00026;author=XL.+Hu&#x00026;author=CX.+Lu&#x00026;author=XJ.+Chen&#x00026;author=L.+Fu&#x00026;author=Q.+Han+&#x00026;publication_year=2018&#x00026;title=Variants+in+the+3&#x00027;-untranslated+region+of+CUL3+is+associated+with+risk+of+esophageal+squamous+cell+carcinoma&#x00026;journal=J+Cancer.&#x00026;volume=9&#x00026;pages=3647-50" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B16" id="B16"></a> 16. Suo C, Yang Y, Yuan Z, Zhang T, Yang X, Qing T, et al. Alcohol intake interacts with functional genetic polymorphisms of Aldehyde Dehydrogenase (ALDH2) and Alcohol Dehydrogenase (ADH) to increase esophageal squamous cell cancer risk. <i>J Thoracic Oncol.</i> (2019) 14:712&#x02013;25. doi: 10.1016/j.jtho.2018.12.023</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30639619" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.jtho.2018.12.023" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Suo&#x00026;author=Y.+Yang&#x00026;author=Z.+Yuan&#x00026;author=T.+Zhang&#x00026;author=X.+Yang&#x00026;author=T.+Qing+&#x00026;publication_year=2019&#x00026;title=Alcohol+intake+interacts+with+functional+genetic+polymorphisms+of+Aldehyde+Dehydrogenase+(ALDH2)+and+Alcohol+Dehydrogenase+(ADH)+to+increase+esophageal+squamous+cell+cancer+risk&#x00026;journal=J+Thoracic+Oncol.&#x00026;volume=14&#x00026;pages=712-25" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B17" id="B17"></a> 17. Huang K, lin Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. <i>Cell.</i> (2018) 173:355&#x02013;70. e14. doi: 10.1158/1538-7445.AM2018-5359</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29625052" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1158/1538-7445.AM2018-5359" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K.+Huang&#x00026;author=RJ.+lin+Mashl&#x00026;author=Y.+Wu&#x00026;author=DI.+Ritter&#x00026;author=J.+Wang&#x00026;author=C.+Oh+&#x00026;publication_year=2018&#x00026;title=Pathogenic+germline+variants+in+10,389+adult+cancers&#x00026;journal=Cell.&#x00026;volume=173&#x00026;pages=355-70. e14" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B18" id="B18"></a> 18. Gr&#x000F6;bner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, et al. The landscape of genomic alterations across childhood cancers. <i>Nature.</i> (2018) 555:321&#x02013;7. doi: 10.1038/nature25480</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29875405" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature25480" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SN.+Gr&#x000F6;bner&#x00026;author=BC.+Worst&#x00026;author=J.+Weischenfeldt&#x00026;author=I.+Buchhalter&#x00026;author=K.+Kleinheinz&#x00026;author=VA.+Rudneva+&#x00026;publication_year=2018&#x00026;title=The+landscape+of+genomic+alterations+across+childhood+cancers&#x00026;journal=Nature.&#x00026;volume=555&#x00026;pages=321-7" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B19" id="B19"></a> 19. Deng J, Weng X, Ye J, Zhou D, Liu Y, Zhao K. Identification of the germline mutation profile in esophageal squamous cell carcinoma by whole exome sequencing. <i>Front Genet.</i> (2019) 10:47. doi: 10.3389/fgene.2019.00047</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30833958" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fgene.2019.00047" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Deng&#x00026;author=X.+Weng&#x00026;author=J.+Ye&#x00026;author=D.+Zhou&#x00026;author=Y.+Liu&#x00026;author=K.+Zhao+&#x00026;publication_year=2019&#x00026;title=Identification+of+the+germline+mutation+profile+in+esophageal+squamous+cell+carcinoma+by+whole+exome+sequencing&#x00026;journal=Front+Genet.&#x00026;volume=10&#x00026;pages=47" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B20" id="B20"></a> 20. Ko JMY, Ning L, Zhao XK, Chai AWY, Lei LC, Choi SSA, et al. BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese. <i>Int J Cancer.</i> (2020) 146:1042&#x02013;51. doi: 10.1002/ijc.32619</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31396961" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/ijc.32619" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JMY.+Ko&#x00026;author=L.+Ning&#x00026;author=XK.+Zhao&#x00026;author=AWY.+Chai&#x00026;author=LC.+Lei&#x00026;author=SSA.+Choi+&#x00026;publication_year=2020&#x00026;title=BRCA2+loss-of-function+germline+mutations+are+associated+with+esophageal+squamous+cell+carcinoma+risk+in+Chinese&#x00026;journal=Int+J+Cancer.&#x00026;volume=146&#x00026;pages=1042-51" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B21" id="B21"></a> 21. Knudson AG. Two genetic hits (more or less) to cancer. <i>Nat Rev Cancer.</i> (2001) 1:157&#x02013;62. doi: 10.1038/35101031</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/11905807" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/35101031" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AG.+Knudson+&#x00026;publication_year=2001&#x00026;title=Two+genetic+hits+(more+or+less)+to+cancer&#x00026;journal=Nat+Rev+Cancer.&#x00026;volume=1&#x00026;pages=157-62" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B22" id="B22"></a> 22. Carlo MI, Mukherjee S, Mandelker D, Vijai J, Kemel Y, Zhang L, et al. Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma. <i>JAMA Oncol</i>. (2018) 4:1228&#x02013;35. doi: 10.1001/jamaoncol.2018.1986</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29978187" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1001/jamaoncol.2018.1986" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MI.+Carlo&#x00026;author=S.+Mukherjee&#x00026;author=D.+Mandelker&#x00026;author=J.+Vijai&#x00026;author=Y.+Kemel&#x00026;author=L.+Zhang+&#x00026;publication_year=2018&#x00026;title=Prevalence+of+germline+mutations+in+cancer+susceptibility+genes+in+patients+with+advanced+renal+cell+carcinoma&#x00026;journal=JAMA+Oncol&#x00026;volume=4&#x00026;pages=1228-35" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B23" id="B23"></a> 23. Park S, Supek F, Lehner B. Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits. <i>Nat Commun.</i> (2018) 9:2601. doi: 10.1038/s41467-018-04900-7</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29973584" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41467-018-04900-7" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Park&#x00026;author=F.+Supek&#x00026;author=B.+Lehner+&#x00026;publication_year=2018&#x00026;title=Systematic+discovery+of+germline+cancer+predisposition+genes+through+the+identification+of+somatic+second+hits&#x00026;journal=Nat+Commun.&#x00026;volume=9&#x00026;pages=2601" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B24" id="B24"></a> 24. Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. <i>Nat Genet.</i> (2014) 46:467&#x02013;73. doi: 10.1038/ng.2935</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24686850" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng.2935" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=DC.+Lin&#x00026;author=JJ.+Hao&#x00026;author=Y.+Nagata&#x00026;author=L.+Xu&#x00026;author=L.+Shang&#x00026;author=X.+Meng+&#x00026;publication_year=2014&#x00026;title=Genomic+and+molecular+characterization+of+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=46&#x00026;pages=467-73" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B25" id="B25"></a> 25. Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. <i>Am J Hum Genet.</i> (2015) 96:597&#x02013;611. doi: 10.1016/j.ajhg.2015.02.017</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32888509" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ajhg.2015.02.017" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L.+Zhang&#x00026;author=Y.+Zhou&#x00026;author=C.+Cheng&#x00026;author=H.+Cui&#x00026;author=L.+Cheng&#x00026;author=P.+Kong+&#x00026;publication_year=2015&#x00026;title=Genomic+analyses+reveal+mutational+signatures+and+frequently+altered+genes+in+esophageal+squamous+cell+carcinoma&#x00026;journal=Am+J+Hum+Genet.&#x00026;volume=96&#x00026;pages=597-611" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B26" id="B26"></a> 26. Hao JJ, Lin DC, Dinh HQ, Mayakonda A, Jiang YY, Chang C, et al. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. <i>Nat Genet.</i> (2016) 48:1500&#x02013;7. doi: 10.1038/ng.3683</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27749841" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng.3683" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JJ.+Hao&#x00026;author=DC.+Lin&#x00026;author=HQ.+Dinh&#x00026;author=A.+Mayakonda&#x00026;author=YY.+Jiang&#x00026;author=C.+Chang+&#x00026;publication_year=2016&#x00026;title=Spatial+intratumoral+heterogeneity+and+temporal+clonal+evolution+in+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=48&#x00026;pages=1500-7" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B27" id="B27"></a> 27. Liu W, Snell JM, Jeck WR, Hoadley KA, Wilkerson MD, Parker JS, et al. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. <i>JCI Insight.</i> (2016) 1:1&#x02013;11. doi: 10.1172/jci.insight.88755</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29148985" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1172/jci.insight.88755" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W.+Liu&#x00026;author=JM.+Snell&#x00026;author=WR.+Jeck&#x00026;author=KA.+Hoadley&#x00026;author=MD.+Wilkerson&#x00026;author=JS.+Parker+&#x00026;publication_year=2016&#x00026;title=Subtyping+sub-Saharan+esophageal+squamous+cell+carcinoma+by+comprehensive+molecular+analysis&#x00026;journal=JCI+Insight.&#x00026;volume=1&#x00026;pages=1-11" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B28" id="B28"></a> 28. Deng J, Chen H, Zhou D, Zhang J, Chen Y, Liu Q, et al. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. <i>Nat Commun.</i> (2017) 8:1533. doi: 10.1038/s41467-017-01730-x</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29142225" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41467-017-01730-x" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Deng&#x00026;author=H.+Chen&#x00026;author=D.+Zhou&#x00026;author=J.+Zhang&#x00026;author=Y.+Chen&#x00026;author=Q.+Liu+&#x00026;publication_year=2017&#x00026;title=Comparative+genomic+analysis+of+esophageal+squamous+cell+carcinoma+between+Asian+and+Caucasian+patient+populations&#x00026;journal=Nat+Commun.&#x00026;volume=8&#x00026;pages=1533" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B29" id="B29"></a> 29. Kim J, Bowlby R, Mungall AJ, Robertson AG, Odze RD, Cherniack AD, et al. Integrated genomic characterization of oesophageal carcinoma. <i>Nature.</i> (2017) 541:169&#x02013;74. doi: 10.1038/nature20805</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28052061" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature20805" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J.+Kim&#x00026;author=R.+Bowlby&#x00026;author=AJ.+Mungall&#x00026;author=AG.+Robertson&#x00026;author=RD.+Odze&#x00026;author=AD.+Cherniack+&#x00026;publication_year=2017&#x00026;title=Integrated+genomic+characterization+of+oesophageal+carcinoma&#x00026;journal=Nature.&#x00026;volume=541&#x00026;pages=169-74" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B30" id="B30"></a> 30. Ajay SS, Parker SCJ, Abaan HO, Fuentes Fajardo KV, Margulies EH. Accurate and comprehensive sequencing of personal genomes. <i>Genome Res.</i> (2011) 21:1498&#x02013;505. doi: 10.1101/gr.123638.111</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/21771779" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/gr.123638.111" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SS.+Ajay&#x00026;author=SCJ.+Parker&#x00026;author=HO.+Abaan&#x00026;author=KV.+Fuentes+Fajardo&#x00026;author=EH.+Margulies+&#x00026;publication_year=2011&#x00026;title=Accurate+and+comprehensive+sequencing+of+personal+genomes&#x00026;journal=Genome+Res.&#x00026;volume=21&#x00026;pages=1498-505" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B31" id="B31"></a> 31. Chen Y, Chen Y, Shi C, Huang Z, Zhang Y. SOAPnuke : a MapReduce acceleration supported software for integrated quality control and preprocessing of high-throughput sequencing data. <i>GigaScience.</i> (2018) 7:gix120. doi: 10.1093/gigascience/gix120</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29220494" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/gigascience/gix120" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+Chen&#x00026;author=Y.+Chen&#x00026;author=C.+Shi&#x00026;author=Z.+Huang&#x00026;author=Y.+Zhang+&#x00026;publication_year=2018&#x00026;title=SOAPnuke+%3A+a+MapReduce+acceleration+supported+software+for+integrated+quality+control+and+preprocessing+of+high-throughput+sequencing+data&#x00026;journal=GigaScience.&#x00026;volume=7&#x00026;pages=gix120" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B32" id="B32"></a> 32. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. <i>Genome Res.</i> (2010) 20:1297&#x02013;303. doi: 10.1101/gr.107524.110</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20644199" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/gr.107524.110" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+McKenna&#x00026;author=M.+Hanna&#x00026;author=E.+Banks&#x00026;author=A.+Sivachenko&#x00026;author=K.+Cibulskis&#x00026;author=A.+Kernytsky+&#x00026;publication_year=2010&#x00026;title=The+genome+analysis+toolkit%3A+a+MapReduce+framework+for+analyzing+next-generation+DNA+sequencing+data&#x00026;journal=Genome+Res.&#x00026;volume=20&#x00026;pages=1297-303" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B33" id="B33"></a> 33. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. <i>Bioinformatics.</i> (2010) 26:589&#x02013;95. doi: 10.1093/bioinformatics/btp698</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20080505" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/bioinformatics/btp698" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H.+Li&#x00026;author=R.+Durbin+&#x00026;publication_year=2010&#x00026;title=Fast+and+accurate+long-read+alignment+with+Burrows-Wheeler+transform&#x00026;journal=Bioinformatics.&#x00026;volume=26&#x00026;pages=589-95" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B34" id="B34"></a> 34. McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensembl variant effect predictor. <i>Genome Biol.</i> (2016) 17:1&#x02013;4. doi: 10.1186/s13059-016-0974-4</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1186/s13059-016-0974-4" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W.+McLaren&#x00026;author=L.+Gil&#x00026;author=SE.+Hunt&#x00026;author=HS.+Riat&#x00026;author=GRS.+Ritchie&#x00026;author=A.+Thormann+&#x00026;publication_year=2016&#x00026;title=The+ensembl+variant+effect+predictor&#x00026;journal=Genome+Biol.&#x00026;volume=17&#x00026;pages=1-4" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B35" id="B35"></a> 35. Ramos AH, Lichtenstein L, Gupta M, Lawrence MS, Pugh TJ. Oncotator : cancer variant annotation tool. <i>Hum Mutation.</i> (2015) 36:E2423&#x02013;9. doi: 10.1002/humu.22771</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25703262" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/humu.22771" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AH.+Ramos&#x00026;author=L.+Lichtenstein&#x00026;author=M.+Gupta&#x00026;author=MS.+Lawrence&#x00026;author=TJ.+Pugh+&#x00026;publication_year=2015&#x00026;title=Oncotator+%3A+cancer+variant+annotation+tool&#x00026;journal=Hum+Mutation.&#x00026;volume=36&#x00026;pages=E2423-9" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B36" id="B36"></a> 36. Shen R, Seshan VE. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. <i>Nucleic Acids Res.</i> (2016) 44:1&#x02013;9. doi: 10.1093/nar/gkw520</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27270079" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkw520" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Shen&#x00026;author=VE.+Seshan+&#x00026;publication_year=2016&#x00026;title=FACETS%3A+allele-specific+copy+number+and+clonal+heterogeneity+analysis+tool+for+high-throughput+DNA+sequencing&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=44&#x00026;pages=1-9" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B37" id="B37"></a> 37. Mayrhofer M, DiLorenzo S, Isaksson A. Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue. <i>Genome Biol.</i> (2013) 14:R24. doi: 10.1186/gb-2013-14-3-r24</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23531354" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/gb-2013-14-3-r24" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Mayrhofer&#x00026;author=S.+DiLorenzo&#x00026;author=A.+Isaksson+&#x00026;publication_year=2013&#x00026;title=Patchwork%3A+allele-specific+copy+number+analysis+of+whole-genome+sequenced+tumor+tissue&#x00026;journal=Genome+Biol.&#x00026;volume=14&#x00026;pages=R24" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B38" id="B38"></a> 38. Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high-resolution. <i>Nucleic Acids Res.</i> (2017) 45:D777&#x02013;83. doi: 10.1093/nar/gkw1121</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27899578" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkw1121" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SA.+Forbes&#x00026;author=D.+Beare&#x00026;author=H.+Boutselakis&#x00026;author=S.+Bamford&#x00026;author=N.+Bindal&#x00026;author=J.+Tate+&#x00026;publication_year=2017&#x00026;title=COSMIC%3A+somatic+cancer+genetics+at+high-resolution&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=45&#x00026;pages=D777-83" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B39" id="B39"></a> 39. Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. <i>JAMA Oncol.</i> (2020) 6:724&#x02013;34. doi: 10.1001/jamaoncol.2020.0197</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32191290" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1001/jamaoncol.2020.0197" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L.+Mirabello&#x00026;author=B.+Zhu&#x00026;author=R.+Koster&#x00026;author=E.+Karlins&#x00026;author=M.+Dean&#x00026;author=M.+Yeager+&#x00026;publication_year=2020&#x00026;title=Frequency+of+pathogenic+germline+variants+in+cancer-susceptibility+genes+in+patients+with+osteosarcoma&#x00026;journal=JAMA+Oncol.&#x00026;volume=6&#x00026;pages=724-34" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B40" id="B40"></a> 40. Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. <i>Nucleic Acids Res.</i> (2013) 41:970&#x02013;6. doi: 10.1093/nar/gks937</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23066107" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gks937" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Zhao&#x00026;author=J.+Sun&#x00026;author=Z.+Zhao+&#x00026;publication_year=2013&#x00026;title=TSGene%3A+a+web+resource+for+tumor+suppressor+genes&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=41&#x00026;pages=970-6" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B41" id="B41"></a> 41. Zhao M, Kim P, Mitra R, Zhao J, Zhao Z. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. <i>Nucleic Acids Res.</i> (2016) 44:D1023&#x02013;31. doi: 10.1093/nar/gkv1268</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26590405" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkv1268" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Zhao&#x00026;author=P.+Kim&#x00026;author=R.+Mitra&#x00026;author=J.+Zhao&#x00026;author=Z.+Zhao+&#x00026;publication_year=2016&#x00026;title=TSGene+2.0%3A+an+updated+literature-based+knowledgebase+for+tumor+suppressor+genes&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=44&#x00026;pages=D1023-31" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B42" id="B42"></a> 42. Liu Y, Sun J, Zhao M. ONGene: a literature-based database for human oncogenes. <i>J Genet Genom.</i> (2017) 44:119&#x02013;21. doi: 10.1016/j.jgg.2016.12.004</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28162959" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.jgg.2016.12.004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+Liu&#x00026;author=J.+Sun&#x00026;author=M.+Zhao+&#x00026;publication_year=2017&#x00026;title=ONGene%3A+a+literature-based+database+for+human+oncogenes&#x00026;journal=J+Genet+Genom.&#x00026;volume=44&#x00026;pages=119-21" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B43" id="B43"></a> 43. Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. <i>Am J Hum Genet.</i> (2017) 100:267&#x02013;80. doi: 10.1016/j.ajhg.2017.01.004</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28132688" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ajhg.2017.01.004" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Q.+Li&#x00026;author=K.+Wang+&#x00026;publication_year=2017&#x00026;title=InterVar%3A+clinical+interpretation+of+genetic+variants+by+the+2015+ACMG-AMP+guidelines&#x00026;journal=Am+J+Hum+Genet.&#x00026;volume=100&#x00026;pages=267-80" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B44" id="B44"></a> 44. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. <i>Genet Med.</i> (2015) 17:405&#x02013;23. doi: 10.1038/gim.2015.30</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25741868" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/gim.2015.30" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Richards&#x00026;author=N.+Aziz&#x00026;author=S.+Bale&#x00026;author=D.+Bick&#x00026;author=S.+Das&#x00026;author=J.+Gastier-Foster+&#x00026;publication_year=2015&#x00026;title=Standards+and+guidelines+for+the+interpretation+of+sequence+variants%3A+a+joint+consensus+recommendation+of+the+American+College+of+Medical+Genetics+and+Genomics+and+the+Association+for+Molecular+Pathology&#x00026;journal=Genet+Med.&#x00026;volume=17&#x00026;pages=405-23" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B45" id="B45"></a> 45. Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, et al. the human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. <i>Hum Genet.</i> (2017) 136:665&#x02013;77. doi: 10.1007/s00439-017-1779-6</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28349240" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00439-017-1779-6" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=PD.+Stenson&#x00026;author=M.+Mort&#x00026;author=EV.+Ball&#x00026;author=K.+Evans&#x00026;author=M.+Hayden&#x00026;author=S.+Heywood+&#x00026;publication_year=2017&#x00026;title=the+human+gene+mutation+database%3A+towards+a+comprehensive+repository+of+inherited+mutation+data+for+medical+research,+genetic+diagnosis+and+next-generation+sequencing+studies&#x00026;journal=Hum+Genet.&#x00026;volume=136&#x00026;pages=665-77" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B46" id="B46"></a> 46. Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. <i>Nucleic Acids Res.</i> (2018) 46:D1062&#x02013;7. doi: 10.1093/nar/gkx1153</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29165669" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gkx1153" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MJ.+Landrum&#x00026;author=JM.+Lee&#x00026;author=M.+Benson&#x00026;author=GR.+Brown&#x00026;author=C.+Chao&#x00026;author=S.+Chitipiralla+&#x00026;publication_year=2018&#x00026;title=ClinVar%3A+improving+access+to+variant+interpretations+and+supporting+evidence&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=46&#x00026;pages=D1062-7" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B47" id="B47"></a> 47. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. <i>Nature.</i> (2016) 536:285&#x02013;91. doi: 10.1038/nature19057</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27535533" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature19057" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Lek&#x00026;author=KJ.+Karczewski&#x00026;author=EV.+Minikel&#x00026;author=KE.+Samocha&#x00026;author=E.+Banks&#x00026;author=T.+Fennell+&#x00026;publication_year=2016&#x00026;title=Analysis+of+protein-coding+genetic+variation+in+60,706+humans&#x00026;journal=Nature.&#x00026;volume=536&#x00026;pages=285-91" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B48" id="B48"></a> 48. Poplin R, Chang PC, Alexander D, Schwartz S, Colthurst T, Ku A, et al. A universal snp and small-indel variant caller using deep neural networks. <i>Nat Biotechnol.</i> (2018) 36:983. doi: 10.1038/nbt.4235</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30247488" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nbt.4235" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Poplin&#x00026;author=PC.+Chang&#x00026;author=D.+Alexander&#x00026;author=S.+Schwartz&#x00026;author=T.+Colthurst&#x00026;author=A.+Ku+&#x00026;publication_year=2018&#x00026;title=A+universal+snp+and+small-indel+variant+caller+using+deep+neural+networks&#x00026;journal=Nat+Biotechnol.&#x00026;volume=36&#x00026;pages=983" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B49" id="B49"></a> 49. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. <i>Nat Protocols.</i> (2009) 4:1073&#x02013;82. doi: 10.1038/nprot.2009.86</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/19561590" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nprot.2009.86" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P.+Kumar&#x00026;author=S.+Henikoff&#x00026;author=PC.+Ng+&#x00026;publication_year=2009&#x00026;title=Predicting+the+effects+of+coding+non-synonymous+variants+on+protein+function+using+the+SIFT+algorithm&#x00026;journal=Nat+Protocols.&#x00026;volume=4&#x00026;pages=1073-82" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B50" id="B50"></a> 50. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. <i>Nat Methods.</i> (2010) 7:248&#x02013;9. doi: 10.1038/nmeth0410-248</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20354512" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nmeth0410-248" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=IA.+Adzhubei&#x00026;author=S.+Schmidt&#x00026;author=L.+Peshkin&#x00026;author=VE.+Ramensky&#x00026;author=A.+Gerasimova&#x00026;author=P.+Bork+&#x00026;publication_year=2010&#x00026;title=A+method+and+server+for+predicting+damaging+missense+mutations&#x00026;journal=Nat+Methods.&#x00026;volume=7&#x00026;pages=248-9" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B51" id="B51"></a> 51. Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. <i>Nucleic Acids Res.</i> (2019) 47:D886&#x02013;94. doi: 10.1093/nar/gky1016</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30371827" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gky1016" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P.+Rentzsch&#x00026;author=D.+Witten&#x00026;author=GM.+Cooper&#x00026;author=J.+Shendure&#x00026;author=M.+Kircher+&#x00026;publication_year=2019&#x00026;title=CADD%3A+predicting+the+deleteriousness+of+variants+throughout+the+human+genome&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=47&#x00026;pages=D886-94" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B52" id="B52"></a> 52. Geurts-Giele WRR, Leenen CHM, Dubbink HJ, Meijssen IC, Post E, Sleddens HFBM, et al. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers. <i>J Pathol.</i> (2014) 234:548&#x02013;59. doi: 10.1002/path.4419</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25111426" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/path.4419" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=WRR.+Geurts-Giele&#x00026;author=CHM.+Leenen&#x00026;author=HJ.+Dubbink&#x00026;author=IC.+Meijssen&#x00026;author=E.+Post&#x00026;author=HFBM.+Sleddens+&#x00026;publication_year=2014&#x00026;title=Somatic+aberrations+of+mismatch+repair+genes+as+a+cause+of+microsatellite-unstable+cancers&#x00026;journal=J+Pathol.&#x00026;volume=234&#x00026;pages=548-59" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B53" id="B53"></a> 53. Cox C, Bignell G, Greenman C, Stabenau A, Warren W, Stephens P, et al. A survey of homozygous deletions in human cancer genomes. <i>Proc Natl Acad Sci USA.</i> (2005) 102:4542&#x02013;7. doi: 10.1073/pnas.0408593102</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/15761058" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1073/pnas.0408593102" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C.+Cox&#x00026;author=G.+Bignell&#x00026;author=C.+Greenman&#x00026;author=A.+Stabenau&#x00026;author=W.+Warren&#x00026;author=P.+Stephens+&#x00026;publication_year=2005&#x00026;title=A+survey+of+homozygous+deletions+in+human+cancer+genomes&#x00026;journal=Proc+Natl+Acad+Sci+USA.&#x00026;volume=102&#x00026;pages=4542-7" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B54" id="B54"></a> 54. Ryland GL, Doyle MA, Goode D, Boyle SE, Choong DYH, Rowley SM, et al. Loss of heterozygosity: What is it good for? <i>BMC Med Genom.</i> (2015) 8:1&#x02013;12. doi: 10.1186/s12920-015-0123-z</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26231170" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1186/s12920-015-0123-z" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=GL.+Ryland&#x00026;author=MA.+Doyle&#x00026;author=D.+Goode&#x00026;author=SE.+Boyle&#x00026;author=DYH.+Choong&#x00026;author=SM.+Rowley+&#x00026;publication_year=2015&#x00026;title=Loss+of+heterozygosity%3A+What+is+it+good+for%3F&#x00026;journal=BMC+Med+Genom.&#x00026;volume=8&#x00026;pages=1-12" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B55" id="B55"></a> 55. Robinson JT, Thorvaldsd&#x000F3;ttir H, Wenger AM, Zehir A, Mesirov JP. Variant review with the integrative genomics viewer. <i>Cancer Res.</i> (2017) 77:e31&#x02013;4. doi: 10.1158/0008-5472.CAN-17-0337</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29092934" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1158/0008-5472.CAN-17-0337" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JT.+Robinson&#x00026;author=H.+Thorvaldsd&#x000F3;ttir&#x00026;author=AM.+Wenger&#x00026;author=A.+Zehir&#x00026;author=JP.+Mesirov+&#x00026;publication_year=2017&#x00026;title=Variant+review+with+the+integrative+genomics+viewer&#x00026;journal=Cancer+Res.&#x00026;volume=77&#x00026;pages=e31-4" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B56" id="B56"></a> 56. Ionita-Laza I, Lee S, Makarov V, Buxbaum JD, Lin X. Sequence kernel association tests for the combined effect of rare and common variants. <i>Am J Hum Genet.</i> (2013) 92:841&#x02013;53. doi: 10.1016/j.ajhg.2013.04.015</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23684009" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.ajhg.2013.04.015" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+Ionita-Laza&#x00026;author=S.+Lee&#x00026;author=V.+Makarov&#x00026;author=JD.+Buxbaum&#x00026;author=X.+Lin+&#x00026;publication_year=2013&#x00026;title=Sequence+kernel+association+tests+for+the+combined+effect+of+rare+and+common+variants&#x00026;journal=Am+J+Hum+Genet.&#x00026;volume=92&#x00026;pages=841-53" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B57" id="B57"></a> 57. Cao Y, Li L, Xu M, Feng Z, Sun X, Lu J, et al. The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals. <i>Cell Res</i>. (2020) 717&#x02013;31. doi: 10.1038/s41422-020-0322-9</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32355288" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41422-020-0322-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+Cao&#x00026;author=L.+Li&#x00026;author=M.+Xu&#x00026;author=Z.+Feng&#x00026;author=X.+Sun&#x00026;author=J.+Lu+&#x00026;publication_year=2020&#x00026;title=The+ChinaMAP+analytics+of+deep+whole+genome+sequences+in+10,588+individuals&#x00026;journal=Cell+Res&#x00026;pages=717-31" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B58" id="B58"></a> 58. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. <i>Hum Mutation.</i> (2002) 19:607&#x02013;14. doi: 10.1002/humu.10081</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12007217" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/humu.10081" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Olivier&#x00026;author=R.+Eeles&#x00026;author=M.+Hollstein&#x00026;author=MA.+Khan&#x00026;author=CC.+Harris&#x00026;author=P.+Hainaut+&#x00026;publication_year=2002&#x00026;title=The+IARC+TP53+database%3A+new+online+mutation+analysis+and+recommendations+to+users&#x00026;journal=Hum+Mutation.&#x00026;volume=19&#x00026;pages=607-14" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B59" id="B59"></a> 59. Dzhemileva LU, Barashkov NA, Posukh OL, Khusainova RI, Akhmetova VL, Kutuev IA, et al. Carrier frequency of GJB2 gene mutations c.35delG, c.235delC and c.167delT among the populations of Eurasia. <i>J Hum Genet.</i> (2010) 55:749&#x02013;54. doi: 10.1038/jhg.2010.101</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20739944" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/jhg.2010.101" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=LU.+Dzhemileva&#x00026;author=NA.+Barashkov&#x00026;author=OL.+Posukh&#x00026;author=RI.+Khusainova&#x00026;author=VL.+Akhmetova&#x00026;author=IA.+Kutuev+&#x00026;publication_year=2010&#x00026;title=Carrier+frequency+of+GJB2+gene+mutations+c.35delG,+c.235delC+and+c.167delT+among+the+populations+of+Eurasia&#x00026;journal=J+Hum+Genet.&#x00026;volume=55&#x00026;pages=749-54" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B60" id="B60"></a> 60. Kwong A, Shin VY, Ho JCW, Kang E, Nakamura S, Teo SH, et al. Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. <i>J Med Genet.</i> (2016) 53:15&#x02013;23. doi: 10.1136/jmedgenet-2015-103132</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26187060" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1136/jmedgenet-2015-103132" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Kwong&#x00026;author=VY.+Shin&#x00026;author=JCW.+Ho&#x00026;author=E.+Kang&#x00026;author=S.+Nakamura&#x00026;author=SH.+Teo+&#x00026;publication_year=2016&#x00026;title=Comprehensive+spectrum+of+BRCA1+and+BRCA2+deleterious+mutations+in+breast+cancer+in+Asian+countries&#x00026;journal=J+Med+Genet.&#x00026;volume=53&#x00026;pages=15-23" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B61" id="B61"></a> 61. Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. <i>Lancet Oncol.</i> (2018) 19:785&#x02013;98. doi: 10.1016/S1470-2045(18)30242-0</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29753700" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/S1470-2045(18)30242-0" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SM.+Waszak&#x00026;author=PA.+Northcott&#x00026;author=I.+Buchhalter&#x00026;author=GW.+Robinson&#x00026;author=C.+Sutter&#x00026;author=S.+Groebner+&#x00026;publication_year=2018&#x00026;title=Spectrum+and+prevalence+of+genetic+predisposition+in+medulloblastoma%3A+a+retrospective+genetic+study+and+prospective+validation+in+a+clinical+trial+cohort&#x00026;journal=Lancet+Oncol.&#x00026;volume=19&#x00026;pages=785-98" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B62" id="B62"></a> 62. Wen WX, Allen J, Lai KN, Mariapun S, Hasan SN, Ng PS, et al. Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia. <i>J Med Genet.</i> (2018) 55:97&#x02013;103. doi: 10.1136/jmedgenet-2017-104947</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/28993434" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1136/jmedgenet-2017-104947" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=WX.+Wen&#x00026;author=J.+Allen&#x00026;author=KN.+Lai&#x00026;author=S.+Mariapun&#x00026;author=SN.+Hasan&#x00026;author=PS.+Ng+&#x00026;publication_year=2018&#x00026;title=Inherited+mutations+in+BRCA1+and+BRCA2+in+an+unselected+multiethnic+cohort+of+Asian+patients+with+breast+cancer+and+healthy+controls+from+Malaysia&#x00026;journal=J+Med+Genet.&#x00026;volume=55&#x00026;pages=97-103" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B63" id="B63"></a> 63. Aretz S, Tricarico R, Papi L, Spier I, Pin E, Horpaopan S, et al. MUTYH-associated polyposis (MAP): Evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events. <i>Eur J Hum Genet.</i> (2014) 22:923&#x02013;9. doi: 10.1038/ejhg.2012.309</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23361220" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ejhg.2012.309" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Aretz&#x00026;author=R.+Tricarico&#x00026;author=L.+Papi&#x00026;author=I.+Spier&#x00026;author=E.+Pin&#x00026;author=S.+Horpaopan+&#x00026;publication_year=2014&#x00026;title=MUTYH-associated+polyposis+(MAP)%3A+Evidence+for+the+origin+of+the+common+European+mutations+p.Tyr179Cys+and+p.Gly396Asp+by+founder+events&#x00026;journal=Eur+J+Hum+Genet.&#x00026;volume=22&#x00026;pages=923-9" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B64" id="B64"></a> 64. Taki K, Sato Y, Nomura S, Ashihara Y, Kita M, Tajima I, et al. Mutation analysis of MUTYH in Japanese colorectal adenomatous polyposis patients. <i>Familial Cancer.</i> (2016) 15:261&#x02013;5. doi: 10.1007/s10689-015-9857-1</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26684191" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s10689-015-9857-1" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K.+Taki&#x00026;author=Y.+Sato&#x00026;author=S.+Nomura&#x00026;author=Y.+Ashihara&#x00026;author=M.+Kita&#x00026;author=I.+Tajima+&#x00026;publication_year=2016&#x00026;title=Mutation+analysis+of+MUTYH+in+Japanese+colorectal+adenomatous+polyposis+patients&#x00026;journal=Familial+Cancer.&#x00026;volume=15&#x00026;pages=261-5" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B65" id="B65"></a> 65. Klift HM, van der Tops &#x000C3;CMJ, Bik EC, Boogaard MW, Borgstein A, Hansson KBM, et al. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of lynch syndrome patients. <i>Hum Mutation.</i> (2010) 31:578&#x02013;87. doi: 10.1002/humu.21229</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20186688" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/humu.21229" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=HM.+Klift&#x00026;author=&#x000C3;CMJ.+van+der+Tops&#x00026;author=EC.+Bik&#x00026;author=MW.+Boogaard&#x00026;author=A.+Borgstein&#x00026;author=KBM.+Hansson+&#x00026;publication_year=2010&#x00026;title=Quantification+of+sequence+exchange+events+between+PMS2+and+PMS2CL+provides+a+basis+for+improved+mutation+scanning+of+lynch+syndrome+patients&#x00026;journal=Hum+Mutation.&#x00026;volume=31&#x00026;pages=578-87" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B66" id="B66"></a> 66. Zhang P, Kitchen-Smith I, Xiong L, Stracquadanio G, Brown K, Richter P, et al. Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response. <i>bioRxiv [Preprint]</i>. (2019). doi: 10.1101/835918</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33558336" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/835918" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P.+Zhang&#x00026;author=I.+Kitchen-Smith&#x00026;author=L.+Xiong&#x00026;author=G.+Stracquadanio&#x00026;author=K.+Brown&#x00026;author=P.+Richter+&#x00026;publication_year=2019&#x00026;title=Germline+and+somatic+genetic+variants+in+the+p53+pathway+interact+to+affect+cancer+risk,+progression+and+drug+response&#x00026;journal=bioRxiv+[Preprint]" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B67" id="B67"></a> 67. Staninova-Stojovska M, Matevska-Geskovska N, Panovski M, Angelovska B, Mitrevski N, Ristevski M, et al. Molecular basis of inherited colorectal carcinomas in the macedonian population: an update. <i>Balkan J Med Genet.</i> (2019) 22:5&#x02013;16. doi: 10.2478/bjmg-2019-0027</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31942411" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2478/bjmg-2019-0027" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Staninova-Stojovska&#x00026;author=N.+Matevska-Geskovska&#x00026;author=M.+Panovski&#x00026;author=B.+Angelovska&#x00026;author=N.+Mitrevski&#x00026;author=M.+Ristevski+&#x00026;publication_year=2019&#x00026;title=Molecular+basis+of+inherited+colorectal+carcinomas+in+the+macedonian+population%3A+an+update&#x00026;journal=Balkan+J+Med+Genet.&#x00026;volume=22&#x00026;pages=5-16" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B68" id="B68"></a> 68. Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. <i>Nature.</i> (2015) 526:68&#x02013;74. doi: 10.1038/nature15393</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26432245" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature15393" target="_blank">CrossRef Full Text</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B69" id="B69"></a> 69. Boland CR, Goel A. Microsatellite instability in colorectal cancer. <i>Gastroenterology.</i> (2010) 138:2073&#x02013;87.e3. doi: 10.1053/j.gastro.2009.12.064</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1053/j.gastro.2009.12.064" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=CR.+Boland&#x00026;author=A.+Goel+&#x00026;publication_year=2010&#x00026;title=Microsatellite+instability+in+colorectal+cancer&#x00026;journal=Gastroenterology.&#x00026;volume=138&#x00026;pages=2073-87.e3" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B70" id="B70"></a> 70. Sourrouille I, Coulet F, Lefevre JH, Colas C, Eyries M, Svrcek M, et al. Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors. <i>Familial Cancer.</i> (2013) 12:27&#x02013;33. doi: 10.1007/s10689-012-9568-9</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22987205" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s10689-012-9568-9" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I.+Sourrouille&#x00026;author=F.+Coulet&#x00026;author=JH.+Lefevre&#x00026;author=C.+Colas&#x00026;author=M.+Eyries&#x00026;author=M.+Svrcek+&#x00026;publication_year=2013&#x00026;title=Somatic+mosaicism+and+double+somatic+hits+can+lead+to+MSI+colorectal+tumors&#x00026;journal=Familial+Cancer.&#x00026;volume=12&#x00026;pages=27-33" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B71" id="B71"></a> 71. Ceccaldi R, Sarangi P, D&#x00027;Andrea AD. The Fanconi anaemia pathway: new players and new functions. <i>Nat Rev Mol Cell Biol.</i> (2016) 17:337. doi: 10.1038/nrm.2016.48</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27145721" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nrm.2016.48" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Ceccaldi&#x00026;author=P.+Sarangi&#x00026;author=AD.+D&#x00027;Andrea+&#x00026;publication_year=2016&#x00026;title=The+Fanconi+anaemia+pathway%3A+new+players+and+new+functions&#x00026;journal=Nat+Rev+Mol+Cell+Biol.&#x00026;volume=17&#x00026;pages=337" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B72" id="B72"></a> 72. Joshi Niraj, Anniina F&#x000E4;rkkil&#x000E4;, D&#x00027;Andrea AD. The fanconi anemia pathway in cancer. <i>Annu Rev Cancer Biol.</i> (2019) 3:457&#x02013;78. doi: 10.1146/annurev-cancerbio-030617-050422</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1146/annurev-cancerbio-030617-050422" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Niraj.+Joshi&#x00026;author=F&#x000E4;rkkil&#x000E4;.+Anniina&#x00026;author=AD.+D&#x00027;Andrea+&#x00026;publication_year=2019&#x00026;title=The+fanconi+anemia+pathway+in+cancer&#x00026;journal=Annu+Rev+Cancer+Biol.&#x00026;volume=3&#x00026;pages=457-78" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B73" id="B73"></a> 73. Hsieh P, Yamane K. DNA mismatch repair: molecular mechanism, cancer, and ageing. <i>Mech Ageing Dev.</i> (2008) 129:391&#x02013;407. doi: 10.1016/j.mad.2008.02.012</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18406444" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.mad.2008.02.012" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P.+Hsieh&#x00026;author=K.+Yamane+&#x00026;publication_year=2008&#x00026;title=DNA+mismatch+repair%3A+molecular+mechanism,+cancer,+and+ageing&#x00026;journal=Mech+Ageing+Dev.&#x00026;volume=129&#x00026;pages=391-407" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B74" id="B74"></a> 74. Li GM. Mechanisms and functions of DNA mismatch repair. <i>Cell Res.</i> (2008) 18:85&#x02013;98. doi: 10.1038/cr.2007.115</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18157157" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/cr.2007.115" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=GM.+Li+&#x00026;publication_year=2008&#x00026;title=Mechanisms+and+functions+of+DNA+mismatch+repair&#x00026;journal=Cell+Res.&#x00026;volume=18&#x00026;pages=85-98" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B75" id="B75"></a> 75. Li X, Heyer W-D. Homologous recombination in DNA reapir and DNA tolerance. <i>Cell Res.</i> (2008) 18:99&#x02013;113. doi: 10.1038/cr.2008.1</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/19674975" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/cr.2008.1" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=X.+Li&#x00026;author=W-D.+Heyer+&#x00026;publication_year=2008&#x00026;title=Homologous+recombination+in+DNA+reapir+and+DNA+tolerance&#x00026;journal=Cell+Res.&#x00026;volume=18&#x00026;pages=99-113" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B76" id="B76"></a> 76. Kanchi KL, Johnson KJ, Lu C, McLellan MD, Leiserson MDM, Wendl MC, et al. Integrated analysis of germline and somatic variants in ovarian cancer. <i>Nat Commun.</i> (2014) 5:3156. doi: 10.1038/ncomms4156</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24448499" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ncomms4156" target="_blank">CrossRef Full Text</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B77" id="B77"></a> 77. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic signaling pathways in the cancer genome atlas. <i>Cell.</i> (2018) 173:321.e10&#x02013;37. doi: 10.1016/j.cell.2018.03.035</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29625050" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.cell.2018.03.035" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F.+Sanchez-Vega&#x00026;author=M.+Mina&#x00026;author=J.+Armenia&#x00026;author=WK.+Chatila&#x00026;author=A.+Luna&#x00026;author=KC.+La+&#x00026;publication_year=2018&#x00026;title=Oncogenic+signaling+pathways+in+the+cancer+genome+atlas&#x00026;journal=Cell.&#x00026;volume=173&#x00026;pages=321.e10-37" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B78" id="B78"></a> 78. Pavletich NP, Chambers KA, Pabo CO. The DNA-binding domain of 53 contains the four conserved regions the major mutation hot spots. <i>Genes Dev.</i> (1993) 7:2556&#x02013;64. doi: 10.1101/gad.7.12b.2556</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/8276238" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1101/gad.7.12b.2556" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=NP.+Pavletich&#x00026;author=KA.+Chambers&#x00026;author=CO.+Pabo+&#x00026;publication_year=1993&#x00026;title=The+DNA-binding+domain+of+53+contains+the+four+conserved+regions+the+major+mutation+hot+spots&#x00026;journal=Genes+Dev.&#x00026;volume=7&#x00026;pages=2556-64" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B79" id="B79"></a> 79. Harms KL, Chen X. The functional domains in p53 family proteins exhibit both common and distinct properties. <i>Cell Death Differ.</i> (2006) 13:890&#x02013;7. doi: 10.1038/sj.cdd.4401904</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16543939" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.cdd.4401904" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=KL.+Harms&#x00026;author=X.+Chen+&#x00026;publication_year=2006&#x00026;title=The+functional+domains+in+p53+family+proteins+exhibit+both+common+and+distinct+properties&#x00026;journal=Cell+Death+Differ.&#x00026;volume=13&#x00026;pages=890-7" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B80" id="B80"></a> 80. Baugh EH, Ke H, Levine AJ, Bonneau RA, Chan CS. Why are there hotspot mutations in the TP53 gene in human cancers? <i>Cell Death Differ.</i> (2018) 25:154&#x02013;60. doi: 10.1038/cdd.2017.180</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29099487" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/cdd.2017.180" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=EH.+Baugh&#x00026;author=H.+Ke&#x00026;author=AJ.+Levine&#x00026;author=RA.+Bonneau&#x00026;author=CS.+Chan+&#x00026;publication_year=2018&#x00026;title=Why+are+there+hotspot+mutations+in+the+TP53+gene+in+human+cancers%3F&#x00026;journal=Cell+Death+Differ.&#x00026;volume=25&#x00026;pages=154-60" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B81" id="B81"></a> 81. Parrales A, Iwakuma T. Targeting oncogenic mutant p53 for cancer therapy. <i>Front Oncol.</i> (2015) 5:288. doi: 10.3389/fonc.2015.00288</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26732534" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fonc.2015.00288" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Parrales&#x00026;author=T.+Iwakuma+&#x00026;publication_year=2015&#x00026;title=Targeting+oncogenic+mutant+p53+for+cancer+therapy&#x00026;journal=Front+Oncol.&#x00026;volume=5&#x00026;pages=288" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B82" id="B82"></a> 82. Pradhan MR, Siau JW, Kannan S, Nguyen MN, Ouaray Z, Kwoh CK, et al. Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket. <i>Nucleic Acids Res.</i> (2019) 47:1637&#x02013;52. doi: 10.1093/nar/gky1314</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30649466" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/nar/gky1314" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MR.+Pradhan&#x00026;author=JW.+Siau&#x00026;author=S.+Kannan&#x00026;author=MN.+Nguyen&#x00026;author=Z.+Ouaray&#x00026;author=CK.+Kwoh+&#x00026;publication_year=2019&#x00026;title=Simulations+of+mutant+p53+DNA+binding+domains+reveal+a+novel+druggable+pocket&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=47&#x00026;pages=1637-52" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B83" id="B83"></a> 83. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. <i>Nat Genet.</i> (2002) 32:355&#x02013;7. doi: 10.1038/ng1013</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12379854" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/ng1013" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K.+Kurose&#x00026;author=K.+Gilley&#x00026;author=S.+Matsumoto&#x00026;author=PH.+Watson&#x00026;author=XP.+Zhou&#x00026;author=C.+Eng+&#x00026;publication_year=2002&#x00026;title=Frequent+somatic+mutations+in+PTEN+and+TP53+are+mutually+exclusive+in+the+stroma+of+breast+carcinomas&#x00026;journal=Nat+Genet.&#x00026;volume=32&#x00026;pages=355-7" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B84" id="B84"></a> 84. Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, et al. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. <i>Nature.</i> (2016) 531:471&#x02013;5. doi: 10.1038/nature17157</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26982726" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/nature17157" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y.+Liu&#x00026;author=C.+Chen&#x00026;author=Z.+Xu&#x00026;author=C.+Scuoppo&#x00026;author=CD.+Rillahan&#x00026;author=J.+Gao+&#x00026;publication_year=2016&#x00026;title=Deletions+linked+to+TP53+loss+drive+cancer+through+p53-independent+mechanisms&#x00026;journal=Nature.&#x00026;volume=531&#x00026;pages=471-5" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B85" id="B85"></a> 85. Buisson R, Dion-C&#x000F4;t&#x000E9; A-M, Coulombe Y, Launay H. Cooperation of breast cancer proteins PALB2 and piccolo BRAC2 in stimulating homologous recombination. <i>Nat Struct Mol Biol.</i> (2010) 17:1247&#x02013;54. doi: 10.1038/nsmb.1915</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1038/nsmb.1915" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R.+Buisson&#x00026;author=A-M.+Dion-C&#x000F4;t&#x000E9;&#x00026;author=Y.+Coulombe&#x00026;author=H.+Launay+&#x00026;publication_year=2010&#x00026;title=Cooperation+of+breast+cancer+proteins+PALB2+and+piccolo+BRAC2+in+stimulating+homologous+recombination&#x00026;journal=Nat+Struct+Mol+Biol.&#x00026;volume=17&#x00026;pages=1247-54" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B86" id="B86"></a> 86. Girardi F, Barnes DR, Barrowdale D, Frost D, Brady AF, Miller C, et al. Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study. <i>Genet Med.</i> (2018) 20:1575&#x02013;82. doi: 10.1038/gim.2018.44</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29565421" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/gim.2018.44" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F.+Girardi&#x00026;author=DR.+Barnes&#x00026;author=D.+Barrowdale&#x00026;author=D.+Frost&#x00026;author=AF.+Brady&#x00026;author=C.+Miller+&#x00026;publication_year=2018&#x00026;title=Risks+of+breast+or+ovarian+cancer+in+BRCA1+or+BRCA2+predictive+test+negatives%3A+findings+from+the+EMBRACE+study&#x00026;journal=Genet+Med.&#x00026;volume=20&#x00026;pages=1575-82" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B87" id="B87"></a> 87. Hu N, Wang C, Han XY, He LJ, Tang ZZ, Giffen C, et al. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer. <i>Oncogene.</i> (2004) 23:852&#x02013;8. doi: 10.1038/sj.onc.1207150</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/14647438" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.onc.1207150" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N.+Hu&#x00026;author=C.+Wang&#x00026;author=XY.+Han&#x00026;author=LJ.+He&#x00026;author=ZZ.+Tang&#x00026;author=C.+Giffen+&#x00026;publication_year=2004&#x00026;title=Evaluation+of+BRCA2+in+the+genetic+susceptibility+of+familial+esophageal+cancer&#x00026;journal=Oncogene.&#x00026;volume=23&#x00026;pages=852-8" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B88" id="B88"></a> 88. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, et al. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. <i>Oncogene.</i> (2008) 27:1290&#x02013;6. doi: 10.1038/sj.onc.1210739</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/31396961" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/sj.onc.1210739" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MR.+Akbari&#x00026;author=R.+Malekzadeh&#x00026;author=D.+Nasrollahzadeh&#x00026;author=D.+Amanian&#x00026;author=F.+Islami&#x00026;author=S.+Li+&#x00026;publication_year=2008&#x00026;title=Germline+BRCA2+mutations+and+the+risk+of+esophageal+squamous+cell+carcinoma&#x00026;journal=Oncogene.&#x00026;volume=27&#x00026;pages=1290-6" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B89" id="B89"></a> 89. Skoulidis F, Cassidy LD, Pisupati V, Jonasson JG, Bjarnason H, Eyfjord JE, et al. Germline Brca2 Heterozygosity Promotes KrasG12D -Driven carcinogenesis in a murine model of familial pancreatic cancer. <i>Cancer Cell.</i> (2010) 18:499&#x02013;509. doi: 10.1016/j.ccr.2010.10.015</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.ccr.2010.10.015" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F.+Skoulidis&#x00026;author=LD.+Cassidy&#x00026;author=V.+Pisupati&#x00026;author=JG.+Jonasson&#x00026;author=H.+Bjarnason&#x00026;author=JE.+Eyfjord+&#x00026;publication_year=2010&#x00026;title=Germline+Brca2+Heterozygosity+Promotes+KrasG12D+-Driven+carcinogenesis+in+a+murine+model+of+familial+pancreatic+cancer&#x00026;journal=Cancer+Cell.&#x00026;volume=18&#x00026;pages=499-509" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B90" id="B90"></a> 90. Arora A, Agarwal D, Abdel-Fatah TMA, Lu H, Croteau DL, Moseley P, et al. RECQL4 helicase has oncogenic potential in sporadic breast cancers. <i>J Pathol.</i> (2016) 238:495&#x02013;501. doi: 10.1002/path.4681</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26690729" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/path.4681" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A.+Arora&#x00026;author=D.+Agarwal&#x00026;author=TMA.+Abdel-Fatah&#x00026;author=H.+Lu&#x00026;author=DL.+Croteau&#x00026;author=P.+Moseley+&#x00026;publication_year=2016&#x00026;title=RECQL4+helicase+has+oncogenic+potential+in+sporadic+breast+cancers&#x00026;journal=J+Pathol.&#x00026;volume=238&#x00026;pages=495-501" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B91" id="B91"></a> 91. Zhao L. Mismatch repair protein expression in patients with stage II and III sporadic colorectal cancer. <i>Oncol Lett.</i> (2018) 15:8053&#x02013;61. doi: 10.3892/ol.2018.8337</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29849807" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3892/ol.2018.8337" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=L.+Zhao+&#x00026;publication_year=2018&#x00026;title=Mismatch+repair+protein+expression+in+patients+with+stage+II+and+III+sporadic+colorectal+cancer&#x00026;journal=Oncol+Lett.&#x00026;volume=15&#x00026;pages=8053-61" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B92" id="B92"></a> 92. Vogelsang M, Wang Y, Veber N, Mwapagha LM, Parker MI. The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk. <i>PLoS ONE.</i> (2012) 7:e36962. doi: 10.1371/journal.pone.0036962</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22623965" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1371/journal.pone.0036962" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M.+Vogelsang&#x00026;author=Y.+Wang&#x00026;author=N.+Veber&#x00026;author=LM.+Mwapagha&#x00026;author=MI.+Parker+&#x00026;publication_year=2012&#x00026;title=The+cumulative+effects+of+polymorphisms+in+the+DNA+mismatch+repair+genes+and+tobacco+smoking+in+oesophageal+cancer+risk&#x00026;journal=PLoS+ONE.&#x00026;volume=7&#x00026;pages=e36962" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B93" id="B93"></a> 93. Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de La Chapelle A, et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. <i>Gastroenterology.</i> (2014) 147:1308&#x02013;16.e1. doi: 10.1053/j.gastro.2014.08.041</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25194673" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1053/j.gastro.2014.08.041" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S.+Haraldsdottir&#x00026;author=H.+Hampel&#x00026;author=J.+Tomsic&#x00026;author=WL.+Frankel&#x00026;author=R.+Pearlman&#x00026;author=A.+de+La+Chapelle+&#x00026;publication_year=2014&#x00026;title=Colon+and+endometrial+cancers+with+mismatch+repair+deficiency+can+arise+from+somatic,+rather+than+germline,+mutations&#x00026;journal=Gastroenterology.&#x00026;volume=147&#x00026;pages=1308-16.e1" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B94" id="B94"></a> 94. Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. <i>Nat Commun.</i> (2020) 11:3635. doi: 10.1038/s41467-020-17374-3</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32820175" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41467-020-17374-3" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AC.+Fahed&#x00026;author=M.+Wang&#x00026;author=JR.+Homburger&#x00026;author=AP.+Patel&#x00026;author=AG.+Bick&#x00026;author=CL.+Neben+&#x00026;publication_year=2020&#x00026;title=Polygenic+background+modifies+penetrance+of+monogenic+variants+for+tier+1+genomic+conditions&#x00026;journal=Nat+Commun.&#x00026;volume=11&#x00026;pages=3635" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B95" id="B95"></a> 95. Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, et al. Ovarian carcinoma <i>in situ</i> with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. <i>J Natl Cancer Instit.</i> (2000) 92:1088&#x02013;91. doi: 10.1093/jnci/92.13.1088</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/10880552" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/jnci/92.13.1088" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=BA.+Werness&#x00026;author=P.+Parvatiyar&#x00026;author=SJ.+Ramus&#x00026;author=AS.+Whittemore&#x00026;author=K.+Garlinghouse-Jones&#x00026;author=I.+Oakley-Girvan+&#x00026;publication_year=2000&#x00026;title=Ovarian+carcinoma+in+situ+with+germline+BRCA1+mutation+and+loss+of+heterozygosity+at+BRCA1+and+TP53&#x00026;journal=J+Natl+Cancer+Instit.&#x00026;volume=92&#x00026;pages=1088-91" target="_blank">Google Scholar</a></p>
</div>
<div class="References" style="margin-bottom:0.5em; margin-left:2em;">
<p class="ReferencesCopy1" style="margin-left:0.7em; text-indent:-1.7em;"><a name="B96" id="B96"></a> 96. Zeng B, Huang P, Du P, Sun X, Huang X, Fang X, et al. Comprehensive study of germline mutations and double-hit events in esophageal squamous cell cancer. <i>medRxiv [Preprint]</i>. (2021). doi: 10.1101/2021.02.04.21251116</p>
<p style="margin-left:1em;" class="ReferencesCopy2"><a href="https://doi.org/10.1101/2021.02.04.21251116" target="_blank">CrossRef Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=B.+Zeng&#x00026;author=P.+Huang&#x00026;author=P.+Du&#x00026;author=X.+Sun&#x00026;author=X.+Huang&#x00026;author=X.+Fang+&#x00026;publication_year=2021&#x00026;title=Comprehensive+study+of+germline+mutations+and+double-hit+events+in+esophageal+squamous+cell+cancer&#x00026;journal=medRxiv+[Preprint]" target="_blank">Google Scholar</a></p>
</div>
</div>
<div class="thinLineM20"></div>
<div class="AbstractSummary">
<p><span>Keywords:</span> esophageal squamous cell cancer, cancer susceptibility gene, double-hit, germline mutation, pathogenicity</p>
<p><span>Citation:</span> Zeng B, Huang P, Du P, Sun X, Huang X, Fang X and Li L (2021) Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer. <i>Front. Oncol.</i> 11:637431. doi: 10.3389/fonc.2021.637431</p>
<p id="timestamps"><span>Received:</span> 03 December 2020; <span>Accepted:</span> 10 February 2021;<br> <span>Published:</span> 06 April 2021.</p>
<div><p>Edited by:</p> <a href="http://loop.frontiersin.org/people/1051675/overview">Jiang Chen</a>, Zhejiang University, China</div>
<div><p>Reviewed by:</p> <a href="http://loop.frontiersin.org/people/25934/overview">Robert Klein</a>, Icahn School of Medicine at Mount Sinai, United States<br> <a href="http://loop.frontiersin.org/people/743175/overview">Zhigang Ren</a>, First Affiliated Hospital of Zhengzhou University, China</div>
<p><span>Copyright</span> &#x000A9; 2021 Zeng, Huang, Du, Sun, Huang, Fang and Li. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<p><span>&#x0002A;Correspondence:</span> Lin Li, <a id="encmail">bGlsaW5fY29udGFjdEAxNjMuY29t</a>; Xiaodong Fang, <a id="encmail">ZmFuZ3hkQGJnaS5jb20=</a></p>
<div class="clear"></div>
</div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fonc.2021.637431" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">4,7K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">2,5K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">10</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/637431#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fonc.2021.637431" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fonc.2021.637431" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/1051675/overview" data-event="editorInfo-a-jiangChen" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">J</span><span class="notranslate">C</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Jiang  Chen</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University, China</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/25934/overview" data-event="editorInfo-a-robertKlein" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">R</span><span class="notranslate">K</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Robert  Klein</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Icahn School of Medicine at Mount Sinai, United States</div></div></a><a href="https://loop.frontiersin.org/people/743175/overview" data-event="editorInfo-a-zhigangRen" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">Z</span><span class="notranslate">R</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Zhigang  Ren</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Gene Hospital of Henan Province, Precision Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, China</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal">
<li><a href="#h1">Abstract</a></li>
<li><a href="#h2">Introduction</a></li>
<li><a href="#h3">Materials and Methods</a></li>
<li><a href="#h4">Results</a></li>
<li><a href="#h5">Discussion</a></li>
<li><a href="#h6">Data Availability Statement</a></li>
<li><a href="#h7">Ethics Statement</a></li>
<li><a href="#h8">Author Contributions</a></li>
<li><a href="#h9">Conflict of Interest</a></li>
<li><a href="#h10">Acknowledgments</a></li>
<li><a href="#h11">Supplementary Material</a></li>
<li><a href="#h12">References</a></li>
</ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fonc.2021.637431" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span> 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>|</span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/oncology/articles/10.3389/fonc.2021.637431/full",["Reactive",16],{"main":17,"user":532,"article":533,"articleHub":814,"mainHeader":818},{"ibar":18,"footer":284,"newsletterComponent":-1,"snackbarItem":366,"toggleShowSnackbar":367,"contentfulJournal":368,"graphJournal":433,"settingsFeaturesSwitchers":437,"templateToggleBanner":438,"tenantConfig":497},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":215,"aboutJournal":216,"mainLinks":265,"journalLinks":272,"helpCenterLink":281},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIR Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=57&specialtyid=0&entitytype=2&entityid=451",{"id":115,"name":116,"slug":117,"sections":118},451,"Frontiers in Oncology","oncology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211],{"id":120,"name":121,"slug":122},500,"Breast Cancer","breast-cancer",{"id":124,"name":125,"slug":126},2606,"Cancer Cell Signaling","cancer-cell-signaling",{"id":128,"name":129,"slug":130},513,"Cancer Epidemiology and Prevention","cancer-epidemiology-and-prevention",{"id":132,"name":133,"slug":134},506,"Cancer Genetics","cancer-genetics",{"id":136,"name":137,"slug":138},515,"Cancer Imaging and Image-directed Interventions","cancer-imaging-and-image-directed-interventions",{"id":140,"name":141,"slug":142},527,"Cancer Immunity and Immunotherapy","cancer-immunity-and-immunotherapy",{"id":144,"name":145,"slug":146},1510,"Cancer Metabolism","cancer-metabolism",{"id":148,"name":149,"slug":150},507,"Cancer Molecular Targets and Therapeutics","cancer-molecular-targets-and-therapeutics",{"id":152,"name":153,"slug":154},1513,"Cardio-Oncology","cardio-oncology",{"id":156,"name":157,"slug":158},2413,"Gastrointestinal Cancers: Colorectal Cancer","gastrointestinal-cancers-colorectal-cancer",{"id":160,"name":161,"slug":162},2415,"Gastrointestinal Cancers: Gastric and Esophageal Cancers","gastrointestinal-cancers-gastric-and-esophageal-cancers",{"id":164,"name":165,"slug":166},2414,"Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers","gastrointestinal-cancers-hepato-pancreatic-biliary-cancers",{"id":168,"name":169,"slug":170},503,"Genitourinary Oncology","genitourinary-oncology",{"id":172,"name":173,"slug":174},2079,"Gynecological Oncology","gynecological-oncology",{"id":176,"name":177,"slug":178},517,"Head and Neck Cancer","head-and-neck-cancer",{"id":180,"name":181,"slug":182},505,"Hematologic Malignancies","hematologic-malignancies",{"id":184,"name":185,"slug":186},508,"Molecular and Cellular Oncology","molecular-and-cellular-oncology",{"id":188,"name":189,"slug":190},150,"Neuro-Oncology and Neurosurgical Oncology","neuro-oncology-and-neurosurgical-oncology",{"id":192,"name":193,"slug":194},509,"Pediatric Oncology","pediatric-oncology",{"id":196,"name":197,"slug":198},192,"Pharmacology of Anti-Cancer Drugs","pharmacology-of-anti-cancer-drugs",{"id":200,"name":201,"slug":202},511,"Radiation Oncology","radiation-oncology",{"id":204,"name":205,"slug":206},1630,"Skin Cancer","skin-cancer",{"id":208,"name":209,"slug":210},512,"Surgical Oncology","surgical-oncology",{"id":212,"name":213,"slug":214},502,"Thoracic Oncology","thoracic-oncology","Sections",[217,241],{"title":218,"links":219},"Scope",[220,223,226,229,232,235,238],{"text":221,"url":222,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/oncology/about#about-editors",{"text":224,"url":225,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/oncology/about#about-scope",{"text":227,"url":228,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/oncology/about#about-facts",{"text":230,"url":231,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/oncology/about#about-submission",{"text":233,"url":234,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/oncology/about#about-open",{"text":236,"url":237,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/oncology/about#copyright-statement",{"text":239,"url":240,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/oncology/about#about-quality",{"title":242,"links":243},"For authors",[244,247,250,253,256,259,262],{"text":245,"url":246,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/oncology/for-authors/why-submit",{"text":248,"url":249,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/oncology/for-authors/article-types",{"text":251,"url":252,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/oncology/for-authors/author-guidelines",{"text":254,"url":255,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/oncology/for-authors/editor-guidelines",{"text":257,"url":258,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/oncology/for-authors/publishing-fees",{"text":260,"url":261,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/oncology/for-authors/submission-checklist",{"text":263,"url":264,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/oncology/for-authors/contact-editorial-office",[266,269],{"text":267,"url":268,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":270,"url":271,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[273,276,278],{"text":274,"url":275,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":277,"target":27,"ariaLabel":28},"research-topics",{"text":279,"url":280,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":282,"url":283,"target":77,"ariaLabel":282},"Help center","https://helpcenter.frontiersin.org",{"blocks":285,"socialLinks":339,"copyright":363,"termsAndConditionsUrl":364,"privacyPolicyUrl":365},[286,300,310,324],{"title":287,"links":288},"Guidelines",[289,291,294,297,299],{"text":251,"url":290,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":292,"url":293,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":295,"url":296,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":254,"url":298,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":301,"links":302},"Explore",[303,304,307,309],{"text":274,"url":271,"target":27,"ariaLabel":28},{"text":305,"url":306,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":308,"url":268,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":311,"links":312},"Outreach",[313,316,319,323],{"text":314,"url":92,"target":77,"ariaLabel":315},"Frontiers Forum ","Frontiers Forum website",{"text":317,"url":318,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":320,"url":321,"target":77,"ariaLabel":322},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":325,"links":326},"Connect",[327,328,332,335,338],{"text":282,"url":283,"target":77,"ariaLabel":282},{"text":329,"url":330,"target":77,"ariaLabel":331},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":333,"url":111,"target":27,"ariaLabel":334},"Contact us ","Subscribe to newsletter",{"text":336,"url":337,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[340,348,353,358],{"link":341,"type":344,"color":345,"icon":346,"size":347,"hiddenText":13},{"text":342,"url":343,"target":77,"ariaLabel":342},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":349,"type":344,"color":345,"icon":352,"size":347,"hiddenText":13},{"text":350,"url":351,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":354,"type":344,"color":345,"icon":357,"size":347,"hiddenText":13},{"text":355,"url":356,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":359,"type":344,"color":345,"icon":362,"size":347,"hiddenText":13},{"text":360,"url":361,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":369,"identifier":115,"name":116,"slug":117,"banner":370,"description":426,"mission":427,"palette":428,"impactFactor":429,"citeScore":430,"citations":431,"showTagline":28,"twitter":432},"Journal",[371],{"id":372,"src":373,"name":374,"tags":375,"type":384,"width":385,"height":386,"idHash":387,"archive":388,"brandId":389,"limited":388,"fileSize":390,"isPublic":391,"original":392,"copyright":393,"extension":394,"thumbnails":396,"dateCreated":404,"description":405,"orientation":406,"userCreated":407,"watermarked":388,"dateModified":404,"datePublished":408,"ecsArchiveFiles":409,"propertyOptions":410,"property_Channel":415,"property_Sub-Type":417,"property_Asset_Type":419,"activeOriginalFocusPoint":421,"property_Office_Department":424},"A08FCA58-05EE-4283-A13E51F93BB73C97","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/webimage-6A59331A-8816-4B2C-BC3F6EF168F6183E.jpg","FONC_Main Visual_Purple_Website",[376,377,378,379,380,381,382,383],"body part","dead","anatomy","defending","protection","skin","treatment","cell","image",7200,4050,"7f2922f165e2e1ba",0,"22C10171-81B3-4DA6-99342F272A32E8BB",9449881,1,"https://brand.frontiersin.org/m/7f2922f165e2e1ba/original/FONC_Main-Visual_Purple_Website.jpeg","Copyright (c) 2021 Design_Cells/Shutterstock.  No use without permission.",[395],"jpeg",{"mini":397,"thul":398,"webimage":373,"Guidelines":399,"WebsiteJpg_XL":400,"WebsiteWebP_L":401,"WebsiteWebP_M":402,"WebsiteWebP_XL":403},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/mini-5795EAF1-94A7-4623-B52EAC7FC8A5098F.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/thul-301BCB38-FCF6-4517-9359D5382707B640.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/352DFCCB-44FF-4821-962507007B815780/Guidelines-FONC_Main Visual_Purple_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/352DFCCB-44FF-4821-962507007B815780/WebsiteJpg_XL-FONC_Main Visual_Purple_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/352DFCCB-44FF-4821-962507007B815780/WebsiteWebP_L-FONC_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/352DFCCB-44FF-4821-962507007B815780/WebsiteWebP_M-FONC_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/A08FCA58-05EE-4283-A13E51F93BB73C97/352DFCCB-44FF-4821-962507007B815780/WebsiteWebP_XL-FONC_Main Visual_Purple_Website.webp","2022-06-27T10:00:39Z","Cancer cell, cell grow out of control and become invasive. 3d illustration","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[411,412,413,414],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[416],"frontiersin_org",[418],"Main_Visual",[420],"Photography",{"x":422,"y":423},3600,2025,[425],"Publishing","Explore global oncology research advancing cancer diagnosis, treatment, and management across diverse populations and healthcare systems.","\u003Cp>Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics, and management strategies.\u003C/p>\n\n\u003Cp>The journal is led by Field Chief Editor Prof Giuseppe Giaccone (Cornell University and Amgen, USA), and Assistant Field Chief Editor Prof Sharon Pine (University of Colorado, USA). Indexed in PubMed Central (PMC), Scopus, Web of Science (SCIE), and the DOAJ, Frontiers in Oncology welcomes clinical and experimental research contributions in the various domains of cancer research, which bridge the gap between basic research and clinical applications. Topics include, but are not limited to:\u003C/p>\n\u003Cul>\n  \u003Cli>breast cancer\u003C/li>\n  \u003Cli>cancer cell signaling\u003C/li>\n  \u003Cli>cancer epidemiology and prevention\u003C/li>\n  \u003Cli>cancer genetics\u003C/li>\n  \u003Cli>cancer imaging and image-directed interventions\u003C/li>\n  \u003Cli>cancer immunity and immunotherapy\u003C/li>\n  \u003Cli>cancer metabolism\u003C/li>\n  \u003Cli>cancer molecular targets and therapeutics\u003C/li>\n  \u003Cli>cardio-oncology\u003C/li>\n  \u003Cli>gastrointestinal cancers\u003C/li>\n  \u003Cli>genitourinary oncology\u003C/li>\n  \u003Cli>gynecological oncology\u003C/li>\n  \u003Cli>head and neck cancer\u003C/li>\n  \u003Cli>hematologic malignancies\u003C/li>\n  \u003Cli>molecular and cellular oncology\u003C/li>\n  \u003Cli>neuro-oncology and neurosurgical oncology\u003C/li>\n  \u003Cli>pediatric oncology\u003C/li>\n  \u003Cli>pharmacology of anti-cancer drugs\u003C/li>\n  \u003Cli>radiation oncology\u003C/li>\n  \u003Cli>skin cancer\u003C/li>\n  \u003Cli>surgical oncology\u003C/li>\n  \u003Cli>thoracic oncology.\u003C/li>\n\u003C/ul>\n\n\u003Cp>In particular, the journal welcomes submissions which support and advance the UNs Sustainable Development Goals (SDGs), notable SDG 3: ensure healthy lives and promote well-being for all at all ages.\u003C/p>\n\n\u003Cp>Frontiers' journals require that manuscripts primarily comprising solely of bioinformatics analyses, computational studies of public data, or findings from Mendelian Randomisation studies must include appropriate validation. Acceptable forms of validation include:\u003Cp>\n\u003Cul>\n  \u003Cli>independent clinical or patient cohorts that are not publicly available\u003C/li>\n  \u003Cli>biological validation of the main conclusions, either \u003Cem>in vitro\u003C/em> or \u003Cem>in vivo\u003C/em>\u003C/li>\n  \u003Cli>multi-database queries (bibliometric studies only)\u003C/li>\n\u003C/ul>\n\n\u003Cp>Manuscripts lacking robust validation will be considered unsuitable for publication, as they do not meet the required evidence standards necessary for scientific conclusions. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology\">Frontiers Standards for research methodology policy\u003C/a>, for more information.\u003C/p>\n\n\u003Cp>Frontiers in Oncology is committed to advancing developments in the field of cancer research by allowing unrestricted access to articles, and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.\u003C/p>","purple","4.7","5.2","464146","@FrontOncology",{"id":115,"name":116,"slug":117,"abbreviation":434,"isOnline":13,"isOpenForSubmissions":13,"citeScore":435,"impactFactor":436},"fonc",6.9,3.3,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":367},{"isPublic":13,"allowCompanyUsers":367,"whiteListEmails":439,"enableAllJournals":13,"whiteListJournals":461},[440,441,442,443,444,445,446,447,448,445,449,450,451,452,453,454,455,456,457,458,459,460],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[462,463,464,465,466,467,391,468,469,470,471,472,473,474,475,476,477,478,479,480,481,115,482,483,484,485,486,487,488,489,490,491,492,493,494,495,496],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,141,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":391,"name":391,"availableJournalPages":498,"announcement":502},[275,280,277,499,500,501],"volumes","about","community-reviewers",{"__typename":503,"sys":504,"preHeader":42,"title":506,"description":507,"image":508,"link":530},"Announcement",{"id":505},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[509],{"archive":388,"brandId":389,"copyright":28,"dateCreated":510,"dateModified":511,"datePublished":512,"description":28,"extension":513,"fileSize":515,"height":516,"id":517,"isPublic":388,"limited":388,"name":518,"orientation":406,"original":28,"thumbnails":519,"type":384,"watermarked":388,"width":526,"videoPreviewURLs":527,"tags":528,"textMetaproperties":529,"src":520},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[514],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":520,"thul":521,"mini":522,"WebsiteWebP_L":523,"WebsiteWebP_M":524,"Guidelines":525},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":531,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":534,"isPreviewPage":367,"hasSupplementalData":367,"showCrossmarkWidget":13,"articleTemplate":680,"currentArticlePageMetaInfo":681,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":535,"doi":536,"title":537,"acceptanceDate":538,"receptionDate":539,"publicationDate":540,"lastModifiedDate":541,"isPublished":13,"abstract":542,"researchTopic":28,"articleType":543,"stage":546,"keywords":548,"authors":554,"editors":605,"reviewers":614,"journal":632,"section":640,"impactMetrics":645,"volume":649,"articleVolume":650,"relatedArticles":651,"isPublishedV2":367,"contents":652,"files":655},637431,"10.3389/fonc.2021.637431","Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer",["Date","2021-02-10T16:53:56.000Z"],["Date","2020-12-03T12:36:34.000Z"],["Date","2021-04-06T00:00:00.000Z"],["Date","2025-11-25T04:38:09.817Z"],"Esophageal squamous cell cancer (ESCC) is the eighth most common cancer around the world. Several reports have focused on somatic mutations and common germline mutations in ESCC. However, the contributions of pathogenic germline alterations in cancer susceptibility genes (CSGs), highly frequently mutated CSGs, and pathogenically mutated CSG-related pathways in ESCC remain unclear. We obtained data on 571 ESCC cases from public databases and East Asian from the 1000 Genomes Project database and the China Metabolic Analytics Project database to characterize pathogenic mutations. We detected 157 mutations in 75 CSGs, accounting for 25.0% (143/571) of ESCC cases. Six genes had more than five mutations: TP53 (n = 15 mutations), GJB2 (n = 8), BRCA2 (n = 6), RECQL4 (n = 6), MUTYH (n = 6), and PMS2 (n = 5). Our results identified significant differences in pathogenic germline mutations of TP53, BRCA2, and RECQL4 between the ESCC and control cohorts. Moreover, we identified 84 double-hit events (16 germline/somatic double-hit events and 68 somatic/somatic double-hit events) occurring in 18 tumor suppressor genes from 83 patients. Patients who had ESCC with germline/somatic double-hit events were diagnosed at younger ages than patients with the somatic/somatic double-hit events, although the correlation was not significant. Fanconi anemia was the most enriched pathway of pathogenically mutated CSGs, and it appeared to be a primary pathway for ESCC predisposition. The results of this study identified the underlying roles that pathogenic germline mutations in CSGs play in ESCC pathogenesis; increased our awareness about the genetic basis of ESCC; and provided suggestions for using highly mutated CSGs and double-hit features in the early discovery, prevention, and genetic counseling of ESCC.",{"id":544,"name":545},24,"Original Research",{"id":547,"name":19},18,[549,550,551,552,553],"Esophageal squamous cell cancer","Cancer susceptibility gene","Double-hit","germline mutation","pathogenicity",[555,566,572,579,585,590,599],{"id":556,"firstName":557,"middleName":19,"lastName":558,"givenNames":559,"isCorresponding":367,"isProfilePublic":13,"userId":556,"email":-1,"affiliations":560},930874,"Bing","Zeng","Bing ",[561,564],{"organizationName":562,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},"BGI Education Center, University of Chinese Academy of Sciences","China",{"organizationName":565,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},"BGI-Shenzhen",{"id":388,"firstName":567,"middleName":19,"lastName":568,"givenNames":569,"isCorresponding":367,"isProfilePublic":367,"userId":388,"email":-1,"affiliations":570},"Peide","Huang","Peide ",[571],{"organizationName":565,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},{"id":388,"firstName":573,"middleName":19,"lastName":574,"givenNames":575,"isCorresponding":367,"isProfilePublic":367,"userId":388,"email":-1,"affiliations":576},"Peina","Du","Peina ",[577],{"organizationName":578,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},"BGI Genomics",{"id":388,"firstName":580,"middleName":19,"lastName":581,"givenNames":582,"isCorresponding":367,"isProfilePublic":367,"userId":388,"email":-1,"affiliations":583},"Xiaohui","Sun","Xiaohui ",[584],{"organizationName":578,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},{"id":388,"firstName":586,"middleName":19,"lastName":568,"givenNames":587,"isCorresponding":367,"isProfilePublic":367,"userId":388,"email":-1,"affiliations":588},"Xuanlin","Xuanlin ",[589],{"organizationName":565,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},{"id":388,"firstName":591,"middleName":19,"lastName":592,"givenNames":593,"isCorresponding":367,"isProfilePublic":367,"userId":388,"email":-1,"affiliations":594},"Xiaodong","Fang","Xiaodong ",[595,596,597],{"organizationName":562,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":565,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":598,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},"China National GeneBank, BGI-Shenzhen",{"id":388,"firstName":600,"middleName":19,"lastName":601,"givenNames":602,"isCorresponding":367,"isProfilePublic":367,"userId":388,"email":-1,"affiliations":603},"Lin","Li","Lin ",[604],{"organizationName":565,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},[606],{"id":607,"firstName":608,"middleName":19,"lastName":609,"givenNames":610,"isCorresponding":367,"isProfilePublic":13,"userId":607,"email":-1,"affiliations":611},1051675,"Jiang","Chen","Jiang ",[612],{"organizationName":613,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},"Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University",[615,624],{"id":616,"firstName":617,"middleName":19,"lastName":618,"givenNames":619,"isCorresponding":367,"isProfilePublic":13,"userId":616,"email":-1,"affiliations":620},25934,"Robert","Klein","Robert ",[621],{"organizationName":622,"countryName":623,"cityName":19,"stateName":19,"zipCode":19},"Icahn School of Medicine at Mount Sinai","United States",{"id":625,"firstName":626,"middleName":19,"lastName":627,"givenNames":628,"isCorresponding":367,"isProfilePublic":13,"userId":625,"email":-1,"affiliations":629},743175,"Zhigang","Ren","Zhigang ",[630],{"organizationName":631,"countryName":563,"cityName":19,"stateName":19,"zipCode":19},"Gene Hospital of Henan Province, Precision Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China",{"id":115,"slug":117,"name":116,"shortName":633,"electronicISSN":634,"field":635,"specialtyId":28,"journalSectionPaths":638},"Front. Oncol.","2234-943X",{"id":636,"domainId":637},57,2,[639],{"section":640},{"id":641,"name":642,"slug":643,"specialtyId":644},501,"Gastrointestinal Cancers","gastrointestinal-cancers",1227,{"views":646,"downloads":647,"citations":648},4654,2524,10,11,"Volume 11 - 2021",[],{"titleHtml":537,"fullTextHtml":653,"menuHtml":654},"\u003Cdiv class=\"JournalAbstract\">\n\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\n\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\n\u003Ca href=\"https://loop.frontiersin.org/people/930874\" class=\"user-id-930874\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/930874/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"\nBing Zeng,\">Bing Zeng\u003C/a>\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Peide Huang\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Peide Huang\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Peina Du\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Peina Du\u003Csup>3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Xiaohui Sun\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Xiaohui Sun\u003Csup>3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Xuanlin Huang\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Xuanlin Huang\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Xiaodong Fang,,&#xA;\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Xiaodong Fang\u003Csup>1,2,4\u003C/sup>\u003Csup>&#x0002A;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Lin Li&#xA;\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Lin Li\u003Csup>2\u003C/sup>\u003Csup>&#x0002A;\u003C/sup>\u003C/span>\u003C/div>\n\u003Cul class=\"notes\">\n\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, China\u003C/li>\n\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>BGI-Shenzhen, Shenzhen, China\u003C/li>\n\u003Cli>\u003Cspan>\u003Csup>3\u003C/sup>\u003C/span>BGI Genomics, BGI-Shenzhen, Shenzhen, China\u003C/li>\n\u003Cli>\u003Cspan>\u003Csup>4\u003C/sup>\u003C/span>China National GeneBank, BGI-Shenzhen, Shenzhen, China\u003C/li>\n\u003C/ul>\n\u003Cp>Esophageal squamous cell cancer (ESCC) is the eighth most common cancer around the world. Several reports have focused on somatic mutations and common germline mutations in ESCC. However, the contributions of pathogenic germline alterations in cancer susceptibility genes (CSGs), highly frequently mutated CSGs, and pathogenically mutated CSG-related pathways in ESCC remain unclear. We obtained data on 571 ESCC cases from public databases and East Asian from the 1000 Genomes Project database and the China Metabolic Analytics Project database to characterize pathogenic mutations. We detected 157 mutations in 75 CSGs, accounting for 25.0% (143/571) of ESCC cases. Six genes had more than five mutations: \u003Ci>TP53\u003C/i> (\u003Ci>n\u003C/i> = 15 mutations), \u003Ci>GJB2\u003C/i> (\u003Ci>n\u003C/i> = 8), \u003Ci>BRCA2\u003C/i> (\u003Ci>n\u003C/i> = 6), \u003Ci>RECQL4\u003C/i> (\u003Ci>n\u003C/i> = 6), \u003Ci>MUTYH\u003C/i> (\u003Ci>n\u003C/i> = 6), and \u003Ci>PMS2\u003C/i> (\u003Ci>n\u003C/i> = 5). Our results identified significant differences in pathogenic germline mutations of \u003Ci>TP53, BRCA2\u003C/i>, and \u003Ci>RECQL4\u003C/i> between the ESCC and control cohorts. Moreover, we identified 84 double-hit events (16 germline/somatic double-hit events and 68 somatic/somatic double-hit events) occurring in 18 tumor suppressor genes from 83 patients. Patients who had ESCC with germline/somatic double-hit events were diagnosed at younger ages than patients with the somatic/somatic double-hit events, though the correlation was not significant. Fanconi anemia was the most enriched pathway of pathogenically mutated CSGs, and it appeared to be a primary pathway for ESCC predisposition. The results of this study identified the underlying roles that pathogenic germline mutations in CSGs play in ESCC pathogenesis, increased our awareness about the genetic basis of ESCC, and provided suggestions for using highly mutated CSGs and double-hit features in the early discovery, prevention, and genetic counseling of ESCC.\u003C/p>\n\u003Cdiv class=\"clear\">\u003C/div>\n\u003C/div>\n\u003Cdiv class=\"JournalFullText\">\n\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>Introduction\u003C/h2>\n\u003Cp class=\"mb15\">Esophageal squamous cell cancer (ESCC) is one of the most common cancers in the world, and it is especially common in Asian countries, North America, and the eastern corridor of Africa (\u003Ca href=\"#B1\">1\u003C/a>). In China, there are &#x0007E;478,000 new cases and &#x0007E;375,000 deaths related to ESCC each year (\u003Ca href=\"#B2\">2\u003C/a>). Many factors reportedly have relationships with ESCC; these include smoking, drinking, and dietary habits (\u003Ca href=\"#B3\">3\u003C/a>). However, the hereditary factors involved in ESCC remain unclear. Thus, understanding the genetic mutations and molecular events in ESCC might be pivotal to reduce the incidence and mortality rate of ESCC.\u003C/p>\n\u003Cp class=\"mb0\">Enormous efforts have been taken to identify somatic alterations by whole-genome sequencing (WGS) or whole-exome sequencing (WES) (\u003Ca href=\"#B4\">4\u003C/a>, \u003Ca href=\"#B5\">5\u003C/a>), and several studies reveal the complex process of tumor development (\u003Ca href=\"#B6\">6\u003C/a>, \u003Ca href=\"#B7\">7\u003C/a>). Many common germline single-nucleotide polymorphisms (SNPs) have been identified by genome-wide association studies (\u003Ca href=\"#B8\">8\u003C/a>&#x02013;\u003Ca href=\"#B16\">16\u003C/a>). rs138478634, a \u003Ci>CYP26B1\u003C/i> low-frequency variant, was proved to be involved in the ESCC development (\u003Ca href=\"#B14\">14\u003C/a>). In 2018, several pan-cancer studies focused on pathogenic germline mutations to explore hereditary factors in cancers; 871 rare cancer predisposition mutations and copy number variations (CNVs) were observed in 8% of 10,389 cases, and 7.6% of the 914 patients with pediatric cancers had tumors that harbored pathogenic mutations in cancer predisposition genes (\u003Ca href=\"#B17\">17\u003C/a>, \u003Ca href=\"#B18\">18\u003C/a>). In 2019, Deng et al. (\u003Ca href=\"#B19\">19\u003C/a>) identified germline profiles in Chinese patients with ESCC and uncovered the association between genotype and environment interactions. Additionally, \u003Ci>BRCA2\u003C/i> was associated with ESCC risk in Chinese patients (\u003Ca href=\"#B20\">20\u003C/a>). Reflecting a critical part of cancer susceptibility, the two-hit hypothesis assumes that hereditary retinoblastoma involves double mutations and that one mutation is in germline DNA whereas non-hereditary retinoblastoma involves two somatic mutations (\u003Ca href=\"#B21\">21\u003C/a>). On the basis of these findings, double-hit events in some studies were used to identify cancer predisposition genes (\u003Ca href=\"#B22\">22\u003C/a>, \u003Ca href=\"#B23\">23\u003C/a>). These studies demonstrated the significance of pathogenic germline mutations and double-hit events in genetic testing and risk assessment for cancer. To our knowledge, cancer predisposition genes and molecular events in ESCC remain poorly understood. Here, we identified pathogenic/likely pathogenic germline predisposition mutations and highly frequently mutated CSGs in a large ESCC cohort. We discovered significantly different pathogenic germline mutations of \u003Ci>TP53, BRCA2\u003C/i>, and \u003Ci>RECQL4\u003C/i> in ESCC cohorts, and we clarified the association between double-hit events and diagnosis age in patients with ESCC. In addition, we identified pathogenically mutated CSG-related pathways for ESCC to illuminate the mechanism affected by pathogenic mutations. Results of this study will improve genetic testing for relatives of patients with ESCC and facilitate the implementation of organizational or institutional measures for the ESCC prevention and surveillance.\u003C/p>\n\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>Materials and Methods\u003C/h2>\n\u003Ch3 class=\"pt0\">Sample Acquisition\u003C/h3>\n\u003Cp class=\"mb0\">We collected 592 ESCC samples from published studies and The Cancer Genome Atlas (a total of nine projects) (\u003Ca href=\"#SM1\">Supplementary Table 1\u003C/a>), and we excluded poor-quality samples and hypermutant samples (\u003Ca href=\"#B4\">4\u003C/a>, \u003Ca href=\"#B5\">5\u003C/a>, \u003Ca href=\"#B24\">24\u003C/a>&#x02013;\u003Ca href=\"#B29\">29\u003C/a>). The clinical information is listed in \u003Ca href=\"#SM1\">Supplementary Table 2\u003C/a>. The WGS and WES data from the same studies came from distinct patient cases. The quality control analysis uncovered an average sequencing depth of 55&#x000D7;&#x0007E;161&#x000D7; for WES samples and 30&#x000D7;&#x0007E;65&#x000D7; for WGS samples (\u003Ca href=\"#SM1\">Supplementary Figure 1A\u003C/a>), the 10&#x000D7; average coverages were more than 90% in most WES and WGS samples (\u003Ca href=\"#SM1\">Supplementary Figure 1B\u003C/a>). Moreover, the relationship between 10&#x000D7; average coverages and average sequencing depths showed a positive correlation (\u003Ca href=\"#SM1\">Supplementary Figure 1C\u003C/a>), suggesting that the qualities of most samples were proofed. The mean depth of our data and the public databases we used as controls were able to provide enough variants to execute the downstream analysis (\u003Ca href=\"#B30\">30\u003C/a>). The study protocol was reviewed by the institutional review board of the Beijing Genomics Institution.\u003C/p>\n\u003Ch3>Data Processing and Mutation Calling\u003C/h3>\n\u003Cp class=\"mb0\">The fastq data from 571 samples (38 WGS samples and 533 WES samples) were trimmed and filtered using SOAPnuke (v1.5.6 with default parameters, except where -n 0.1 -l 11 -q 0.5 -G -T 1) (\u003Ca href=\"#B31\">31\u003C/a>). Data from ESCC-P006 was transformed from bam files using the GATK SamToFastq (v4.0.6.0 with default parameters) (\u003Ca href=\"#B32\">32\u003C/a>). The high-quality reads were aligned to the hg19 human reference genome with a Burrows-Wheeler Aligner (v0.7.17-r1194-dirty with default parameters, except where -o 1 -e 50 -m 100,000 -i 15 -q 10 -a 600) (\u003Ca href=\"#B33\">33\u003C/a>). MarkDuplicates GATK (version as above with default parameters, except where -CREATE_INDEX true, -reportMemoryStats true, -VALIDATION_STRINGENCY SILENT) was used to mark duplicated reads. BaseRecalibrator (version as above with default parameters) and ApplyBQSR (version as above with default parameters, except where -create-output-bam-index true) were performed to base quality score recalibration (\u003Ca href=\"#B32\">32\u003C/a>). Germline variants were joint-called using GenotypeGVCFs (version as above with default parameters, except where -ignore-variants-starting-outside-interval true) after CombineGVCFs (version as above with default parameters) and annotated with the Variant Effect Predictor (VEP v98.3) (\u003Ca href=\"#B32\">32\u003C/a>, \u003Ca href=\"#B34\">34\u003C/a>). The calling germline variants of nine projects are shown in \u003Ca href=\"#SM1\">Supplementary Figure 1D\u003C/a>. Samples with fewer than 80,000 variants were filtered out. Somatic variants were detected by GATK MuTect2 (version as above with default parameters except where -af-of-alleles-not-in-resource 0.0000025, -native-pair-hmm-threads 1, -add-output-vcf-command-line false), and Oncotator (v1.9.9.0) was used for annotation (\u003Ca href=\"#B32\">32\u003C/a>, \u003Ca href=\"#B35\">35\u003C/a>). Loss of heterozygosity (LOH) and other somatic CNVs (SCNVs) were detected with FACETS (v0.5.14) and Pathwork (v1.0) for 533 WES and 38 WGS samples, respectively (\u003Ca href=\"#B36\">36\u003C/a>, \u003Ca href=\"#B37\">37\u003C/a>).\u003C/p>\n\u003Ch3>CSG Sets\u003C/h3>\n\u003Cp class=\"mb0\">We curated CSGs from published papers and the Catalogue of Somatic Mutations in Cancer (COSMIC, V92) database (\u003Ca href=\"#B38\">38\u003C/a>); we included cancer predisposition genes from three papers (\u003Ca href=\"#B17\">17\u003C/a>, \u003Ca href=\"#B18\">18\u003C/a>, \u003Ca href=\"#B39\">39\u003C/a>) and genes with recorded germline associations in COSMIC (\u003Ca href=\"#SM1\">Supplementary Table 4\u003C/a>). After we removed duplicated genes, the CSG set included 260 genes. CSGs were divided into three groups according to the literature (\u003Ca href=\"#B17\">17\u003C/a>, \u003Ca href=\"#B40\">40\u003C/a>&#x02013;\u003Ca href=\"#B42\">42\u003C/a>); these groups were tumor suppressor genes (TSGs; \u003Ci>n\u003C/i> = 139), oncogenes (\u003Ci>n\u003C/i> = 36), and non-classified genes (\u003Ci>n\u003C/i> = 85).\u003C/p>\n\u003Ch3>Pathogenicity Evaluation\u003C/h3>\n\u003Cp class=\"mb0\">We first leveraged an in-house pathogenicity database to match germline variants; the rest of the germline variants were evaluated using InterVar (InterVar_20190327) as a supplemental method to find germline pathogenic/likely pathogenic mutations (\u003Ca href=\"#B43\">43\u003C/a>). Germline pathogenic or likely pathogenic variants are hereafter referred to as pathogenic mutations. The pathogenicity database included ClinVar, the Human Gene Mutation Database, mutations collected from papers, and mutations we assessed according to consensus guidelines by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (\u003Ca href=\"#B17\">17\u003C/a>, \u003Ca href=\"#B44\">44\u003C/a>&#x02013;\u003Ca href=\"#B46\">46\u003C/a>). We filtered for pathogenic variants with an allele frequency of 0.5% or lower in the Genome Aggregation Database (gnomAD version v2.1) (\u003Ca href=\"#B47\">47\u003C/a>). Pathogenic mutations in 260 high-interest CSGs (\u003Ca href=\"#SM1\">Supplementary Table 6\u003C/a>) were selected for analysis and were checked by Deep Variant (\u003Ca href=\"#B48\">48\u003C/a>); manual verification ruled out false-positive results. For somatic nonsilent variants, with the exception of frameshift, non-sense, and splice-site mutations, three silico tools SIFT (\u003Ca href=\"#B49\">49\u003C/a>), Polyphen2_HDIV (\u003Ca href=\"#B50\">50\u003C/a>), and CADD (\u003Ca href=\"#B51\">51\u003C/a>) were used to predict pathogenicity. If a variant was predicted as damaging in any two silico tools (SIFT: D, Polyphen2_HDIV: D/P, CADD score &#x0003E;15), the variant was categorized as deleterious (\u003Ca href=\"#B39\">39\u003C/a>, \u003Ca href=\"#B52\">52\u003C/a>).\u003C/p>\n\u003Ch3>Identification of potential Double-Hit Events\u003C/h3>\n\u003Cp class=\"mb0\">According to the two-hit hypothesis, potential double-hit events are identified after two or more hits have been found in the same CSG; in this study, we set rigorous standards for determining hits. Pathogenic germline mutations were considered hits. Effective somatic variations were defined as hits if they met the following requirements: frameshift, non-sense, splice-site mutations, or deleterious missense and in-frame variants and SCNVs that caused allele loss. Copy-neutral LOH, duplication LOH, homozygous deletion, and hemizygous deletion were assumed to be linked to allele loss and were termed allele loss SCNVs (\u003Ca href=\"#B53\">53\u003C/a>, \u003Ca href=\"#B54\">54\u003C/a>). Integrative Genomics Viewer software was used to examine the authenticity of biallelic events (\u003Ca href=\"#B55\">55\u003C/a>). For double-hit events comprised of germline hits and allele loss SCNVs, we calculated SNP average depths and variant allelic frequency in normal and tumor tissues of ESCC to further validate allele loss SCNV events. Samples with variant allele frequencies &#x0003C;0.5 in tumors were removed.\u003C/p>\n\u003Ch3>Statistical Analyses\u003C/h3>\n\u003Cp class=\"mb0\">To evaluate the correlations of the clinical features and genetic events, we used the two-sided Student&#x00027;s \u003Ci>t\u003C/i>-test. We conducted the two-sided Fisher&#x00027;s exact test to assess the gene-based association analysis and pathway enrichment. We also performed a burden test to determine the exact relationships between pathogenic mutations in CSGs and ESCC (\u003Ca href=\"#B56\">56\u003C/a>); \u003Ci>p\u003C/i> &#x0003C; 0.05 was defined as statistically significant.\u003C/p>\n\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>Results\u003C/h2>\n\u003Ch3 class=\"pt0\">Population Characteristics\u003C/h3>\n\u003Cp class=\"mb0\">Overall, 469 of 571 patient cases were Asian (424 Chinese, 41 Vietnamese, one Canadian, one Brazilian, and two without country information), 41 were Caucasian, 58 were Black or African American, and the rest were Brazilian without ethnicity information. The entire population consisted of 105 women, 465 men, and one patient without gender information. The average diagnosed age for 567 patients (the rest had no information) was 58.81 years (the minimum diagnosed age was 24 years, and the maximum diagnosed age was 93 years). About 35 patients had family histories of ESCC, and the average age of patients with ESCC with a family history [mean age (SD) was 56.80 (9.3) years; range: 41&#x02013;82 years]. This average was lower than the age of patients with ESCC without a family history [mean age (SD): 60.00 (8.2) years; range: 36&#x02013;78 years; \u003Ci>t\u003C/i>-test \u003Ci>p\u003C/i> = 0.059; 95% CI, &#x02212;6.511 to 0.121) (\u003Ca href=\"#SM1\">Supplementary Figure 2\u003C/a>). The average survival for 399 patients (the rest had no information) was 879.8 days (minimum survival, 3 days; maximum survival, 2,580 days). In this study, 347 patients had a smoking history, and 215 patients had histories of alcoholism. With regard to disease grade, 334 patients had disease with pathological grade 2 or lower, and 86 patients had disease with pathological grade &#x0003E;2; the pathological grade information was missing for 151 patients. All patients were diagnosed with disease stages I (\u003Ci>n\u003C/i> = 72), stage II (\u003Ci>n\u003C/i> = 207), stage III (\u003Ci>n\u003C/i> = 203), and stage IV (\u003Ci>n\u003C/i> = 7); 82 patients were not assigned disease stages for this study (their information was lost).\u003C/p>\n\u003Ch3>Pathogenic Germline Mutations in CSGs\u003C/h3>\n\u003Cp class=\"mb0\">Overall, 2,484 pathogenic germline mutations were identified, including 1,973 SNPs and 511 insertions or deletions (\u003Ca href=\"#SM1\">Supplementary Table 5\u003C/a>). Each sample had an average of 4.4 pathogenic mutations. After filtration by CSGs, 157 pathogenic mutations (113 SNPs and 44 insertions or deletions) were discovered from 25.0% (143/571) of the population (\u003Ca href=\"#SM1\">Supplementary Figure 3\u003C/a>). Although each sample had an average of 1.1 pathogenic mutation in CSGs, only 12 (2.10%) of the 571 patients harbored one or more pathogenic mutation in CSGs (\u003Ca href=\"#F1\">Figure 1\u003C/a>, \u003Ca href=\"#SM1\">Supplementary Table 6\u003C/a>). The frequency of most mutations was rare in the gnomAD noncancer database and in the China Metabolic Analytics Project (ChinaMAP) database (\u003Ca href=\"#B47\">47\u003C/a>, \u003Ca href=\"#B57\">57\u003C/a>), indicating the sparsity of these deleterious mutations in the general population. As expected, most of the frequently mutated CSGs belonged to TSGs, and they were involved in biological processes, such as DNA repair.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div>\n\u003Cdiv class=\"FigureDesc\">\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg\" name=\"figure1\" target=\"_blank\">\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cstrong>Figure 1\u003C/strong>. The frequency and distribution of cancer susceptibility genes (CSGs) with more than one pathogenic/likely pathogenic germline mutation detected in patients with esophageal squamous cell cancer (ESCC). Only tumor suppressor genes with more than five mutations are shown. Upper bars represent the cumulative mutation numbers of each sample. Bottom bars represent the clinical information (race, gender, age, and survival/death) about the patients. The left table presents the frequency of mutations shown in the non-cancer Genome Aggregation Database (gnomAD) and the China Metabolic Analytics Project (ChinaMAP) database. Right bars represent the mutation counts. The classification of the CSG is next to the mutation name (gene name &#x0002B; reference SNP number or gene name &#x0002B; chromosome position &#x0002B; nucleotide change).\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"clear\">\u003C/div>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cp class=\"mb15 w100pc float_left mt15\">In general, the CSGs detected more than five times were \u003Ci>TP53\u003C/i> (\u003Ci>n\u003C/i> = 15 mutations), \u003Ci>GJB2\u003C/i> (\u003Ci>n\u003C/i> = 8), \u003Ci>BRCA2\u003C/i> (\u003Ci>n\u003C/i> = 6), \u003Ci>RECQL4\u003C/i> (\u003Ci>n\u003C/i> = 6), \u003Ci>MUTYH\u003C/i> (\u003Ci>n\u003C/i> = 6), and \u003Ci>PMS2\u003C/i> (\u003Ci>n\u003C/i> = 5). \u003Ci>TP53\u003C/i> was the most frequently mutated CSG, with pathogenic germline mutations in 2.63% (15/571) of patients with ESCC (\u003Ca href=\"#F1\">Figure 1\u003C/a>, \u003Ca href=\"#SM1\">Supplementary Table 6\u003C/a>, \u003Ca href=\"#SM1\">Supplementary Figure 4\u003C/a>). The result was the same as \u003Ci>TP53\u003C/i> pathogenic mutations in a study of osteosarcoma (\u003Ca href=\"#B39\">39\u003C/a>). In our study, 86.7% (13/15) of \u003Ci>TP53\u003C/i> mutations were non-synonymous single-nucleotide variations. c.A1073T (rs773553186; in 0.35%, or 2/571) and c.C742T (rs121912851; in 0.18%, or 1/571) were recorded in the International Agency for Research on Cancer TP53 database (\u003Ca href=\"#B58\">58\u003C/a>). All \u003Ci>TP53\u003C/i> pathogenic mutations were found in Chinese patients, except c.A1073T (one each in a Chinese and a Caucasian patient) (\u003Ca href=\"#SM1\">Supplementary Figure 4\u003C/a>). Three of the \u003Ci>TP53\u003C/i> mutations, c.C742T, c.C586T, and c.C817T, have been reported in osteosarcoma (\u003Ca href=\"#B39\">39\u003C/a>), and \u003Ci>TP53\u003C/i> c.C742T has also been identified in low-grade glioma (\u003Ca href=\"#B17\">17\u003C/a>) (\u003Ca href=\"#SM1\">Supplementary Figure 4\u003C/a>). Pathogenic mutations in \u003Ci>GJB2\u003C/i> represented the second most frequently mutated CSGs (\u003Ca href=\"#F1\">Figure 1\u003C/a>); their detection rate was 1.40% (8/571). The c.235delC (rs80338943) mutation, a common pathogenic frameshift deletion mutation in East Asian (EAS) populations, has been detected in six Asian (Chinese) patients with ESCC (\u003Ca href=\"#B59\">59\u003C/a>). Because this mutation has not been detected in other populations, rs80338943 may be specific to Chinese or Asian populations.\u003C/p>\n\u003Cp class=\"mb15\">Non-synonymous single-nucleotide variations occupied &#x0003E;50% of pathogenic germline mutations in \u003Ci>BRCA2, RECQL4\u003C/i>, and \u003Ci>MUTYH\u003C/i> (\u003Ca href=\"#SM1\">Supplementary Table 6\u003C/a>). In the upstream region, we detected a pathogenic splice mutation, \u003Ci>BRCA2\u003C/i> c.-39-1_-39delGA (rs758732038), in a patient, and the mutation was reported in ClinVar as likely pathogenic (\u003Ca href=\"#B46\">46\u003C/a>). The mutation has also been reported in patients with breast cancer and medulloblastoma (\u003Ca href=\"#B60\">60\u003C/a>&#x02013;\u003Ca href=\"#B62\">62\u003C/a>). \u003Ci>RECQL4\u003C/i> pathogenic mutations were only detected in Asian (Chinese) patients in our study, and \u003Ci>RECQL4\u003C/i> c.C2272T has been reported in ovarian cancer/Rothmund&#x02013;Thomson syndrome. In our study, \u003Ci>MUTYH\u003C/i> c.C1178T (rs36053993) and c.C458T (rs762307622) were detected three times (0.53%, or 3/571) and two times (0.35%, or 2/571), respectively. rs36053993 only detected in Caucasian patients and rs762307622 only detected in Asian (Chinese) patients. From gnomAD, rs36053993 in a homozygous state was found in three non-Finnish Europeans; this mutation may have been caused by founder events (\u003Ca href=\"#B63\">63\u003C/a>, \u003Ca href=\"#B64\">64\u003C/a>). Pathogenic mutations in \u003Ci>PMS2\u003C/i> were detected five times in five patients in our study (0.88%), and c.2192_2196delAGTTA (rs63750695) was observed in only four patients, who were all African. The rs63750695 mutation has also been discovered in Lynch syndrome, colorectal cancer, and ovarian carcinoma (\u003Ca href=\"#B65\">65\u003C/a>&#x02013;\u003Ca href=\"#B67\">67\u003C/a>); however, it was rare in non-cancer gnomAD and ChinaMAP, for which frequencies were 1.15 &#x000D7;10\u003Csup>&#x02212;5\u003C/sup> and 0, respectively (\u003Ca href=\"#F1\">Figure 1\u003C/a>). rs63750695 is possibly specific to African ethnicity in ESCC.\u003C/p>\n\u003Cp class=\"mb15\">The total number of pathogenic germline mutations and the frequency of mutations were relatively lower in oncogenes and non-classified genes compared with TSGs. \u003Ci>TSHR\u003C/i> and \u003Ci>MPL\u003C/i> were oncogenes that were mutated in two patients with ESCC; other oncogenes occurred in just one patient. \u003Ci>SLC25A13\u003C/i> was one of the non-classified genes with the most pathogenic mutations.\u003C/p>\n\u003Cp class=\"mb0\">We also investigated our pathogenic germline mutations in a previous pan-cancer study (\u003Ca href=\"#B17\">17\u003C/a>). Nine mutations were spread over 22 samples with diverse cancers (\u003Ca href=\"#SM1\">Supplementary Table 9\u003C/a>). \u003Ci>SLC25A13\u003C/i> c.852_855delCATA (\u003Ci>n\u003C/i> = 7), \u003Ci>GJB2\u003C/i> c.235delC (\u003Ci>n\u003C/i> = 7), and \u003Ci>PALB2\u003C/i> c.C2257T (\u003Ci>n\u003C/i> = 2) were the variants observed more than once across cancers. We detected multiple susceptibility loci (31/47), also identified in previous genome-wide association studies, in our patients with ESCC (\u003Ca href=\"#SM1\">Supplementary Table 10\u003C/a>) (\u003Ca href=\"#B8\">8\u003C/a>&#x02013;\u003Ca href=\"#B16\">16\u003C/a>). Of those genes with susceptibility loci, pathogenic mutations \u003Ci>PDE4D\u003C/i> c.T108A and \u003Ci>RUNX1\u003C/i> c.61&#x0002B;1delG were found in two patients separately (\u003Ca href=\"#SM1\">Supplementary Table 5\u003C/a>). We also confirmed from the COSMIC database that 87.3% (137/157) of pathogenic mutations in CSGs had non-silent somatic mutations in the same or a nearby (within five) amino acid position (\u003Ca href=\"#SM1\">Supplementary Table 6\u003C/a>). Among 137 mutations, 107 mutations were observed in TSGs, representing 89.2% (107/120) of all mutations.\u003C/p>\n\u003Ch3>Pathogenic Germline Mutations Frequency in ESCC Cases vs. Controls\u003C/h3>\n\u003Cp class=\"mb0\">To reveal the relationships between highly frequent mutated CSGs and ESCC, we chose the Chinese patients to continue the study, to leverage the most population data and avoid any ethnicity-specific effect. We conducted gene-based association analyses by comparing various germline mutation data from individuals with ESCC vs. a 1000 Genomes Project EAS population and ESCC vs. a ChinaMAP population separately (\u003Ca href=\"#B57\">57\u003C/a>, \u003Ca href=\"#B68\">68\u003C/a>). We also conducted rare variant burden tests on the ESCC individuals and the 1000 Genomes Project EAS population (\u003Ca href=\"#B68\">68\u003C/a>). Through the same pathogenicity evaluation pipeline, pathogenic mutations were identified in two public database populations. Analysis of results identified significantly higher pathogenic mutations in Chinese patients with ESCC vs. public population databases (including 1000 Genomes Project EAS and ChinaMAP data), as reflected by odd ratios (ORs) of pathogenic mutations in \u003Ci>TP53\u003C/i> from the Chinese ESCC populations compared with the 1000 Genomes Project EAS populations (OR = 4.26; 95% CI, 1.33&#x02013;17.91; Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 7.359 &#x000D7; 10\u003Csup>&#x02212;3\u003C/sup>) and compared with the ChinaMAP populations (OR = 10.59; 95% CI, 5.21&#x02013;20.45; Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 1.851 &#x000D7; 10\u003Csup>&#x02212;9\u003C/sup>); in \u003Ci>BRCA2\u003C/i> from the Chinese ESCC populations compared with the 1000 Genomes Project EAS populations (OR = infinity; 95% CI, 1.09&#x02013;infinity; Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 0.0197) and compared with the ChinaMAP populations (OR = 2.68; 95% CI, 0.83&#x02013;6.75; Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 0.0489); and in \u003Ci>RECQL4\u003C/i> from the Chinese ESCC populations compared with the 1000 Genomes Project EAS populations (OR = 7.21; 95% CI, 0.87&#x02013;332.23; Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 0.0519) and compared with the ChinaMAP populations (OR = 3.69; 95% CI, 1.27&#x02013;8.81; Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 0.0089) (\u003Ca href=\"#T1\">Table 1\u003C/a>). Likewise, in the burden analyses (\u003Ca href=\"#T1\">Table 1\u003C/a>), the numbers of pathogenic mutations from \u003Ci>TP53\u003C/i> (14/424, or 3.30%; burden test \u003Ci>p\u003C/i> = 3.050 &#x000D7; 10\u003Csup>&#x02212;3\u003C/sup>), \u003Ci>BRCA2\u003C/i> (5/424, or 1.18%; burden test \u003Ci>p\u003C/i> = 0.015), and \u003Ci>RECQL4\u003C/i> (6/424, or 1.14%; burden test \u003Ci>p\u003C/i> = 0.035) in our Chinese ESCC cohort were higher than those observed in the 1000 Genomes Project EAS group.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cdiv class=\"Imageheaders\">TABLE 1\u003C/div>\n\u003Cdiv class=\"FigureDesc\">\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg\" name=\"Table1\" target=\"_blank\">\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\n\u003C/a>\n\u003Cp>\u003Cstrong>Table 1\u003C/strong>. Significance of \u003Ci>TP53, BRCA2\u003C/i>, and \u003Ci>RECQL4\u003C/i> pathogenic or likely pathogenic variants for ESCC risk in Chinese patients.\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"clear\">\u003C/div>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Ch3>Potential Double-Hit Events\u003C/h3>\n\u003Cp class=\"mb0\">To further survey the genetic predisposition of ESCC, we tried to identify potential double-hit events in ESCC. First, we identified 49,876 non-silent mutations (\u003Ca href=\"#SM1\">Supplementary Table 3\u003C/a>) in protein-coding regions from patients with ESCC. (We filtered the somatic mutations that overlapped with our own panel of normal datasets and the Exome Aggregation Consortium database V1.0.) Then, by integrating pathogenic germline mutations and effective somatic mutations (\u003Ca href=\"#SM1\">Supplementary Table 8\u003C/a>) or allele loss SCNVs, we found 84 potential double-hit events (\u003Ca href=\"#F2\">Figure 2\u003C/a>). To distinguish hits with germline mutations, the double-hit events were classified as germline/somatic double-hit events and somatic/somatic double-hit events. We identified 16 potential germline/somatic double-hit events (two germline mutations coupled with somatic mutations, and 14 germline mutations accompanied with allele loss SCNVs) (\u003Ca href=\"#F2\">Figure 2\u003C/a>, \u003Ca href=\"#SM1\">Supplementary Table 11\u003C/a>, \u003Ca href=\"#SM1\">Supplementary Figures 5\u003C/a>, \u003Ca href=\"#SM1\">6\u003C/a>) in 16 patients with ESCC, and we identified 68 potential somatic/somatic double-hit events (three somatic mutations accompanied by allele loss SCNVs and 65 double somatic mutations) (\u003Ca href=\"#F2\">Figure 2\u003C/a>, \u003Ca href=\"#SM1\">Supplementary Table 12\u003C/a>) in 67 cases. The likelihood of two or more somatic mutations happening on the same chromosome was very low (\u003Ca href=\"#B52\">52\u003C/a>, \u003Ca href=\"#B69\">69\u003C/a>, \u003Ca href=\"#B70\">70\u003C/a>). Therefore, we assumed that double somatic mutations were likely in the trans position. Briefly, 83 individuals with ESCC possessed potential double-hit events, representing 14.5% of the ESCC cohort (\u003Ca href=\"#F2\">Figure 2\u003C/a>). Notably, one patient had two somatic/somatic double-hit events in different genes.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cdiv class=\"Imageheaders\">FIGURE 2\u003C/div>\n\u003Cdiv class=\"FigureDesc\">\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg\" name=\"figure2\" target=\"_blank\">\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g002.jpg\" alt=\"www.frontiersin.org\" id=\"F2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cstrong>Figure 2\u003C/strong>. The distribution of pathogenic/likely pathogenic germline mutations, somatic mutations, and allele loss somatic copy number variations (SCNVs) in esophageal squamous cell cancer (ESCC) cases with potential double-hit events. Upper bars represent the clinical information (age and race) about those patients. Squares represent somatic mutations, triangles represent germline mutations, and circles represent allele loss SCNVs.\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"clear\">\u003C/div>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cp class=\"mb15 w100pc float_left mt15\">\u003Ci>GJB2\u003C/i> and \u003Ci>TP53\u003C/i> were the top two CSGs that found germline/somatic double-hit events. Germline/somatic double-hit events were identified in eight CSGs, including \u003Ci>BRCA2, BRCA1, MUTYH, CDKN2A\u003C/i>, and \u003Ci>ATM\u003C/i>. The dominant type of germline/somatic double-hit events was a germline mutation accompanied by an allele loss SCNV. In the remaining, germline mutations were coupled with somatic mutations; these were only discovered in \u003Ci>TP53\u003C/i> and \u003Ci>BRCA1\u003C/i>, possibly because SCNVs are relatively abundant in tumors and cover large genome region. In the somatic/somatic double-hit events, the \u003Ci>TP53\u003C/i> gene had the highest frequency, and most of the remaining genes had one potential double-hit event. Double somatic mutation was the main type of somatic/somatic double-hit event (\u003Ca href=\"#SM1\">Supplementary Table 12\u003C/a>).\u003C/p>\n\u003Cp class=\"mb0\">When we compared diagnosis ages of patients with different double-hit events, we found that patients with germline/somatic double-hit events (with pathogenic germline mutations) had younger diagnosis ages [mean age (SD), 54.6 (11.2) years; range, 36&#x02013;71 years] compared with patients in the somatic/somatic double-hit events [without pathogenic germline mutations; mean age (SD), 60.6 (7.8) years; range, 4&#x02013;80 years; \u003Ci>t\u003C/i>-test \u003Ci>p\u003C/i> = 0.056; 95% CI, &#x02212;12.216 to 0.177] (\u003Ca href=\"#F3\">Figure 3\u003C/a>). The comparison was non-significant, maybe it was due to the limited number of samples with double-hit events in this comparison. However, the finding was consistent in the study by Knudson (\u003Ca href=\"#B21\">21\u003C/a>). Using the empirical cumulative distribution function (ecdf) to calculated the expression percentiles of TSGs in an ESCC-P006 cancer cohort, two patients with somatic/somatic double-hit events showed low expression: one in \u003Ci>TP53\u003C/i> (5.32%) and one in \u003Ci>PTEN\u003C/i> (6.38%) (\u003Ca href=\"#SM1\">Supplementary Figure 8\u003C/a>) (\u003Ca href=\"#B17\">17\u003C/a>). Those results support the two-hit hypothesis and suggest that genetic screening in specific TSGs can detect patients with germline/somatic double-hit events earlier.\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cdiv class=\"Imageheaders\">FIGURE 3\u003C/div>\n\u003Cdiv class=\"FigureDesc\">\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg\" name=\"figure3\" target=\"_blank\">\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g003.jpg\" alt=\"www.frontiersin.org\" id=\"F3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cstrong>Figure 3\u003C/strong>. The two types of double-hit events. \u003Cstrong>(A)\u003C/strong> The paradigm of double-hit events. \u003Cstrong>(B)\u003C/strong> The correlation between age and double-hit event type in esophageal squamous cell cancer (ESCC) cases. The position of line is the median age, and the position of rhombus is the mean age in specific ESCC cohorts. The digits in the boxes are the numbers of ESCC cases in each category.\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"clear\">\u003C/div>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Ch3>Pathway Enrichment\u003C/h3>\n\u003Cp class=\"mb0\">To obtain a more comprehensive understanding of pathogenic germline genetic mutations affecting pathways, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed for multiple gene lists. The Fanconi anemia (FA) pathway was the most significantly enriched in the analysis of 75 pathogenically mutated CSGs (Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 6.634 &#x000D7; 10\u003Csup>&#x02212;19\u003C/sup>) (\u003Ca href=\"#F4\">Figure 4A\u003C/a>, \u003Ca href=\"#SM1\">Supplementary Table 7\u003C/a>). In addition, 1,226 pathogenic mutated genes and the genes involved in germline/somatic double-hit events were significantly enriched in this pathway. The top four pathways for CSGs involved in somatic/somatic double-hit events vs. for CSGs involved in germline/somatic double-hit events differed significantly (\u003Ca href=\"#SM1\">Supplementary Figures 7A&#x02013;D\u003C/a>).\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cdiv class=\"Imageheaders\">FIGURE 4\u003C/div>\n\u003Cdiv class=\"FigureDesc\">\n\u003Ca href=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg\" name=\"figure4\" target=\"_blank\">\n\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g004.jpg\" alt=\"www.frontiersin.org\" id=\"F4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cstrong>Figure 4\u003C/strong>. Significantly enriched pathways and networks in esophageal squamous cell cancer (ESCC). \u003Cstrong>(A)\u003C/strong> The network composed of genes involved in the top 10 pathways in the Kyoto Encyclopedia of Genes and Genomes pathway enrichment. The red dots represent genes, and the purple circles represent pathways. The larger the area, the higher the degree of enrichment. The different lines represent various categories of pathways; green lines indicate genetic information processing, and purple lines indicate human disease. \u003Cstrong>(B)\u003C/strong> The \u003Ci>y\u003C/i>-axis represents cancer susceptibility genes mutated in the Fanconi anemia pathway; the \u003Ci>x\u003C/i>-axis represents the number of patients affected in our cohort. Red font: tumor-suppressor genes.\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"clear\">\u003C/div>\n\u003Cdiv class=\"DottedLine\">\u003C/div>\n\u003Cp class=\"mb0 w100pc float_left mt15\">In the tumor-suppressor network, the FA pathway functions to preserve genomic integrity by repairing DNA interstrand crosslinks, regulating cytokinesis, and mitigating replication stress (\u003Ca href=\"#B71\">71\u003C/a>, \u003Ca href=\"#B72\">72\u003C/a>). About 33 ESCC samples carried pathogenic mutations in 13 CSGs included in the FA pathway (\u003Ca href=\"#F4\">Figure 4B\u003C/a>). The homologous recombination pathway and the mismatch repair pathway described in a previous ESCC project, and associated with cancer susceptibility, were found in our study (\u003Ca href=\"#SM1\">Supplementary Figure 7A\u003C/a>) (\u003Ca href=\"#B19\">19\u003C/a>, \u003Ca href=\"#B73\">73\u003C/a>&#x02013;\u003Ca href=\"#B75\">75\u003C/a>). Those pathways were also reported in pathway enrichments of ovarian cancer and osteosarcoma (\u003Ca href=\"#B39\">39\u003C/a>, \u003Ca href=\"#B76\">76\u003C/a>). We also interrogated the oncogenic signaling pathways upon which our mutated CSGs converged (\u003Ca href=\"#B77\">77\u003C/a>). The cell cycle pathway was the most enriched, followed by p53 pathway, the phosphatidylinositol 3&#x02032;-kinase-Akt pathway, and the receptor tyrosine kinases-Ras pathway.\u003C/p>\n\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>Discussion\u003C/h2>\n\u003Cp class=\"mb15\">We reported the profile of pathogenic germline mutations of a larger ESCC cohort comparing with previous studies (\u003Ca href=\"#B17\">17\u003C/a>, \u003Ca href=\"#B19\">19\u003C/a>). We found 157 pathogenic mutations in CSGs from 143 (25.0%) of 571 patients with ESCC and identified 84 double-hit events in 83 individuals (14.5%). The double-hit events were found in almost all projects in our study except ESCC-P008, which demonstrated that double-hit events are relatively common in ESCC. As far as we know, there was no report about pathogenic mutations in \u003Ci>GJB2, RECQL4, MUTYH\u003C/i>, and \u003Ci>PMS2\u003C/i> in ESCC, however, they were discovered in our study. Overall, \u003Ci>TP53, GJB2, BRCA2, RECQL4, MUTYH\u003C/i>, and \u003Ci>PMS2\u003C/i> were highly frequently mutated CSGs. Significant pathways were identified for different CSGs with pathogenic mutations; the FA pathway appeared to be a primary pathway for cancer predisposition in ESCC. We showed that significantly more pathogenic mutations from \u003Ci>TP53, BRCA2\u003C/i>, and \u003Ci>RECQL4\u003C/i> occurred in patients with ESCC than in control cohorts, which indicates that these three CSGs may play vital roles in ESCC. Interestingly, \u003Ci>TP53\u003C/i> and \u003Ci>RECQL4\u003C/i> have also been found significantly associated with osteosarcoma (\u003Ca href=\"#B39\">39\u003C/a>). The relationship with diagnosis age was not significant in our study, but double-hit events may be pivotal in ESCC carcinogenesis.\u003C/p>\n\u003Cp class=\"mb15\">We found that \u003Ci>TP53\u003C/i> had the highest frequency of pathogenic germline mutations and the most double-hit events in CSGs. In our study, 80% (12/15) of germline mutations in \u003Ci>TP53\u003C/i> were located in the p53 domain, which functions in DNA binding. This domain contains four conserved regions that are enriched for somatic mutation hot spots and are essential for the function of the TP53 protein as a transcription factor (\u003Ca href=\"#B78\">78\u003C/a>, \u003Ca href=\"#B79\">79\u003C/a>). Six of the 12 mutations were discovered in conserved regions. Environmental factors and specific DNA sequences drive higher mutation rates, which may explain why p53 domain was a hot-spot region (\u003Ca href=\"#B80\">80\u003C/a>). Those pathogenic \u003Ci>TP53\u003C/i> mutations may disrupt the p53 transcriptional pathway, which would enhance tumor progression and metastatic potential (\u003Ca href=\"#B81\">81\u003C/a>). The US Food and Drug Administration had approved drugs against the pocket in p53 domain (\u003Ca href=\"#B82\">82\u003C/a>). These drugs provide treatment options to patients with tumors that have mutations in the p53 domain. Results of studies in other cancers contrast with our findings about \u003Ci>TP53\u003C/i>. In a renal cell carcinoma study, \u003Ci>FH\u003C/i>, instead of \u003Ci>TP53\u003C/i>, harbored the most double-hit events, and \u003Ci>BRCA1\u003C/i> harbored the most in a pan-cancer study (\u003Ca href=\"#B17\">17\u003C/a>, \u003Ca href=\"#B22\">22\u003C/a>). Previous studies have reported that most double-hit events with \u003Ci>TP53\u003C/i> involve a mutation accompanied by LOH (\u003Ca href=\"#B83\">83\u003C/a>, \u003Ca href=\"#B84\">84\u003C/a>). However, in our research, double somatic mutations were the dominant type of double-hit event. It was partially due to the lack of researches on \u003Ci>TP53\u003C/i> double somatic mutations before.\u003C/p>\n\u003Cp class=\"mb15\">\u003Ci>BRCA2\u003C/i> and \u003Ci>RECQL4\u003C/i> harbored more pathogenic germline mutations in ESCC than in public population. \u003Ci>BRCA2\u003C/i> is known for its involvement in breast cancer and ovarian cancer \u003Ci>via\u003C/i> the homologous recombination pathway, which is essential for repairing damaged DNA (\u003Ca href=\"#B85\">85\u003C/a>, \u003Ca href=\"#B86\">86\u003C/a>). And studies have reported \u003Ci>BRCA2\u003C/i> mutations related to ESCC risk in Chinese and Turkmen populations (\u003Ca href=\"#B20\">20\u003C/a>, \u003Ca href=\"#B87\">87\u003C/a>, \u003Ca href=\"#B88\">88\u003C/a>). The double-hit events detected in \u003Ci>BRCA2\u003C/i> in our study were germline/somatic double-hit events; the germline mutations were accompanied by allele loss SCNVs. These results were distinct from those reported in pancreatic acinar-cell carcinomas (\u003Ca href=\"#B89\">89\u003C/a>). \u003Ci>RECQL4\u003C/i> is a TSG that encodes RECQL4 helicase, which is involved in DNA replication and DNA repair. Germline mutations in \u003Ci>RECQL4\u003C/i> can cause the Rothmund&#x02013;Thomson syndrome and sporadic breast cancer (\u003Ca href=\"#B90\">90\u003C/a>). Although the pathogenic mutations in our ESCC cohort and in the 1000 Genomes EAS group were not significantly different (Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 0.0519), the difference between them was also confirmed by analysis of the ChinaMAP cohort (Fisher&#x00027;s exact test \u003Ci>p\u003C/i> = 0.0089). Importantly, this is the first report, to our knowledge, that illustrates the role of pathogenic mutations in \u003Ci>RECQL4\u003C/i> in ESCC.\u003C/p>\n\u003Cp class=\"mb15\">The PMS2 protein is a homolog of the PMS1 protein (\u003Ca href=\"#B91\">91\u003C/a>) and both of them are components of the mismatch repair system. Common polymorphisms of \u003Ci>PMS1\u003C/i> have been positively associated with ESCC in an African population (\u003Ca href=\"#B92\">92\u003C/a>). This finding, together with the connection between PMS1 and PMS2, suggests a possible relationship between \u003Ci>PMS2\u003C/i> and ESCC. The double-hit events of mismatch repair genes could result in Lynch syndrome, as described in several studies (\u003Ca href=\"#B70\">70\u003C/a>, \u003Ca href=\"#B93\">93\u003C/a>), but we did not detect double-hit events in \u003Ci>PMS2\u003C/i> in our ESCC cohort. A larger ESCC cohort study might uncover double-hit events in \u003Ci>PMS2\u003C/i>, which would strengthen our understanding about ESCC susceptibility.\u003C/p>\n\u003Cp class=\"mb15\">The genetic variations in ESCC are complicated. Although not all ESCC samples carried pathogenic germline mutations in CSGs, the detection rate of pathogenic mutations was close to that found in osteosarcoma (\u003Ca href=\"#B39\">39\u003C/a>). Because numerous susceptibility loci reported in genome-wide association studies were found in this research, we acknowledge that pathogenic mutations and known susceptibility loci may inform a genetic basis of ESCC. Our findings of variants and genes shared between ESCC and other cancers suggests that common hereditary factors exist in pan-cancer. Given the interplay of common SNPs and pathogenic mutations reported in breast cancer and colorectal cancer, the interaction between susceptibility loci and pathogenic mutations in ESCC suggests a need for future exploration (\u003Ca href=\"#B94\">94\u003C/a>).\u003C/p>\n\u003Cp class=\"mb15\">To better understand the genetic factors causing ESCC initiation and development, we confirmed the putative germline&#x02013;somatic interplay by COSMIC proximity match. The results not only support the pathogenicity of those germline mutations but also imply a signal functional relevance between germline and somatic mutations (\u003Ca href=\"#B76\">76\u003C/a>). In addition, we identified potential double-hit events in 83 patients with ESCC; although the difference was not significant, the patients with germline/somatic double-hit events were more likely to be diagnosed at younger ages. It is possible that pathogenic mutations confer the earliest genetic hits to TSGs in cells, so a somatic hit alone would cause loss of function in TSGs (\u003Ca href=\"#B95\">95\u003C/a>). As a result of double-hit events, the cells generate malignancy. Furthermore, enriched pathways revealed the process of pathogenic mutations that affect ESCC tumorigenesis and development. In patients without pathogenic mutations or double-hit events, limited CSG sets, potential alternations in methylations of a promoter region, germline CNVs, and gene-environmental or gene&#x02013;lifestyle interactions are possible explanations for ESCC development.\u003C/p>\n\u003Cp class=\"mb15\">Despite our findings about the genetic characterization of and double-hit events in ESCC, we still acknowledge limitations to our study. The first is our inability to obtain detailed clinical information because of limited access to public databases. Second, merging different data, such as WGS and WES, may induce biases in cohort-wide variant processing. Third, directly adopting variants from different sources may influence comparisons, because the different sources applied distinct platforms and variant detection pipelines. Fourth, our sample size was not large enough for statistical tests, especially for individual variants.\u003C/p>\n\u003Cp class=\"mb0\">In sum, we report that &#x0007E;25.0% of patients with ESCC harbored at least one pathogenic germline mutation in CSGs, and &#x0007E;14.5% of ESCC cases could be explained by a two-hit hypothesis. Significantly enriched pathways also validated the significance of those pathogenic mutations. Myriad genome variations occur in patients; our findings represent, to our knowledge, the largest discovery of rare, germline predisposition mutations in ESCC so far. These results strengthen the understanding about genetic factors involved in ESCC and will help improve prevention, early detection, and risk management of ESCC for patients. We acknowledge the shortcomings in the analytical methods and the data sources used. Additional studies are needed to improve our observations and results.\u003C/p>\n\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>Data Availability Statement\u003C/h2>\n\u003Cp class=\"mb0\">The original contributions presented in the study are included in the article/\u003Ca href=\"#h11\">Supplementary Material\u003C/a>, further inquiries can be directed to the corresponding author/s.\u003C/p>\n\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>Ethics Statement\u003C/h2>\n\u003Cp class=\"mb0\">The studies involving human participants were collected from published papers and were approved in corresponding ethical review organizations in previous studies, respectively. And our project was reviewed by the institutional review broad of Beijing Genomics institution.\u003C/p>\n\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>Author Contributions\u003C/h2>\n\u003Cp class=\"mb0\">LL and BZ contributed to the conceptualization of the study. BZ wrote the manuscript and performed the analysis. PD, XS, and XH provided help in the analysis. BZ, LL, XH, and PD collected the data from published literature or database. PH revised the manuscript. LL and XF supervised and supported this project. All authors contributed to the article and approved the submitted version.\u003C/p>\n\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Conflict of Interest\u003C/h2>\n\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\n\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\n\u003Cp class=\"mb0\">This study makes use of data generated by the Molecular Oncology Laboratory of Prof. Qimin Zhan, the Translational Medicine Research Center, Shanxi Medical University of Prof. Yongping Cui, the Department of Radiation Oncology, Fudan University Shanghai Cancer Center of Prof. Kuaile Zhao, the Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center of Prof. Han Liang, The Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine of Prof. Norman E. Sharpless, the Institute of Clinical Pathology, Shantou University Medical College of Prof. Min Su, the Cedars-Sinai Medical Center, UCLA School of Medicine, Prof. H. Phillip Koeffler and Prof. Jie He of Cancer Institute and Hospital, Chinese Academy of Medical Sciences. We also acknowledge other Professors for sharing the fastq data, and we acknowledge The National Center for Biotechnology Information, The European Genome-phenome Archive, and The Cancer Genome Atlas for sharing the esophageal squamous cell cancer data. This manuscript has been released as a pre-print at medRxiv (\u003Ca href=\"#B96\">96\u003C/a>).\u003C/p>\n\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Supplementary Material\u003C/h2>\n\u003Cp class=\"mb0\" id=\"SM1\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fonc.2021.637431/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fonc.2021.637431/full#supplementary-material\u003C/a>\u003C/p>\n\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>References\u003C/h2>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a> 1. Brown J, Stepien AJ, Willem P. Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa. \u003Ci>BMC Cancer.\u003C/i> (2020) 20:281. doi: 10.1186/s12885-020-06788-3 \u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1186/s12885-020-06788-3\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Brown&#x00026;author=AJ.+Stepien&#x00026;author=P.+Willem+&#x00026;publication_year=2020&#x00026;title=Landscape+of+copy+number+aberrations+in+esophageal+squamous+cell+carcinoma+from+a+high+endemic+region+of+South+Africa&#x00026;journal=BMC+Cancer.&#x00026;volume=20&#x00026;pages=281\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a> 2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. \u003Ci>CA Cancer J Clin.\u003C/i> (2016) 66:115&#x02013;32. doi: 10.3322/caac.21338\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.3322/caac.21338\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W.+Chen&#x00026;author=R.+Zheng&#x00026;author=PD.+Baade&#x00026;author=S.+Zhang&#x00026;author=H.+Zeng&#x00026;author=F.+Bray+&#x00026;publication_year=2016&#x00026;title=Cancer+statistics+in+China,+2015&#x00026;journal=CA+Cancer+J+Clin.&#x00026;volume=66&#x00026;pages=115-32\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a> 3. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. \u003Ci>J Natl Cancer Inst.\u003C/i> (2003) 95:1404&#x02013;13. doi: 10.1093/jnci/djg047\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/13130116\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/jnci/djg047\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=LS.+Engel&#x00026;author=WH.+Chow&#x00026;author=TL.+Vaughan&#x00026;author=MD.+Gammon&#x00026;author=HA.+Risch&#x00026;author=JL.+Stanford+&#x00026;publication_year=2003&#x00026;title=Population+attributable+risks+of+esophageal+and+gastric+cancers&#x00026;journal=J+Natl+Cancer+Inst.&#x00026;volume=95&#x00026;pages=1404-13\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a> 4. Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. Identification of genomic alterations in oesophageal squamous cell cancer. \u003Ci>Nature.\u003C/i> (2014) 508:91&#x02013;5. doi: 10.1038/nature13176\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24670651\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nature13176\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+Song&#x00026;author=L.+Li&#x00026;author=Y.+Ou&#x00026;author=Z.+Gao&#x00026;author=E.+Li&#x00026;author=X.+Li+&#x00026;publication_year=2014&#x00026;title=Identification+of+genomic+alterations+in+oesophageal+squamous+cell+cancer&#x00026;journal=Nature.&#x00026;volume=508&#x00026;pages=91-5\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a> 5. Gao YB, Chen ZL, Li JG, Hu X, da Shi XJ, Sun ZM, et al. Genetic landscape of esophageal squamous cell carcinoma. \u003Ci>Nat Genet.\u003C/i> (2014) 46:1097&#x02013;102. doi: 10.1038/ng.3076\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25151357\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng.3076\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=YB.+Gao&#x00026;author=ZL.+Chen&#x00026;author=JG.+Li&#x00026;author=X.+Hu&#x00026;author=XJ.++da+Shi&#x00026;author=ZM.+Sun+&#x00026;publication_year=2014&#x00026;title=Genetic+landscape+of+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=46&#x00026;pages=1097-102\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a> 6. Chen XX, Zhong Q, Liu Y, Yan SM, Chen ZH, Jin SZ, et al. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing. \u003Ci>Nat Commun.\u003C/i> (2017) 8:524. doi: 10.1038/s41467-017-00650-0\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28900112\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41467-017-00650-0\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=XX.+Chen&#x00026;author=Q.+Zhong&#x00026;author=Y.+Liu&#x00026;author=SM.+Yan&#x00026;author=ZH.+Chen&#x00026;author=SZ.+Jin+&#x00026;publication_year=2017&#x00026;title=Genomic+comparison+of+esophageal+squamous+cell+carcinoma+and+its+precursor+lesions+by+multi-region+whole-exome+sequencing&#x00026;journal=Nat+Commun.&#x00026;volume=8&#x00026;pages=524\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a> 7. Liu X, Zhang M, Ying S, Zhang C, Lin R, Zheng J, et al. Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma. \u003Ci>Gastroenterology.\u003C/i> (2017) 153:166&#x02013;77. doi: 10.1053/j.gastro.2017.03.033\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28365443\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1053/j.gastro.2017.03.033\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X.+Liu&#x00026;author=M.+Zhang&#x00026;author=S.+Ying&#x00026;author=C.+Zhang&#x00026;author=R.+Lin&#x00026;author=J.+Zheng+&#x00026;publication_year=2017&#x00026;title=Genetic+alterations+in+esophageal+tissues+from+squamous+dysplasia+to+carcinoma&#x00026;journal=Gastroenterology.&#x00026;volume=153&#x00026;pages=166-77\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a> 8. Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kawaguchi T, et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. \u003Ci>Gastroenterology.\u003C/i> (2009) 137:1768&#x02013;75. doi: 10.1053/j.gastro.2009.07.070\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19698717\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1053/j.gastro.2009.07.070\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Cui&#x00026;author=Y.+Kamatani&#x00026;author=A.+Takahashi&#x00026;author=M.+Usami&#x00026;author=N.+Hosono&#x00026;author=T.+Kawaguchi+&#x00026;publication_year=2009&#x00026;title=Functional+variants+in+ADH1B+and+ALDH2+coupled+with+alcohol+and+smoking+synergistically+enhance+esophageal+cancer+risk&#x00026;journal=Gastroenterology.&#x00026;volume=137&#x00026;pages=1768-75\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.1em;\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a> 9. Wang LD, Zhou FY, Li XMXCXM, Sun LD, Song X, Jin Y, et al. Genome-wide association study of esophageal squamous cell carcinoma in chinese subjects identifies a susceptibility locus at PLCE1. \u003Ci>Nat Genet.\u003C/i> (2010) 42:759&#x02013;65. doi: 10.1038/ng.648\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1038/ng.648\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=LD.+Wang&#x00026;author=FY.+Zhou&#x00026;author=XMXCXM.+Li&#x00026;author=LD.+Sun&#x00026;author=X.+Song&#x00026;author=Y.+Jin+&#x00026;publication_year=2010&#x00026;title=Genome-wide+association+study+of+esophageal+squamous+cell+carcinoma+in+chinese+subjects+identifies+a+susceptibility+locus+at+PLCE1&#x00026;journal=Nat+Genet.&#x00026;volume=42&#x00026;pages=759-65\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a> 10. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. \u003Ci>Nat Genet.\u003C/i> (2011) 43:679&#x02013;84. doi: 10.1038/ng.849\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21642993\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng.849\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Wu&#x00026;author=Z.+Hu&#x00026;author=Z.+He&#x00026;author=W.+Jia&#x00026;author=F.+Wang&#x00026;author=Y.+Zhou+&#x00026;publication_year=2011&#x00026;title=Genome-wide+association+study+identifies+three+new+susceptibility+loci+for+esophageal+squamous-cell+carcinoma+in+Chinese+populations&#x00026;journal=Nat+Genet.&#x00026;volume=43&#x00026;pages=679-84\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a> 11. Wu C, Kraft P, Zhai K, Chang J, Wang Z, Li Y, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. \u003Ci>Nat Genet.\u003C/i> (2012) 44:1090&#x02013;7. doi: 10.1038/ng.2411\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22960999\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng.2411\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Wu&#x00026;author=P.+Kraft&#x00026;author=K.+Zhai&#x00026;author=J.+Chang&#x00026;author=Z.+Wang&#x00026;author=Y.+Li+&#x00026;publication_year=2012&#x00026;title=Genome-wide+association+analyses+of+esophageal+squamous+cell+carcinoma+in+Chinese+identify+multiple+susceptibility+loci+and+gene-environment+interactions&#x00026;journal=Nat+Genet.&#x00026;volume=44&#x00026;pages=1090-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a> 12. Wu C, Wang Z, Song X, Feng XS, Abnet CC, He J, et al. Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. \u003Ci>Nat Genet.\u003C/i> (2014) 46:1001&#x02013;6. doi: 10.1158/1538-7445.AM2014-2204\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25129146\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1158/1538-7445.AM2014-2204\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Wu&#x00026;author=Z.+Wang&#x00026;author=X.+Song&#x00026;author=XS.+Feng&#x00026;author=CC.+Abnet&#x00026;author=J.+He+&#x00026;publication_year=2014&#x00026;title=Joint+analysis+of+three+genome-wide+association+studies+of+esophageal+squamous+cell+carcinoma+in+Chinese+populations&#x00026;journal=Nat+Genet.&#x00026;volume=46&#x00026;pages=1001-6\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a> 13. Lin D, Wu C, Li D, Jia W, Hu Z, Zhou Y, et al. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. \u003Ci>Nat Genet.\u003C/i> (2013) 45:632&#x02013;8. doi: 10.1038/ng.2638\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23644492\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng.2638\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D.+Lin&#x00026;author=C.+Wu&#x00026;author=D.+Li&#x00026;author=W.+Jia&#x00026;author=Z.+Hu&#x00026;author=Y.+Zhou+&#x00026;publication_year=2013&#x00026;title=Genome-wide+association+study+identifies+common+variants+in+SLC39A6+associated+with+length+of+survival+in+esophageal+squamous-cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=45&#x00026;pages=632-8\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a> 14. Chang J, Zhong R, Tian J, Li J, Zhai K, Ke J, et al. Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma. \u003Ci>Nat Genet.\u003C/i> (2018) 50:338&#x02013;43. doi: 10.1038/s41588-018-0045-8\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29379198\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41588-018-0045-8\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Chang&#x00026;author=R.+Zhong&#x00026;author=J.+Tian&#x00026;author=J.+Li&#x00026;author=K.+Zhai&#x00026;author=J.+Ke+&#x00026;publication_year=2018&#x00026;title=Exome-wide+analyses+identify+low-frequency+variant+in+CYP26B1+and+additional+coding+variants+associated+with+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=50&#x00026;pages=338-43\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a> 15. Hu JL, Hu XL, Lu CX, Chen XJ, Fu L, Han Q, et al. Variants in the 3&#x00027;-untranslated region of CUL3 is associated with risk of esophageal squamous cell carcinoma. \u003Ci>J Cancer.\u003C/i> (2018) 9:3647&#x02013;50. doi: 10.7150/jca.27052\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30405832\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.7150/jca.27052\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JL.+Hu&#x00026;author=XL.+Hu&#x00026;author=CX.+Lu&#x00026;author=XJ.+Chen&#x00026;author=L.+Fu&#x00026;author=Q.+Han+&#x00026;publication_year=2018&#x00026;title=Variants+in+the+3&#x00027;-untranslated+region+of+CUL3+is+associated+with+risk+of+esophageal+squamous+cell+carcinoma&#x00026;journal=J+Cancer.&#x00026;volume=9&#x00026;pages=3647-50\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a> 16. Suo C, Yang Y, Yuan Z, Zhang T, Yang X, Qing T, et al. Alcohol intake interacts with functional genetic polymorphisms of Aldehyde Dehydrogenase (ALDH2) and Alcohol Dehydrogenase (ADH) to increase esophageal squamous cell cancer risk. \u003Ci>J Thoracic Oncol.\u003C/i> (2019) 14:712&#x02013;25. doi: 10.1016/j.jtho.2018.12.023\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30639619\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.jtho.2018.12.023\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Suo&#x00026;author=Y.+Yang&#x00026;author=Z.+Yuan&#x00026;author=T.+Zhang&#x00026;author=X.+Yang&#x00026;author=T.+Qing+&#x00026;publication_year=2019&#x00026;title=Alcohol+intake+interacts+with+functional+genetic+polymorphisms+of+Aldehyde+Dehydrogenase+(ALDH2)+and+Alcohol+Dehydrogenase+(ADH)+to+increase+esophageal+squamous+cell+cancer+risk&#x00026;journal=J+Thoracic+Oncol.&#x00026;volume=14&#x00026;pages=712-25\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a> 17. Huang K, lin Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, et al. Pathogenic germline variants in 10,389 adult cancers. \u003Ci>Cell.\u003C/i> (2018) 173:355&#x02013;70. e14. doi: 10.1158/1538-7445.AM2018-5359\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29625052\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1158/1538-7445.AM2018-5359\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K.+Huang&#x00026;author=RJ.+lin+Mashl&#x00026;author=Y.+Wu&#x00026;author=DI.+Ritter&#x00026;author=J.+Wang&#x00026;author=C.+Oh+&#x00026;publication_year=2018&#x00026;title=Pathogenic+germline+variants+in+10,389+adult+cancers&#x00026;journal=Cell.&#x00026;volume=173&#x00026;pages=355-70. e14\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a> 18. Gr&#x000F6;bner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, et al. The landscape of genomic alterations across childhood cancers. \u003Ci>Nature.\u003C/i> (2018) 555:321&#x02013;7. doi: 10.1038/nature25480\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29875405\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nature25480\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SN.+Gr&#x000F6;bner&#x00026;author=BC.+Worst&#x00026;author=J.+Weischenfeldt&#x00026;author=I.+Buchhalter&#x00026;author=K.+Kleinheinz&#x00026;author=VA.+Rudneva+&#x00026;publication_year=2018&#x00026;title=The+landscape+of+genomic+alterations+across+childhood+cancers&#x00026;journal=Nature.&#x00026;volume=555&#x00026;pages=321-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a> 19. Deng J, Weng X, Ye J, Zhou D, Liu Y, Zhao K. Identification of the germline mutation profile in esophageal squamous cell carcinoma by whole exome sequencing. \u003Ci>Front Genet.\u003C/i> (2019) 10:47. doi: 10.3389/fgene.2019.00047\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30833958\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fgene.2019.00047\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Deng&#x00026;author=X.+Weng&#x00026;author=J.+Ye&#x00026;author=D.+Zhou&#x00026;author=Y.+Liu&#x00026;author=K.+Zhao+&#x00026;publication_year=2019&#x00026;title=Identification+of+the+germline+mutation+profile+in+esophageal+squamous+cell+carcinoma+by+whole+exome+sequencing&#x00026;journal=Front+Genet.&#x00026;volume=10&#x00026;pages=47\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a> 20. Ko JMY, Ning L, Zhao XK, Chai AWY, Lei LC, Choi SSA, et al. BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese. \u003Ci>Int J Cancer.\u003C/i> (2020) 146:1042&#x02013;51. doi: 10.1002/ijc.32619\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31396961\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/ijc.32619\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JMY.+Ko&#x00026;author=L.+Ning&#x00026;author=XK.+Zhao&#x00026;author=AWY.+Chai&#x00026;author=LC.+Lei&#x00026;author=SSA.+Choi+&#x00026;publication_year=2020&#x00026;title=BRCA2+loss-of-function+germline+mutations+are+associated+with+esophageal+squamous+cell+carcinoma+risk+in+Chinese&#x00026;journal=Int+J+Cancer.&#x00026;volume=146&#x00026;pages=1042-51\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a> 21. Knudson AG. Two genetic hits (more or less) to cancer. \u003Ci>Nat Rev Cancer.\u003C/i> (2001) 1:157&#x02013;62. doi: 10.1038/35101031\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/11905807\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/35101031\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AG.+Knudson+&#x00026;publication_year=2001&#x00026;title=Two+genetic+hits+(more+or+less)+to+cancer&#x00026;journal=Nat+Rev+Cancer.&#x00026;volume=1&#x00026;pages=157-62\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a> 22. Carlo MI, Mukherjee S, Mandelker D, Vijai J, Kemel Y, Zhang L, et al. Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma. \u003Ci>JAMA Oncol\u003C/i>. (2018) 4:1228&#x02013;35. doi: 10.1001/jamaoncol.2018.1986\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29978187\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1001/jamaoncol.2018.1986\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MI.+Carlo&#x00026;author=S.+Mukherjee&#x00026;author=D.+Mandelker&#x00026;author=J.+Vijai&#x00026;author=Y.+Kemel&#x00026;author=L.+Zhang+&#x00026;publication_year=2018&#x00026;title=Prevalence+of+germline+mutations+in+cancer+susceptibility+genes+in+patients+with+advanced+renal+cell+carcinoma&#x00026;journal=JAMA+Oncol&#x00026;volume=4&#x00026;pages=1228-35\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a> 23. Park S, Supek F, Lehner B. Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits. \u003Ci>Nat Commun.\u003C/i> (2018) 9:2601. doi: 10.1038/s41467-018-04900-7\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29973584\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41467-018-04900-7\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Park&#x00026;author=F.+Supek&#x00026;author=B.+Lehner+&#x00026;publication_year=2018&#x00026;title=Systematic+discovery+of+germline+cancer+predisposition+genes+through+the+identification+of+somatic+second+hits&#x00026;journal=Nat+Commun.&#x00026;volume=9&#x00026;pages=2601\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a> 24. Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. \u003Ci>Nat Genet.\u003C/i> (2014) 46:467&#x02013;73. doi: 10.1038/ng.2935\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24686850\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng.2935\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=DC.+Lin&#x00026;author=JJ.+Hao&#x00026;author=Y.+Nagata&#x00026;author=L.+Xu&#x00026;author=L.+Shang&#x00026;author=X.+Meng+&#x00026;publication_year=2014&#x00026;title=Genomic+and+molecular+characterization+of+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=46&#x00026;pages=467-73\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a> 25. Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P, et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. \u003Ci>Am J Hum Genet.\u003C/i> (2015) 96:597&#x02013;611. doi: 10.1016/j.ajhg.2015.02.017\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32888509\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.ajhg.2015.02.017\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=L.+Zhang&#x00026;author=Y.+Zhou&#x00026;author=C.+Cheng&#x00026;author=H.+Cui&#x00026;author=L.+Cheng&#x00026;author=P.+Kong+&#x00026;publication_year=2015&#x00026;title=Genomic+analyses+reveal+mutational+signatures+and+frequently+altered+genes+in+esophageal+squamous+cell+carcinoma&#x00026;journal=Am+J+Hum+Genet.&#x00026;volume=96&#x00026;pages=597-611\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a> 26. Hao JJ, Lin DC, Dinh HQ, Mayakonda A, Jiang YY, Chang C, et al. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. \u003Ci>Nat Genet.\u003C/i> (2016) 48:1500&#x02013;7. doi: 10.1038/ng.3683\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27749841\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng.3683\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JJ.+Hao&#x00026;author=DC.+Lin&#x00026;author=HQ.+Dinh&#x00026;author=A.+Mayakonda&#x00026;author=YY.+Jiang&#x00026;author=C.+Chang+&#x00026;publication_year=2016&#x00026;title=Spatial+intratumoral+heterogeneity+and+temporal+clonal+evolution+in+esophageal+squamous+cell+carcinoma&#x00026;journal=Nat+Genet.&#x00026;volume=48&#x00026;pages=1500-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a> 27. Liu W, Snell JM, Jeck WR, Hoadley KA, Wilkerson MD, Parker JS, et al. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. \u003Ci>JCI Insight.\u003C/i> (2016) 1:1&#x02013;11. doi: 10.1172/jci.insight.88755\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29148985\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1172/jci.insight.88755\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W.+Liu&#x00026;author=JM.+Snell&#x00026;author=WR.+Jeck&#x00026;author=KA.+Hoadley&#x00026;author=MD.+Wilkerson&#x00026;author=JS.+Parker+&#x00026;publication_year=2016&#x00026;title=Subtyping+sub-Saharan+esophageal+squamous+cell+carcinoma+by+comprehensive+molecular+analysis&#x00026;journal=JCI+Insight.&#x00026;volume=1&#x00026;pages=1-11\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a> 28. Deng J, Chen H, Zhou D, Zhang J, Chen Y, Liu Q, et al. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. \u003Ci>Nat Commun.\u003C/i> (2017) 8:1533. doi: 10.1038/s41467-017-01730-x\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29142225\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41467-017-01730-x\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Deng&#x00026;author=H.+Chen&#x00026;author=D.+Zhou&#x00026;author=J.+Zhang&#x00026;author=Y.+Chen&#x00026;author=Q.+Liu+&#x00026;publication_year=2017&#x00026;title=Comparative+genomic+analysis+of+esophageal+squamous+cell+carcinoma+between+Asian+and+Caucasian+patient+populations&#x00026;journal=Nat+Commun.&#x00026;volume=8&#x00026;pages=1533\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a> 29. Kim J, Bowlby R, Mungall AJ, Robertson AG, Odze RD, Cherniack AD, et al. Integrated genomic characterization of oesophageal carcinoma. \u003Ci>Nature.\u003C/i> (2017) 541:169&#x02013;74. doi: 10.1038/nature20805\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28052061\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nature20805\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J.+Kim&#x00026;author=R.+Bowlby&#x00026;author=AJ.+Mungall&#x00026;author=AG.+Robertson&#x00026;author=RD.+Odze&#x00026;author=AD.+Cherniack+&#x00026;publication_year=2017&#x00026;title=Integrated+genomic+characterization+of+oesophageal+carcinoma&#x00026;journal=Nature.&#x00026;volume=541&#x00026;pages=169-74\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a> 30. Ajay SS, Parker SCJ, Abaan HO, Fuentes Fajardo KV, Margulies EH. Accurate and comprehensive sequencing of personal genomes. \u003Ci>Genome Res.\u003C/i> (2011) 21:1498&#x02013;505. doi: 10.1101/gr.123638.111\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/21771779\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/gr.123638.111\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SS.+Ajay&#x00026;author=SCJ.+Parker&#x00026;author=HO.+Abaan&#x00026;author=KV.+Fuentes+Fajardo&#x00026;author=EH.+Margulies+&#x00026;publication_year=2011&#x00026;title=Accurate+and+comprehensive+sequencing+of+personal+genomes&#x00026;journal=Genome+Res.&#x00026;volume=21&#x00026;pages=1498-505\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a> 31. Chen Y, Chen Y, Shi C, Huang Z, Zhang Y. SOAPnuke : a MapReduce acceleration supported software for integrated quality control and preprocessing of high-throughput sequencing data. \u003Ci>GigaScience.\u003C/i> (2018) 7:gix120. doi: 10.1093/gigascience/gix120\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29220494\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/gigascience/gix120\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+Chen&#x00026;author=Y.+Chen&#x00026;author=C.+Shi&#x00026;author=Z.+Huang&#x00026;author=Y.+Zhang+&#x00026;publication_year=2018&#x00026;title=SOAPnuke+%3A+a+MapReduce+acceleration+supported+software+for+integrated+quality+control+and+preprocessing+of+high-throughput+sequencing+data&#x00026;journal=GigaScience.&#x00026;volume=7&#x00026;pages=gix120\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a> 32. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. \u003Ci>Genome Res.\u003C/i> (2010) 20:1297&#x02013;303. doi: 10.1101/gr.107524.110\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20644199\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/gr.107524.110\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+McKenna&#x00026;author=M.+Hanna&#x00026;author=E.+Banks&#x00026;author=A.+Sivachenko&#x00026;author=K.+Cibulskis&#x00026;author=A.+Kernytsky+&#x00026;publication_year=2010&#x00026;title=The+genome+analysis+toolkit%3A+a+MapReduce+framework+for+analyzing+next-generation+DNA+sequencing+data&#x00026;journal=Genome+Res.&#x00026;volume=20&#x00026;pages=1297-303\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a> 33. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. \u003Ci>Bioinformatics.\u003C/i> (2010) 26:589&#x02013;95. doi: 10.1093/bioinformatics/btp698\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20080505\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/bioinformatics/btp698\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H.+Li&#x00026;author=R.+Durbin+&#x00026;publication_year=2010&#x00026;title=Fast+and+accurate+long-read+alignment+with+Burrows-Wheeler+transform&#x00026;journal=Bioinformatics.&#x00026;volume=26&#x00026;pages=589-95\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a> 34. McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The ensembl variant effect predictor. \u003Ci>Genome Biol.\u003C/i> (2016) 17:1&#x02013;4. doi: 10.1186/s13059-016-0974-4\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1186/s13059-016-0974-4\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W.+McLaren&#x00026;author=L.+Gil&#x00026;author=SE.+Hunt&#x00026;author=HS.+Riat&#x00026;author=GRS.+Ritchie&#x00026;author=A.+Thormann+&#x00026;publication_year=2016&#x00026;title=The+ensembl+variant+effect+predictor&#x00026;journal=Genome+Biol.&#x00026;volume=17&#x00026;pages=1-4\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a> 35. Ramos AH, Lichtenstein L, Gupta M, Lawrence MS, Pugh TJ. Oncotator : cancer variant annotation tool. \u003Ci>Hum Mutation.\u003C/i> (2015) 36:E2423&#x02013;9. doi: 10.1002/humu.22771\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25703262\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/humu.22771\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AH.+Ramos&#x00026;author=L.+Lichtenstein&#x00026;author=M.+Gupta&#x00026;author=MS.+Lawrence&#x00026;author=TJ.+Pugh+&#x00026;publication_year=2015&#x00026;title=Oncotator+%3A+cancer+variant+annotation+tool&#x00026;journal=Hum+Mutation.&#x00026;volume=36&#x00026;pages=E2423-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B36\" id=\"B36\">\u003C/a> 36. Shen R, Seshan VE. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. \u003Ci>Nucleic Acids Res.\u003C/i> (2016) 44:1&#x02013;9. doi: 10.1093/nar/gkw520\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27270079\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkw520\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Shen&#x00026;author=VE.+Seshan+&#x00026;publication_year=2016&#x00026;title=FACETS%3A+allele-specific+copy+number+and+clonal+heterogeneity+analysis+tool+for+high-throughput+DNA+sequencing&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=44&#x00026;pages=1-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B37\" id=\"B37\">\u003C/a> 37. Mayrhofer M, DiLorenzo S, Isaksson A. Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue. \u003Ci>Genome Biol.\u003C/i> (2013) 14:R24. doi: 10.1186/gb-2013-14-3-r24\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23531354\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/gb-2013-14-3-r24\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Mayrhofer&#x00026;author=S.+DiLorenzo&#x00026;author=A.+Isaksson+&#x00026;publication_year=2013&#x00026;title=Patchwork%3A+allele-specific+copy+number+analysis+of+whole-genome+sequenced+tumor+tissue&#x00026;journal=Genome+Biol.&#x00026;volume=14&#x00026;pages=R24\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B38\" id=\"B38\">\u003C/a> 38. Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high-resolution. \u003Ci>Nucleic Acids Res.\u003C/i> (2017) 45:D777&#x02013;83. doi: 10.1093/nar/gkw1121\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27899578\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkw1121\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SA.+Forbes&#x00026;author=D.+Beare&#x00026;author=H.+Boutselakis&#x00026;author=S.+Bamford&#x00026;author=N.+Bindal&#x00026;author=J.+Tate+&#x00026;publication_year=2017&#x00026;title=COSMIC%3A+somatic+cancer+genetics+at+high-resolution&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=45&#x00026;pages=D777-83\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B39\" id=\"B39\">\u003C/a> 39. Mirabello L, Zhu B, Koster R, Karlins E, Dean M, Yeager M, et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. \u003Ci>JAMA Oncol.\u003C/i> (2020) 6:724&#x02013;34. doi: 10.1001/jamaoncol.2020.0197\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32191290\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1001/jamaoncol.2020.0197\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=L.+Mirabello&#x00026;author=B.+Zhu&#x00026;author=R.+Koster&#x00026;author=E.+Karlins&#x00026;author=M.+Dean&#x00026;author=M.+Yeager+&#x00026;publication_year=2020&#x00026;title=Frequency+of+pathogenic+germline+variants+in+cancer-susceptibility+genes+in+patients+with+osteosarcoma&#x00026;journal=JAMA+Oncol.&#x00026;volume=6&#x00026;pages=724-34\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B40\" id=\"B40\">\u003C/a> 40. Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. \u003Ci>Nucleic Acids Res.\u003C/i> (2013) 41:970&#x02013;6. doi: 10.1093/nar/gks937\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23066107\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gks937\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Zhao&#x00026;author=J.+Sun&#x00026;author=Z.+Zhao+&#x00026;publication_year=2013&#x00026;title=TSGene%3A+a+web+resource+for+tumor+suppressor+genes&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=41&#x00026;pages=970-6\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B41\" id=\"B41\">\u003C/a> 41. Zhao M, Kim P, Mitra R, Zhao J, Zhao Z. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. \u003Ci>Nucleic Acids Res.\u003C/i> (2016) 44:D1023&#x02013;31. doi: 10.1093/nar/gkv1268\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26590405\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkv1268\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Zhao&#x00026;author=P.+Kim&#x00026;author=R.+Mitra&#x00026;author=J.+Zhao&#x00026;author=Z.+Zhao+&#x00026;publication_year=2016&#x00026;title=TSGene+2.0%3A+an+updated+literature-based+knowledgebase+for+tumor+suppressor+genes&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=44&#x00026;pages=D1023-31\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B42\" id=\"B42\">\u003C/a> 42. Liu Y, Sun J, Zhao M. ONGene: a literature-based database for human oncogenes. \u003Ci>J Genet Genom.\u003C/i> (2017) 44:119&#x02013;21. doi: 10.1016/j.jgg.2016.12.004\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28162959\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.jgg.2016.12.004\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+Liu&#x00026;author=J.+Sun&#x00026;author=M.+Zhao+&#x00026;publication_year=2017&#x00026;title=ONGene%3A+a+literature-based+database+for+human+oncogenes&#x00026;journal=J+Genet+Genom.&#x00026;volume=44&#x00026;pages=119-21\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B43\" id=\"B43\">\u003C/a> 43. Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. \u003Ci>Am J Hum Genet.\u003C/i> (2017) 100:267&#x02013;80. doi: 10.1016/j.ajhg.2017.01.004\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28132688\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.ajhg.2017.01.004\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Q.+Li&#x00026;author=K.+Wang+&#x00026;publication_year=2017&#x00026;title=InterVar%3A+clinical+interpretation+of+genetic+variants+by+the+2015+ACMG-AMP+guidelines&#x00026;journal=Am+J+Hum+Genet.&#x00026;volume=100&#x00026;pages=267-80\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B44\" id=\"B44\">\u003C/a> 44. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. \u003Ci>Genet Med.\u003C/i> (2015) 17:405&#x02013;23. doi: 10.1038/gim.2015.30\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25741868\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/gim.2015.30\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Richards&#x00026;author=N.+Aziz&#x00026;author=S.+Bale&#x00026;author=D.+Bick&#x00026;author=S.+Das&#x00026;author=J.+Gastier-Foster+&#x00026;publication_year=2015&#x00026;title=Standards+and+guidelines+for+the+interpretation+of+sequence+variants%3A+a+joint+consensus+recommendation+of+the+American+College+of+Medical+Genetics+and+Genomics+and+the+Association+for+Molecular+Pathology&#x00026;journal=Genet+Med.&#x00026;volume=17&#x00026;pages=405-23\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B45\" id=\"B45\">\u003C/a> 45. Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, et al. the human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. \u003Ci>Hum Genet.\u003C/i> (2017) 136:665&#x02013;77. doi: 10.1007/s00439-017-1779-6\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28349240\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00439-017-1779-6\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=PD.+Stenson&#x00026;author=M.+Mort&#x00026;author=EV.+Ball&#x00026;author=K.+Evans&#x00026;author=M.+Hayden&#x00026;author=S.+Heywood+&#x00026;publication_year=2017&#x00026;title=the+human+gene+mutation+database%3A+towards+a+comprehensive+repository+of+inherited+mutation+data+for+medical+research,+genetic+diagnosis+and+next-generation+sequencing+studies&#x00026;journal=Hum+Genet.&#x00026;volume=136&#x00026;pages=665-77\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B46\" id=\"B46\">\u003C/a> 46. Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. \u003Ci>Nucleic Acids Res.\u003C/i> (2018) 46:D1062&#x02013;7. doi: 10.1093/nar/gkx1153\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29165669\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gkx1153\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MJ.+Landrum&#x00026;author=JM.+Lee&#x00026;author=M.+Benson&#x00026;author=GR.+Brown&#x00026;author=C.+Chao&#x00026;author=S.+Chitipiralla+&#x00026;publication_year=2018&#x00026;title=ClinVar%3A+improving+access+to+variant+interpretations+and+supporting+evidence&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=46&#x00026;pages=D1062-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B47\" id=\"B47\">\u003C/a> 47. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. \u003Ci>Nature.\u003C/i> (2016) 536:285&#x02013;91. doi: 10.1038/nature19057\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27535533\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nature19057\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Lek&#x00026;author=KJ.+Karczewski&#x00026;author=EV.+Minikel&#x00026;author=KE.+Samocha&#x00026;author=E.+Banks&#x00026;author=T.+Fennell+&#x00026;publication_year=2016&#x00026;title=Analysis+of+protein-coding+genetic+variation+in+60,706+humans&#x00026;journal=Nature.&#x00026;volume=536&#x00026;pages=285-91\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B48\" id=\"B48\">\u003C/a> 48. Poplin R, Chang PC, Alexander D, Schwartz S, Colthurst T, Ku A, et al. A universal snp and small-indel variant caller using deep neural networks. \u003Ci>Nat Biotechnol.\u003C/i> (2018) 36:983. doi: 10.1038/nbt.4235\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30247488\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nbt.4235\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Poplin&#x00026;author=PC.+Chang&#x00026;author=D.+Alexander&#x00026;author=S.+Schwartz&#x00026;author=T.+Colthurst&#x00026;author=A.+Ku+&#x00026;publication_year=2018&#x00026;title=A+universal+snp+and+small-indel+variant+caller+using+deep+neural+networks&#x00026;journal=Nat+Biotechnol.&#x00026;volume=36&#x00026;pages=983\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B49\" id=\"B49\">\u003C/a> 49. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. \u003Ci>Nat Protocols.\u003C/i> (2009) 4:1073&#x02013;82. doi: 10.1038/nprot.2009.86\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19561590\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nprot.2009.86\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P.+Kumar&#x00026;author=S.+Henikoff&#x00026;author=PC.+Ng+&#x00026;publication_year=2009&#x00026;title=Predicting+the+effects+of+coding+non-synonymous+variants+on+protein+function+using+the+SIFT+algorithm&#x00026;journal=Nat+Protocols.&#x00026;volume=4&#x00026;pages=1073-82\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B50\" id=\"B50\">\u003C/a> 50. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. \u003Ci>Nat Methods.\u003C/i> (2010) 7:248&#x02013;9. doi: 10.1038/nmeth0410-248\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20354512\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nmeth0410-248\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=IA.+Adzhubei&#x00026;author=S.+Schmidt&#x00026;author=L.+Peshkin&#x00026;author=VE.+Ramensky&#x00026;author=A.+Gerasimova&#x00026;author=P.+Bork+&#x00026;publication_year=2010&#x00026;title=A+method+and+server+for+predicting+damaging+missense+mutations&#x00026;journal=Nat+Methods.&#x00026;volume=7&#x00026;pages=248-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B51\" id=\"B51\">\u003C/a> 51. Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. \u003Ci>Nucleic Acids Res.\u003C/i> (2019) 47:D886&#x02013;94. doi: 10.1093/nar/gky1016\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30371827\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gky1016\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P.+Rentzsch&#x00026;author=D.+Witten&#x00026;author=GM.+Cooper&#x00026;author=J.+Shendure&#x00026;author=M.+Kircher+&#x00026;publication_year=2019&#x00026;title=CADD%3A+predicting+the+deleteriousness+of+variants+throughout+the+human+genome&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=47&#x00026;pages=D886-94\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B52\" id=\"B52\">\u003C/a> 52. Geurts-Giele WRR, Leenen CHM, Dubbink HJ, Meijssen IC, Post E, Sleddens HFBM, et al. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers. \u003Ci>J Pathol.\u003C/i> (2014) 234:548&#x02013;59. doi: 10.1002/path.4419\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25111426\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/path.4419\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=WRR.+Geurts-Giele&#x00026;author=CHM.+Leenen&#x00026;author=HJ.+Dubbink&#x00026;author=IC.+Meijssen&#x00026;author=E.+Post&#x00026;author=HFBM.+Sleddens+&#x00026;publication_year=2014&#x00026;title=Somatic+aberrations+of+mismatch+repair+genes+as+a+cause+of+microsatellite-unstable+cancers&#x00026;journal=J+Pathol.&#x00026;volume=234&#x00026;pages=548-59\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B53\" id=\"B53\">\u003C/a> 53. Cox C, Bignell G, Greenman C, Stabenau A, Warren W, Stephens P, et al. A survey of homozygous deletions in human cancer genomes. \u003Ci>Proc Natl Acad Sci USA.\u003C/i> (2005) 102:4542&#x02013;7. doi: 10.1073/pnas.0408593102\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15761058\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1073/pnas.0408593102\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C.+Cox&#x00026;author=G.+Bignell&#x00026;author=C.+Greenman&#x00026;author=A.+Stabenau&#x00026;author=W.+Warren&#x00026;author=P.+Stephens+&#x00026;publication_year=2005&#x00026;title=A+survey+of+homozygous+deletions+in+human+cancer+genomes&#x00026;journal=Proc+Natl+Acad+Sci+USA.&#x00026;volume=102&#x00026;pages=4542-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B54\" id=\"B54\">\u003C/a> 54. Ryland GL, Doyle MA, Goode D, Boyle SE, Choong DYH, Rowley SM, et al. Loss of heterozygosity: What is it good for? \u003Ci>BMC Med Genom.\u003C/i> (2015) 8:1&#x02013;12. doi: 10.1186/s12920-015-0123-z\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26231170\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1186/s12920-015-0123-z\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=GL.+Ryland&#x00026;author=MA.+Doyle&#x00026;author=D.+Goode&#x00026;author=SE.+Boyle&#x00026;author=DYH.+Choong&#x00026;author=SM.+Rowley+&#x00026;publication_year=2015&#x00026;title=Loss+of+heterozygosity%3A+What+is+it+good+for%3F&#x00026;journal=BMC+Med+Genom.&#x00026;volume=8&#x00026;pages=1-12\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B55\" id=\"B55\">\u003C/a> 55. Robinson JT, Thorvaldsd&#x000F3;ttir H, Wenger AM, Zehir A, Mesirov JP. Variant review with the integrative genomics viewer. \u003Ci>Cancer Res.\u003C/i> (2017) 77:e31&#x02013;4. doi: 10.1158/0008-5472.CAN-17-0337\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29092934\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1158/0008-5472.CAN-17-0337\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JT.+Robinson&#x00026;author=H.+Thorvaldsd&#x000F3;ttir&#x00026;author=AM.+Wenger&#x00026;author=A.+Zehir&#x00026;author=JP.+Mesirov+&#x00026;publication_year=2017&#x00026;title=Variant+review+with+the+integrative+genomics+viewer&#x00026;journal=Cancer+Res.&#x00026;volume=77&#x00026;pages=e31-4\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B56\" id=\"B56\">\u003C/a> 56. Ionita-Laza I, Lee S, Makarov V, Buxbaum JD, Lin X. Sequence kernel association tests for the combined effect of rare and common variants. \u003Ci>Am J Hum Genet.\u003C/i> (2013) 92:841&#x02013;53. doi: 10.1016/j.ajhg.2013.04.015\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23684009\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.ajhg.2013.04.015\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+Ionita-Laza&#x00026;author=S.+Lee&#x00026;author=V.+Makarov&#x00026;author=JD.+Buxbaum&#x00026;author=X.+Lin+&#x00026;publication_year=2013&#x00026;title=Sequence+kernel+association+tests+for+the+combined+effect+of+rare+and+common+variants&#x00026;journal=Am+J+Hum+Genet.&#x00026;volume=92&#x00026;pages=841-53\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B57\" id=\"B57\">\u003C/a> 57. Cao Y, Li L, Xu M, Feng Z, Sun X, Lu J, et al. The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals. \u003Ci>Cell Res\u003C/i>. (2020) 717&#x02013;31. doi: 10.1038/s41422-020-0322-9\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32355288\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41422-020-0322-9\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+Cao&#x00026;author=L.+Li&#x00026;author=M.+Xu&#x00026;author=Z.+Feng&#x00026;author=X.+Sun&#x00026;author=J.+Lu+&#x00026;publication_year=2020&#x00026;title=The+ChinaMAP+analytics+of+deep+whole+genome+sequences+in+10,588+individuals&#x00026;journal=Cell+Res&#x00026;pages=717-31\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B58\" id=\"B58\">\u003C/a> 58. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. \u003Ci>Hum Mutation.\u003C/i> (2002) 19:607&#x02013;14. doi: 10.1002/humu.10081\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12007217\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/humu.10081\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Olivier&#x00026;author=R.+Eeles&#x00026;author=M.+Hollstein&#x00026;author=MA.+Khan&#x00026;author=CC.+Harris&#x00026;author=P.+Hainaut+&#x00026;publication_year=2002&#x00026;title=The+IARC+TP53+database%3A+new+online+mutation+analysis+and+recommendations+to+users&#x00026;journal=Hum+Mutation.&#x00026;volume=19&#x00026;pages=607-14\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B59\" id=\"B59\">\u003C/a> 59. Dzhemileva LU, Barashkov NA, Posukh OL, Khusainova RI, Akhmetova VL, Kutuev IA, et al. Carrier frequency of GJB2 gene mutations c.35delG, c.235delC and c.167delT among the populations of Eurasia. \u003Ci>J Hum Genet.\u003C/i> (2010) 55:749&#x02013;54. doi: 10.1038/jhg.2010.101\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20739944\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/jhg.2010.101\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=LU.+Dzhemileva&#x00026;author=NA.+Barashkov&#x00026;author=OL.+Posukh&#x00026;author=RI.+Khusainova&#x00026;author=VL.+Akhmetova&#x00026;author=IA.+Kutuev+&#x00026;publication_year=2010&#x00026;title=Carrier+frequency+of+GJB2+gene+mutations+c.35delG,+c.235delC+and+c.167delT+among+the+populations+of+Eurasia&#x00026;journal=J+Hum+Genet.&#x00026;volume=55&#x00026;pages=749-54\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B60\" id=\"B60\">\u003C/a> 60. Kwong A, Shin VY, Ho JCW, Kang E, Nakamura S, Teo SH, et al. Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. \u003Ci>J Med Genet.\u003C/i> (2016) 53:15&#x02013;23. doi: 10.1136/jmedgenet-2015-103132\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26187060\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1136/jmedgenet-2015-103132\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Kwong&#x00026;author=VY.+Shin&#x00026;author=JCW.+Ho&#x00026;author=E.+Kang&#x00026;author=S.+Nakamura&#x00026;author=SH.+Teo+&#x00026;publication_year=2016&#x00026;title=Comprehensive+spectrum+of+BRCA1+and+BRCA2+deleterious+mutations+in+breast+cancer+in+Asian+countries&#x00026;journal=J+Med+Genet.&#x00026;volume=53&#x00026;pages=15-23\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B61\" id=\"B61\">\u003C/a> 61. Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. \u003Ci>Lancet Oncol.\u003C/i> (2018) 19:785&#x02013;98. doi: 10.1016/S1470-2045(18)30242-0\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29753700\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/S1470-2045(18)30242-0\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SM.+Waszak&#x00026;author=PA.+Northcott&#x00026;author=I.+Buchhalter&#x00026;author=GW.+Robinson&#x00026;author=C.+Sutter&#x00026;author=S.+Groebner+&#x00026;publication_year=2018&#x00026;title=Spectrum+and+prevalence+of+genetic+predisposition+in+medulloblastoma%3A+a+retrospective+genetic+study+and+prospective+validation+in+a+clinical+trial+cohort&#x00026;journal=Lancet+Oncol.&#x00026;volume=19&#x00026;pages=785-98\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B62\" id=\"B62\">\u003C/a> 62. Wen WX, Allen J, Lai KN, Mariapun S, Hasan SN, Ng PS, et al. Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia. \u003Ci>J Med Genet.\u003C/i> (2018) 55:97&#x02013;103. doi: 10.1136/jmedgenet-2017-104947\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/28993434\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1136/jmedgenet-2017-104947\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=WX.+Wen&#x00026;author=J.+Allen&#x00026;author=KN.+Lai&#x00026;author=S.+Mariapun&#x00026;author=SN.+Hasan&#x00026;author=PS.+Ng+&#x00026;publication_year=2018&#x00026;title=Inherited+mutations+in+BRCA1+and+BRCA2+in+an+unselected+multiethnic+cohort+of+Asian+patients+with+breast+cancer+and+healthy+controls+from+Malaysia&#x00026;journal=J+Med+Genet.&#x00026;volume=55&#x00026;pages=97-103\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B63\" id=\"B63\">\u003C/a> 63. Aretz S, Tricarico R, Papi L, Spier I, Pin E, Horpaopan S, et al. MUTYH-associated polyposis (MAP): Evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events. \u003Ci>Eur J Hum Genet.\u003C/i> (2014) 22:923&#x02013;9. doi: 10.1038/ejhg.2012.309\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23361220\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ejhg.2012.309\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Aretz&#x00026;author=R.+Tricarico&#x00026;author=L.+Papi&#x00026;author=I.+Spier&#x00026;author=E.+Pin&#x00026;author=S.+Horpaopan+&#x00026;publication_year=2014&#x00026;title=MUTYH-associated+polyposis+(MAP)%3A+Evidence+for+the+origin+of+the+common+European+mutations+p.Tyr179Cys+and+p.Gly396Asp+by+founder+events&#x00026;journal=Eur+J+Hum+Genet.&#x00026;volume=22&#x00026;pages=923-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B64\" id=\"B64\">\u003C/a> 64. Taki K, Sato Y, Nomura S, Ashihara Y, Kita M, Tajima I, et al. Mutation analysis of MUTYH in Japanese colorectal adenomatous polyposis patients. \u003Ci>Familial Cancer.\u003C/i> (2016) 15:261&#x02013;5. doi: 10.1007/s10689-015-9857-1\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26684191\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s10689-015-9857-1\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K.+Taki&#x00026;author=Y.+Sato&#x00026;author=S.+Nomura&#x00026;author=Y.+Ashihara&#x00026;author=M.+Kita&#x00026;author=I.+Tajima+&#x00026;publication_year=2016&#x00026;title=Mutation+analysis+of+MUTYH+in+Japanese+colorectal+adenomatous+polyposis+patients&#x00026;journal=Familial+Cancer.&#x00026;volume=15&#x00026;pages=261-5\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B65\" id=\"B65\">\u003C/a> 65. Klift HM, van der Tops &#x000C3;CMJ, Bik EC, Boogaard MW, Borgstein A, Hansson KBM, et al. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of lynch syndrome patients. \u003Ci>Hum Mutation.\u003C/i> (2010) 31:578&#x02013;87. doi: 10.1002/humu.21229\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20186688\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/humu.21229\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=HM.+Klift&#x00026;author=&#x000C3;CMJ.+van+der+Tops&#x00026;author=EC.+Bik&#x00026;author=MW.+Boogaard&#x00026;author=A.+Borgstein&#x00026;author=KBM.+Hansson+&#x00026;publication_year=2010&#x00026;title=Quantification+of+sequence+exchange+events+between+PMS2+and+PMS2CL+provides+a+basis+for+improved+mutation+scanning+of+lynch+syndrome+patients&#x00026;journal=Hum+Mutation.&#x00026;volume=31&#x00026;pages=578-87\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B66\" id=\"B66\">\u003C/a> 66. Zhang P, Kitchen-Smith I, Xiong L, Stracquadanio G, Brown K, Richter P, et al. Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response. \u003Ci>bioRxiv [Preprint]\u003C/i>. (2019). doi: 10.1101/835918\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33558336\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/835918\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P.+Zhang&#x00026;author=I.+Kitchen-Smith&#x00026;author=L.+Xiong&#x00026;author=G.+Stracquadanio&#x00026;author=K.+Brown&#x00026;author=P.+Richter+&#x00026;publication_year=2019&#x00026;title=Germline+and+somatic+genetic+variants+in+the+p53+pathway+interact+to+affect+cancer+risk,+progression+and+drug+response&#x00026;journal=bioRxiv+[Preprint]\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B67\" id=\"B67\">\u003C/a> 67. Staninova-Stojovska M, Matevska-Geskovska N, Panovski M, Angelovska B, Mitrevski N, Ristevski M, et al. Molecular basis of inherited colorectal carcinomas in the macedonian population: an update. \u003Ci>Balkan J Med Genet.\u003C/i> (2019) 22:5&#x02013;16. doi: 10.2478/bjmg-2019-0027\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31942411\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2478/bjmg-2019-0027\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Staninova-Stojovska&#x00026;author=N.+Matevska-Geskovska&#x00026;author=M.+Panovski&#x00026;author=B.+Angelovska&#x00026;author=N.+Mitrevski&#x00026;author=M.+Ristevski+&#x00026;publication_year=2019&#x00026;title=Molecular+basis+of+inherited+colorectal+carcinomas+in+the+macedonian+population%3A+an+update&#x00026;journal=Balkan+J+Med+Genet.&#x00026;volume=22&#x00026;pages=5-16\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B68\" id=\"B68\">\u003C/a> 68. Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. \u003Ci>Nature.\u003C/i> (2015) 526:68&#x02013;74. doi: 10.1038/nature15393\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26432245\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nature15393\" target=\"_blank\">CrossRef Full Text\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B69\" id=\"B69\">\u003C/a> 69. Boland CR, Goel A. Microsatellite instability in colorectal cancer. \u003Ci>Gastroenterology.\u003C/i> (2010) 138:2073&#x02013;87.e3. doi: 10.1053/j.gastro.2009.12.064\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1053/j.gastro.2009.12.064\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=CR.+Boland&#x00026;author=A.+Goel+&#x00026;publication_year=2010&#x00026;title=Microsatellite+instability+in+colorectal+cancer&#x00026;journal=Gastroenterology.&#x00026;volume=138&#x00026;pages=2073-87.e3\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B70\" id=\"B70\">\u003C/a> 70. Sourrouille I, Coulet F, Lefevre JH, Colas C, Eyries M, Svrcek M, et al. Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors. \u003Ci>Familial Cancer.\u003C/i> (2013) 12:27&#x02013;33. doi: 10.1007/s10689-012-9568-9\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22987205\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s10689-012-9568-9\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I.+Sourrouille&#x00026;author=F.+Coulet&#x00026;author=JH.+Lefevre&#x00026;author=C.+Colas&#x00026;author=M.+Eyries&#x00026;author=M.+Svrcek+&#x00026;publication_year=2013&#x00026;title=Somatic+mosaicism+and+double+somatic+hits+can+lead+to+MSI+colorectal+tumors&#x00026;journal=Familial+Cancer.&#x00026;volume=12&#x00026;pages=27-33\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B71\" id=\"B71\">\u003C/a> 71. Ceccaldi R, Sarangi P, D&#x00027;Andrea AD. The Fanconi anaemia pathway: new players and new functions. \u003Ci>Nat Rev Mol Cell Biol.\u003C/i> (2016) 17:337. doi: 10.1038/nrm.2016.48\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27145721\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nrm.2016.48\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Ceccaldi&#x00026;author=P.+Sarangi&#x00026;author=AD.+D&#x00027;Andrea+&#x00026;publication_year=2016&#x00026;title=The+Fanconi+anaemia+pathway%3A+new+players+and+new+functions&#x00026;journal=Nat+Rev+Mol+Cell+Biol.&#x00026;volume=17&#x00026;pages=337\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B72\" id=\"B72\">\u003C/a> 72. Joshi Niraj, Anniina F&#x000E4;rkkil&#x000E4;, D&#x00027;Andrea AD. The fanconi anemia pathway in cancer. \u003Ci>Annu Rev Cancer Biol.\u003C/i> (2019) 3:457&#x02013;78. doi: 10.1146/annurev-cancerbio-030617-050422\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1146/annurev-cancerbio-030617-050422\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Niraj.+Joshi&#x00026;author=F&#x000E4;rkkil&#x000E4;.+Anniina&#x00026;author=AD.+D&#x00027;Andrea+&#x00026;publication_year=2019&#x00026;title=The+fanconi+anemia+pathway+in+cancer&#x00026;journal=Annu+Rev+Cancer+Biol.&#x00026;volume=3&#x00026;pages=457-78\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B73\" id=\"B73\">\u003C/a> 73. Hsieh P, Yamane K. DNA mismatch repair: molecular mechanism, cancer, and ageing. \u003Ci>Mech Ageing Dev.\u003C/i> (2008) 129:391&#x02013;407. doi: 10.1016/j.mad.2008.02.012\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18406444\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.mad.2008.02.012\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P.+Hsieh&#x00026;author=K.+Yamane+&#x00026;publication_year=2008&#x00026;title=DNA+mismatch+repair%3A+molecular+mechanism,+cancer,+and+ageing&#x00026;journal=Mech+Ageing+Dev.&#x00026;volume=129&#x00026;pages=391-407\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B74\" id=\"B74\">\u003C/a> 74. Li GM. Mechanisms and functions of DNA mismatch repair. \u003Ci>Cell Res.\u003C/i> (2008) 18:85&#x02013;98. doi: 10.1038/cr.2007.115\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18157157\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/cr.2007.115\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=GM.+Li+&#x00026;publication_year=2008&#x00026;title=Mechanisms+and+functions+of+DNA+mismatch+repair&#x00026;journal=Cell+Res.&#x00026;volume=18&#x00026;pages=85-98\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B75\" id=\"B75\">\u003C/a> 75. Li X, Heyer W-D. Homologous recombination in DNA reapir and DNA tolerance. \u003Ci>Cell Res.\u003C/i> (2008) 18:99&#x02013;113. doi: 10.1038/cr.2008.1\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/19674975\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/cr.2008.1\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=X.+Li&#x00026;author=W-D.+Heyer+&#x00026;publication_year=2008&#x00026;title=Homologous+recombination+in+DNA+reapir+and+DNA+tolerance&#x00026;journal=Cell+Res.&#x00026;volume=18&#x00026;pages=99-113\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B76\" id=\"B76\">\u003C/a> 76. Kanchi KL, Johnson KJ, Lu C, McLellan MD, Leiserson MDM, Wendl MC, et al. Integrated analysis of germline and somatic variants in ovarian cancer. \u003Ci>Nat Commun.\u003C/i> (2014) 5:3156. doi: 10.1038/ncomms4156\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24448499\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ncomms4156\" target=\"_blank\">CrossRef Full Text\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B77\" id=\"B77\">\u003C/a> 77. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic signaling pathways in the cancer genome atlas. \u003Ci>Cell.\u003C/i> (2018) 173:321.e10&#x02013;37. doi: 10.1016/j.cell.2018.03.035\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29625050\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.cell.2018.03.035\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F.+Sanchez-Vega&#x00026;author=M.+Mina&#x00026;author=J.+Armenia&#x00026;author=WK.+Chatila&#x00026;author=A.+Luna&#x00026;author=KC.+La+&#x00026;publication_year=2018&#x00026;title=Oncogenic+signaling+pathways+in+the+cancer+genome+atlas&#x00026;journal=Cell.&#x00026;volume=173&#x00026;pages=321.e10-37\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B78\" id=\"B78\">\u003C/a> 78. Pavletich NP, Chambers KA, Pabo CO. The DNA-binding domain of 53 contains the four conserved regions the major mutation hot spots. \u003Ci>Genes Dev.\u003C/i> (1993) 7:2556&#x02013;64. doi: 10.1101/gad.7.12b.2556\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/8276238\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1101/gad.7.12b.2556\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=NP.+Pavletich&#x00026;author=KA.+Chambers&#x00026;author=CO.+Pabo+&#x00026;publication_year=1993&#x00026;title=The+DNA-binding+domain+of+53+contains+the+four+conserved+regions+the+major+mutation+hot+spots&#x00026;journal=Genes+Dev.&#x00026;volume=7&#x00026;pages=2556-64\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B79\" id=\"B79\">\u003C/a> 79. Harms KL, Chen X. The functional domains in p53 family proteins exhibit both common and distinct properties. \u003Ci>Cell Death Differ.\u003C/i> (2006) 13:890&#x02013;7. doi: 10.1038/sj.cdd.4401904\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16543939\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.cdd.4401904\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=KL.+Harms&#x00026;author=X.+Chen+&#x00026;publication_year=2006&#x00026;title=The+functional+domains+in+p53+family+proteins+exhibit+both+common+and+distinct+properties&#x00026;journal=Cell+Death+Differ.&#x00026;volume=13&#x00026;pages=890-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B80\" id=\"B80\">\u003C/a> 80. Baugh EH, Ke H, Levine AJ, Bonneau RA, Chan CS. Why are there hotspot mutations in the TP53 gene in human cancers? \u003Ci>Cell Death Differ.\u003C/i> (2018) 25:154&#x02013;60. doi: 10.1038/cdd.2017.180\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29099487\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/cdd.2017.180\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=EH.+Baugh&#x00026;author=H.+Ke&#x00026;author=AJ.+Levine&#x00026;author=RA.+Bonneau&#x00026;author=CS.+Chan+&#x00026;publication_year=2018&#x00026;title=Why+are+there+hotspot+mutations+in+the+TP53+gene+in+human+cancers%3F&#x00026;journal=Cell+Death+Differ.&#x00026;volume=25&#x00026;pages=154-60\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B81\" id=\"B81\">\u003C/a> 81. Parrales A, Iwakuma T. Targeting oncogenic mutant p53 for cancer therapy. \u003Ci>Front Oncol.\u003C/i> (2015) 5:288. doi: 10.3389/fonc.2015.00288\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26732534\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fonc.2015.00288\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Parrales&#x00026;author=T.+Iwakuma+&#x00026;publication_year=2015&#x00026;title=Targeting+oncogenic+mutant+p53+for+cancer+therapy&#x00026;journal=Front+Oncol.&#x00026;volume=5&#x00026;pages=288\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B82\" id=\"B82\">\u003C/a> 82. Pradhan MR, Siau JW, Kannan S, Nguyen MN, Ouaray Z, Kwoh CK, et al. Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket. \u003Ci>Nucleic Acids Res.\u003C/i> (2019) 47:1637&#x02013;52. doi: 10.1093/nar/gky1314\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30649466\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/nar/gky1314\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MR.+Pradhan&#x00026;author=JW.+Siau&#x00026;author=S.+Kannan&#x00026;author=MN.+Nguyen&#x00026;author=Z.+Ouaray&#x00026;author=CK.+Kwoh+&#x00026;publication_year=2019&#x00026;title=Simulations+of+mutant+p53+DNA+binding+domains+reveal+a+novel+druggable+pocket&#x00026;journal=Nucleic+Acids+Res.&#x00026;volume=47&#x00026;pages=1637-52\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B83\" id=\"B83\">\u003C/a> 83. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. \u003Ci>Nat Genet.\u003C/i> (2002) 32:355&#x02013;7. doi: 10.1038/ng1013\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12379854\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/ng1013\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K.+Kurose&#x00026;author=K.+Gilley&#x00026;author=S.+Matsumoto&#x00026;author=PH.+Watson&#x00026;author=XP.+Zhou&#x00026;author=C.+Eng+&#x00026;publication_year=2002&#x00026;title=Frequent+somatic+mutations+in+PTEN+and+TP53+are+mutually+exclusive+in+the+stroma+of+breast+carcinomas&#x00026;journal=Nat+Genet.&#x00026;volume=32&#x00026;pages=355-7\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B84\" id=\"B84\">\u003C/a> 84. Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, et al. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. \u003Ci>Nature.\u003C/i> (2016) 531:471&#x02013;5. doi: 10.1038/nature17157\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26982726\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/nature17157\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y.+Liu&#x00026;author=C.+Chen&#x00026;author=Z.+Xu&#x00026;author=C.+Scuoppo&#x00026;author=CD.+Rillahan&#x00026;author=J.+Gao+&#x00026;publication_year=2016&#x00026;title=Deletions+linked+to+TP53+loss+drive+cancer+through+p53-independent+mechanisms&#x00026;journal=Nature.&#x00026;volume=531&#x00026;pages=471-5\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B85\" id=\"B85\">\u003C/a> 85. Buisson R, Dion-C&#x000F4;t&#x000E9; A-M, Coulombe Y, Launay H. Cooperation of breast cancer proteins PALB2 and piccolo BRAC2 in stimulating homologous recombination. \u003Ci>Nat Struct Mol Biol.\u003C/i> (2010) 17:1247&#x02013;54. doi: 10.1038/nsmb.1915\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1038/nsmb.1915\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R.+Buisson&#x00026;author=A-M.+Dion-C&#x000F4;t&#x000E9;&#x00026;author=Y.+Coulombe&#x00026;author=H.+Launay+&#x00026;publication_year=2010&#x00026;title=Cooperation+of+breast+cancer+proteins+PALB2+and+piccolo+BRAC2+in+stimulating+homologous+recombination&#x00026;journal=Nat+Struct+Mol+Biol.&#x00026;volume=17&#x00026;pages=1247-54\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B86\" id=\"B86\">\u003C/a> 86. Girardi F, Barnes DR, Barrowdale D, Frost D, Brady AF, Miller C, et al. Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study. \u003Ci>Genet Med.\u003C/i> (2018) 20:1575&#x02013;82. doi: 10.1038/gim.2018.44\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29565421\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/gim.2018.44\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F.+Girardi&#x00026;author=DR.+Barnes&#x00026;author=D.+Barrowdale&#x00026;author=D.+Frost&#x00026;author=AF.+Brady&#x00026;author=C.+Miller+&#x00026;publication_year=2018&#x00026;title=Risks+of+breast+or+ovarian+cancer+in+BRCA1+or+BRCA2+predictive+test+negatives%3A+findings+from+the+EMBRACE+study&#x00026;journal=Genet+Med.&#x00026;volume=20&#x00026;pages=1575-82\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B87\" id=\"B87\">\u003C/a> 87. Hu N, Wang C, Han XY, He LJ, Tang ZZ, Giffen C, et al. Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer. \u003Ci>Oncogene.\u003C/i> (2004) 23:852&#x02013;8. doi: 10.1038/sj.onc.1207150\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/14647438\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.onc.1207150\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=N.+Hu&#x00026;author=C.+Wang&#x00026;author=XY.+Han&#x00026;author=LJ.+He&#x00026;author=ZZ.+Tang&#x00026;author=C.+Giffen+&#x00026;publication_year=2004&#x00026;title=Evaluation+of+BRCA2+in+the+genetic+susceptibility+of+familial+esophageal+cancer&#x00026;journal=Oncogene.&#x00026;volume=23&#x00026;pages=852-8\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B88\" id=\"B88\">\u003C/a> 88. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, et al. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. \u003Ci>Oncogene.\u003C/i> (2008) 27:1290&#x02013;6. doi: 10.1038/sj.onc.1210739\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/31396961\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/sj.onc.1210739\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MR.+Akbari&#x00026;author=R.+Malekzadeh&#x00026;author=D.+Nasrollahzadeh&#x00026;author=D.+Amanian&#x00026;author=F.+Islami&#x00026;author=S.+Li+&#x00026;publication_year=2008&#x00026;title=Germline+BRCA2+mutations+and+the+risk+of+esophageal+squamous+cell+carcinoma&#x00026;journal=Oncogene.&#x00026;volume=27&#x00026;pages=1290-6\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B89\" id=\"B89\">\u003C/a> 89. Skoulidis F, Cassidy LD, Pisupati V, Jonasson JG, Bjarnason H, Eyfjord JE, et al. Germline Brca2 Heterozygosity Promotes KrasG12D -Driven carcinogenesis in a murine model of familial pancreatic cancer. \u003Ci>Cancer Cell.\u003C/i> (2010) 18:499&#x02013;509. doi: 10.1016/j.ccr.2010.10.015\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.ccr.2010.10.015\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F.+Skoulidis&#x00026;author=LD.+Cassidy&#x00026;author=V.+Pisupati&#x00026;author=JG.+Jonasson&#x00026;author=H.+Bjarnason&#x00026;author=JE.+Eyfjord+&#x00026;publication_year=2010&#x00026;title=Germline+Brca2+Heterozygosity+Promotes+KrasG12D+-Driven+carcinogenesis+in+a+murine+model+of+familial+pancreatic+cancer&#x00026;journal=Cancer+Cell.&#x00026;volume=18&#x00026;pages=499-509\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B90\" id=\"B90\">\u003C/a> 90. Arora A, Agarwal D, Abdel-Fatah TMA, Lu H, Croteau DL, Moseley P, et al. RECQL4 helicase has oncogenic potential in sporadic breast cancers. \u003Ci>J Pathol.\u003C/i> (2016) 238:495&#x02013;501. doi: 10.1002/path.4681\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26690729\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/path.4681\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A.+Arora&#x00026;author=D.+Agarwal&#x00026;author=TMA.+Abdel-Fatah&#x00026;author=H.+Lu&#x00026;author=DL.+Croteau&#x00026;author=P.+Moseley+&#x00026;publication_year=2016&#x00026;title=RECQL4+helicase+has+oncogenic+potential+in+sporadic+breast+cancers&#x00026;journal=J+Pathol.&#x00026;volume=238&#x00026;pages=495-501\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B91\" id=\"B91\">\u003C/a> 91. Zhao L. Mismatch repair protein expression in patients with stage II and III sporadic colorectal cancer. \u003Ci>Oncol Lett.\u003C/i> (2018) 15:8053&#x02013;61. doi: 10.3892/ol.2018.8337\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29849807\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3892/ol.2018.8337\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=L.+Zhao+&#x00026;publication_year=2018&#x00026;title=Mismatch+repair+protein+expression+in+patients+with+stage+II+and+III+sporadic+colorectal+cancer&#x00026;journal=Oncol+Lett.&#x00026;volume=15&#x00026;pages=8053-61\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B92\" id=\"B92\">\u003C/a> 92. Vogelsang M, Wang Y, Veber N, Mwapagha LM, Parker MI. The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk. \u003Ci>PLoS ONE.\u003C/i> (2012) 7:e36962. doi: 10.1371/journal.pone.0036962\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22623965\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1371/journal.pone.0036962\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M.+Vogelsang&#x00026;author=Y.+Wang&#x00026;author=N.+Veber&#x00026;author=LM.+Mwapagha&#x00026;author=MI.+Parker+&#x00026;publication_year=2012&#x00026;title=The+cumulative+effects+of+polymorphisms+in+the+DNA+mismatch+repair+genes+and+tobacco+smoking+in+oesophageal+cancer+risk&#x00026;journal=PLoS+ONE.&#x00026;volume=7&#x00026;pages=e36962\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B93\" id=\"B93\">\u003C/a> 93. Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de La Chapelle A, et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. \u003Ci>Gastroenterology.\u003C/i> (2014) 147:1308&#x02013;16.e1. doi: 10.1053/j.gastro.2014.08.041\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25194673\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1053/j.gastro.2014.08.041\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S.+Haraldsdottir&#x00026;author=H.+Hampel&#x00026;author=J.+Tomsic&#x00026;author=WL.+Frankel&#x00026;author=R.+Pearlman&#x00026;author=A.+de+La+Chapelle+&#x00026;publication_year=2014&#x00026;title=Colon+and+endometrial+cancers+with+mismatch+repair+deficiency+can+arise+from+somatic,+rather+than+germline,+mutations&#x00026;journal=Gastroenterology.&#x00026;volume=147&#x00026;pages=1308-16.e1\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B94\" id=\"B94\">\u003C/a> 94. Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. \u003Ci>Nat Commun.\u003C/i> (2020) 11:3635. doi: 10.1038/s41467-020-17374-3\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32820175\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41467-020-17374-3\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AC.+Fahed&#x00026;author=M.+Wang&#x00026;author=JR.+Homburger&#x00026;author=AP.+Patel&#x00026;author=AG.+Bick&#x00026;author=CL.+Neben+&#x00026;publication_year=2020&#x00026;title=Polygenic+background+modifies+penetrance+of+monogenic+variants+for+tier+1+genomic+conditions&#x00026;journal=Nat+Commun.&#x00026;volume=11&#x00026;pages=3635\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B95\" id=\"B95\">\u003C/a> 95. Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, et al. Ovarian carcinoma \u003Ci>in situ\u003C/i> with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. \u003Ci>J Natl Cancer Instit.\u003C/i> (2000) 92:1088&#x02013;91. doi: 10.1093/jnci/92.13.1088\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/10880552\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/jnci/92.13.1088\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=BA.+Werness&#x00026;author=P.+Parvatiyar&#x00026;author=SJ.+Ramus&#x00026;author=AS.+Whittemore&#x00026;author=K.+Garlinghouse-Jones&#x00026;author=I.+Oakley-Girvan+&#x00026;publication_year=2000&#x00026;title=Ovarian+carcinoma+in+situ+with+germline+BRCA1+mutation+and+loss+of+heterozygosity+at+BRCA1+and+TP53&#x00026;journal=J+Natl+Cancer+Instit.&#x00026;volume=92&#x00026;pages=1088-91\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em; margin-left:2em;\">\n\u003Cp class=\"ReferencesCopy1\" style=\"margin-left:0.7em; text-indent:-1.7em;\">\u003Ca name=\"B96\" id=\"B96\">\u003C/a> 96. Zeng B, Huang P, Du P, Sun X, Huang X, Fang X, et al. Comprehensive study of germline mutations and double-hit events in esophageal squamous cell cancer. \u003Ci>medRxiv [Preprint]\u003C/i>. (2021). doi: 10.1101/2021.02.04.21251116\u003C/p>\n\u003Cp style=\"margin-left:1em;\" class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1101/2021.02.04.21251116\" target=\"_blank\">CrossRef Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=B.+Zeng&#x00026;author=P.+Huang&#x00026;author=P.+Du&#x00026;author=X.+Sun&#x00026;author=X.+Huang&#x00026;author=X.+Fang+&#x00026;publication_year=2021&#x00026;title=Comprehensive+study+of+germline+mutations+and+double-hit+events+in+esophageal+squamous+cell+cancer&#x00026;journal=medRxiv+[Preprint]\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\n\u003C/div>\n\u003C/div>\n\u003Cdiv class=\"thinLineM20\">\u003C/div>\n\u003Cdiv class=\"AbstractSummary\">\n\u003Cp>\u003Cspan>Keywords:\u003C/span> esophageal squamous cell cancer, cancer susceptibility gene, double-hit, germline mutation, pathogenicity\u003C/p>\n\u003Cp>\u003Cspan>Citation:\u003C/span> Zeng B, Huang P, Du P, Sun X, Huang X, Fang X and Li L (2021) Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer. \u003Ci>Front. Oncol.\u003C/i> 11:637431. doi: 10.3389/fonc.2021.637431\u003C/p>\n\u003Cp id=\"timestamps\">\u003Cspan>Received:\u003C/span> 03 December 2020; \u003Cspan>Accepted:\u003C/span> 10 February 2021;\u003Cbr> \u003Cspan>Published:\u003C/span> 06 April 2021.\u003C/p>\n\u003Cdiv>\u003Cp>Edited by:\u003C/p> \u003Ca href=\"http://loop.frontiersin.org/people/1051675/overview\">Jiang Chen\u003C/a>, Zhejiang University, China\u003C/div>\n\u003Cdiv>\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"http://loop.frontiersin.org/people/25934/overview\">Robert Klein\u003C/a>, Icahn School of Medicine at Mount Sinai, United States\u003Cbr> \u003Ca href=\"http://loop.frontiersin.org/people/743175/overview\">Zhigang Ren\u003C/a>, First Affiliated Hospital of Zhengzhou University, China\u003C/div>\n\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000A9; 2021 Zeng, Huang, Du, Sun, Huang, Fang and Li. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY)\u003C/a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\n\u003Cp>\u003Cspan>&#x0002A;Correspondence:\u003C/span> Lin Li, \u003Ca id=\"encmail\">bGlsaW5fY29udGFjdEAxNjMuY29t\u003C/a>; Xiaodong Fang, \u003Ca id=\"encmail\">ZmFuZ3hkQGJnaS5jb20=\u003C/a>\u003C/p>\n\u003Cdiv class=\"clear\">\u003C/div>\n\u003C/div>","\u003Cul class=\"flyoutJournal\">\r\n\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h3\">Materials and Methods\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h6\">Data Availability Statement\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h7\">Ethics Statement\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h8\">Author Contributions\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h9\">Conflict of Interest\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h10\">Acknowledgments\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h11\">Supplementary Material\u003C/a>\u003C/li>\r\n\u003Cli>\u003Ca href=\"#h12\">References\u003C/a>\u003C/li>\r\n\u003C/ul>",[656,661,667,670,676],{"name":657,"fileServerPackageEntryId":19,"fileServerId":658,"fileServerVersionNumber":637,"type":659},"EPUB.epub","637431/epub",{"code":660,"name":660},"EPUB",{"name":662,"fileServerPackageEntryId":663,"fileServerId":664,"fileServerVersionNumber":637,"type":665},"fonc-11-637431.pdf","fonc-11-637431-r1/fonc-11-637431.pdf","637431/pubmed-zip",{"code":666,"name":666},"PDF",{"name":662,"fileServerPackageEntryId":19,"fileServerId":668,"fileServerVersionNumber":637,"type":669},"637431/publishers-proof/pdf",{"code":666,"name":666},{"name":671,"fileServerPackageEntryId":672,"fileServerId":664,"fileServerVersionNumber":637,"type":673},"fonc-11-637431.xml","fonc-11-637431-r1/fonc-11-637431.xml",{"code":674,"name":675},"NLM_XML","XML",{"name":677,"fileServerPackageEntryId":19,"fileServerId":678,"fileServerVersionNumber":391,"type":679},"Provisional PDF.pdf","637431/provisional-pdf",{"code":666,"name":666},"v3",{"title":682,"link":683,"meta":687,"script":802},"Frontiers | Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer",[684],{"rel":685,"href":686},"canonical","https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/full",[688,691,694,696,699,703,706,710,713,716,719,721,723,725,727,729,732,735,737,740,742,744,747,750,753,756,759,763,767,770,773,776,779,782,784,787,789,792,794,797,799],{"hid":689,"property":689,"name":689,"content":690},"description","Esophageal squamous cell cancer (ESCC) is the eighth most common cancer around the world. Several reports have focused on somatic mutations and common germli...",{"hid":692,"property":692,"name":693,"content":682},"og:title","title",{"hid":695,"property":695,"name":689,"content":690},"og:description",{"hid":697,"name":697,"content":698},"keywords","Esophageal squamous cell cancer,Cancer susceptibility gene,Double-hit,germline mutation,pathogenicity",{"hid":700,"property":700,"name":701,"content":702},"og:site_name","site_name","Frontiers",{"hid":704,"property":704,"name":384,"content":705},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/637431/fonc-11-637431-HTML-r1/image_m/fonc-11-637431-g001.jpg",{"hid":707,"property":707,"name":708,"content":709},"og:type","type","article",{"hid":711,"property":711,"name":712,"content":686},"og:url","url",{"hid":714,"name":714,"content":715},"twitter:card","summary_large_image",{"hid":717,"name":717,"content":718},"citation_volume","11",{"hid":720,"name":720,"content":116},"citation_journal_title",{"hid":722,"name":722,"content":702},"citation_publisher",{"hid":724,"name":724,"content":633},"citation_journal_abbrev",{"hid":726,"name":726,"content":634},"citation_issn",{"hid":728,"name":728,"content":536},"citation_doi",{"hid":730,"name":730,"content":731},"citation_firstpage","637431",{"hid":733,"name":733,"content":734},"citation_language","English",{"hid":736,"name":736,"content":537},"citation_title",{"hid":738,"name":738,"content":739},"citation_keywords","Esophageal squamous cell cancer; Cancer susceptibility gene; Double-hit; germline mutation; pathogenicity",{"hid":741,"name":741,"content":542},"citation_abstract",{"hid":743,"name":743,"content":545},"citation_article_type",{"hid":745,"name":745,"content":746},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/pdf",{"hid":748,"name":748,"content":749},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.637431/xml",{"hid":751,"name":751,"content":752},"citation_fulltext_world_readable","yes",{"hid":754,"name":754,"content":755},"citation_online_date","2021/02/10",{"hid":757,"name":757,"content":758},"citation_publication_date","2021/04/06",{"hid":760,"name":761,"content":762},"citation_author_0","citation_author","Zeng, Bing ",{"hid":764,"name":765,"content":766},"citation_author_institution_0","citation_author_institution","BGI Education Center, University of Chinese Academy of Sciences, China",{"hid":768,"name":761,"content":769},"citation_author_1","Huang, Peide ",{"hid":771,"name":765,"content":772},"citation_author_institution_1","BGI-Shenzhen, China",{"hid":774,"name":761,"content":775},"citation_author_2","Du, Peina ",{"hid":777,"name":765,"content":778},"citation_author_institution_2","BGI Genomics, China",{"hid":780,"name":761,"content":781},"citation_author_3","Sun, Xiaohui ",{"hid":783,"name":765,"content":778},"citation_author_institution_3",{"hid":785,"name":761,"content":786},"citation_author_4","Huang, Xuanlin ",{"hid":788,"name":765,"content":772},"citation_author_institution_4",{"hid":790,"name":761,"content":791},"citation_author_5","Fang, Xiaodong ",{"hid":793,"name":765,"content":766},"citation_author_institution_5",{"hid":795,"name":761,"content":796},"citation_author_6","Li, Lin ",{"hid":798,"name":765,"content":772},"citation_author_institution_6",{"hid":800,"name":800,"content":801},"dc.identifier","doi:10.3389/fonc.2021.637431",[803,806,808,810,812],{"src":804,"body":13,"type":805,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":807,"body":13,"type":805,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":809,"body":13,"type":805,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":811,"body":13,"type":805,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fonc.2021.637431?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":813,"body":13,"type":805,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":815,"articleHubArticlesList":816,"canJournalHasArticleHub":367,"articleDoiList":817},{},[],[],{"title":19,"image":-1,"breadcrumbs":819,"linksCollection":820,"metricsCollection":822},[],{"total":388,"items":821},[],{"total":388,"items":823},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fonc.2021.637431?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>